Id,Country,City,Latitude,Longitude,Population,IdProche,NCTNumber,Disease,Condition,Intervention,Phases,Enrollment,PrincipalInvestigationLocation
1,united states of america,new york,40.7141667,-74.0063889,8107916,1,NCT02369926,Multiple Sclerosis,RRMS,Other,Phase 2,20,Icahn School of Medicine at Mount Sinai
2,italy,sassari,40.727222,8.560278,119187,0,NCT02010398,Multiple Sclerosis,All,Other,Phase 1-Phase 2,45,Department of Biomedical Sciences- University of Sassari
3,italy,sassari,40.727222,8.560278,119187,0,NCT02010398,Multiple Sclerosis,All,Other,Phase 1-Phase 2,45,Department of Clinical and Experimental Medicine - University of Sassari
4,italy,sassari,40.727222,8.560278,119187,0,NCT02010398,Multiple Sclerosis,All,Other,Phase 1-Phase 2,45,Department of Surgery - Microsurgery and Medical-Surgical Specialties
5,united states of america,baltimore,39.2902778,-76.6125,610892,5,NCT02346734,Multiple Sclerosis,All,Device,N/A,170,University of Maryland
6,brazil,sao paulo,-23.473293,-46.665803,10021437,6,NCT02489877,Multiple Sclerosis,All,Other,N/A,84,Faculdade de Ciências Médicas da Santa Casa de São Paulo
7,italy,milan,45.466667,9.2,1156903,7,NCT02364505,Multiple Sclerosis,All,Behavioral,N/A,120,Fondazione Don Carlo Gnocchi Onlus
8,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT01737372,Multiple Sclerosis,All,Other,Phase 1,45,Rocky Mountain MS Clinic
9,finland,turku,60.45,22.283333,175944,0,NCT02403570,Multiple Sclerosis,RRMS,Other,N/A,80,Division of Clinical Neurosciences - Turku University Hospital
10,united states of america,kenmore,47.7575,-122.2427778,19284,73,NCT01711255,Multiple Sclerosis,All,Other,N/A,100,Bastyr University Clinical Research Center
11,germany,rostock,54.083333,12.133333,196833,0,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,University of Rostock - Albrecht-Kossel-Institute for Neuroregeneration
12,germany,aachen,50.770833,6.105278,251104,16,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Universitätsklinikum Aachen - Klink für Neurologie
13,germany,asbach,49.816667,7.283333,171,0,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Kamillusklinik - Abtl. Neurologie
14,germany,berlin,52.516667,13.4,3398362,14,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Berlin Charite - Klinisches und experimentelles Forschungszentrum für Multiple Sklerose
15,germany,berlin,52.516667,13.4,3398362,15,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Jüdisches Krankenhaus Berlin - Abt. Neurologie
16,germany,dusseldorf,51.216667,6.766667,577139,16,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,HHU Düsseldorf - Klinik und Poliklinik für Neurologie
17,germany,essen,51.45,7.016667,576914,17,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Alfried Krupp Krankenhaus Rüttenscheid - Abt. Neurologie
18,germany,giessen,50.583333,8.65,83280,33,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Universitätsklinikum Gießen und Marburg - Neurovaskuläre AG
19,germany,isselburg,51.833333,6.466667,11274,17,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Augustahospital AnholT GmbH - Abt. Neurologie
20,germany,munster,51.966667,7.633333,272452,1655,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Universität Münster - Klinik & Poliklinik für Neurologie
21,germany,trier,49.75,6.633333,100649,0,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Krankenhaus der Bamherzigen Brüder Trier - Neurologische Klinik
22,germany,ulm,48.4,10,120745,768,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Universitätsklinikum Ulm - Klinik für Neurologie
23,germany,wurzburg,49.787778,9.936111,134499,0,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Universitätsklinik Würzburg - Neurologische Klinik
24,france,montpellier,43.61092,3.87723,238887,0,NCT02580669,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,N/A,66,Hopital Gui de Chauliac -Service de Neurologie
25,united kingdom,bristol,51.45,-2.583333,430714,25,NCT01815632,Multiple Sclerosis,Progressive Multiple Sclerosis,Stem Cells,Phase 2,80,University of Bristol & North Bristol NHS Trust
26,united states of america,los angeles,34.0522222,-118.2427778,3877129,26,NCT01466114,Multiple Sclerosis,RRMS,Drug,Phase 2,64,University of California - Los Angeles
27,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT01466114,Multiple Sclerosis,RRMS,Drug,Phase 2,64,The University of Colorado Denver
28,united states of america,albuquerque,35.0844444,-106.6505556,487378,28,NCT01466114,Multiple Sclerosis,RRMS,Drug,Phase 2,64,The University of New Mexico
29,united states of america,philadelphia,39.9522222,-75.1641667,1453268,29,NCT01466114,Multiple Sclerosis,RRMS,Drug,Phase 2,64,The University of Pennsylvania
30,spain,barcelona,41.398371,2.1741,1570378,30,NCT02495766,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,8,Hospital Vall Hebron
31,germany,muenster,51.966667,7.633333,302178,1655,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,University Hospital Muenster
32,germany,bonn,50.733333,7.1,314081,807,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,Neurologisches Studienzentrum Dr. Schmidt/Dr. Neudecker/ Dr. Viehbahn/Dr. Kronenberger
33,germany,frankfurt,50.116667,8.683333,648034,33,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,Neurologische Gemeinschaftspraxis im Bienenkorbhaus
34,germany,heidelberg,49.416667,8.7,144703,33,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,Neurologische Univ.-Klinik
35,germany,mainz,50,8.271111,187940,33,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,Klinik und Poliklinik für Neurologie - Universitätsklinikum Mainz
36,germany,osnabruck,52.266667,8.05,165372,0,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,MVZ-Neurologie Klinikum Osnabrück GmbH
37,denmark,copenhagen,55.666667,12.583333,1089958,37,NCT02760082,Multiple Sclerosis,All,Other,N/A,500,University of Copenhagen
38,united states of america,waltham,42.3763889,-71.2361111,58570,45,NCT02486562,Multiple Sclerosis,All,Behavioral,N/A,20000,Accelerated Cure Project
39,united states of america,san francisco,37.775,-122.4183333,732072,39,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,UCSF Pediatric MS Center
40,united states of america,birmingham,33.5205556,-86.8025,231621,0,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama - Birmingham
41,united states of america,san bernardino,34.1083333,-117.2888889,202381,0,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Children's Hospital - Loma Linda University
42,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Children's Hospital Colorado - University of Colorado School of Medicine
43,united states of america,washington,38.895,-77.0366667,552433,43,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Children's National Medical Center
44,united states of america,chicago,41.85,-87.65,2841952,44,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Ann & Robert H. Lurie Children's Hospital of Chicago
45,united states of america,boston,42.3583333,-71.0602778,571281,45,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Partners Pediatric MS Center at the Massachusetts General Hospital for Children
46,united states of america,boston,42.3583333,-71.0602778,571281,46,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Children's Hospital Boston
47,united states of america,rochester,44.0216667,-92.4697222,96355,0,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Regional Pediatric MS Center at Mayo Clinic
48,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Washington University School of Medicine
49,united states of america,buffalo,42.8863889,-78.8786111,279557,0,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Center of the Jacobs Neurological Institute - University of Buffalo
50,united states of america,stony brook,40.9255556,-73.1413889,13620,1,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Stony Brook National Pediatric MS Center
51,united states of america,cleveland,41.4994444,-81.6955556,449514,51,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,The Cleveland Clinic
52,united states of america,philadelphia,39.9522222,-75.1641667,1453268,52,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Children's Hospital of Philadelphia
53,united states of america,dallas,32.7833333,-96.8,1211704,53,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Center - University of Texas - Southwestern Medical Center
54,united states of america,houston,29.7630556,-95.3630556,2027712,54,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,The Blue Bird Circle Clinic for MS at Texas Children's Hospital
55,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric Neurology Clinic - Primary Children's Hospital
56,italy,ferrara,44.833333,11.583333,131252,0,NCT02421744,Multiple Sclerosis,All,Behavioral,Phase 3,60,Ferrara University Hospital
57,italy,pisa,43.716667,10.383333,83803,0,NCT02421744,Multiple Sclerosis,All,Behavioral,Phase 3,60,Azienda Ospedaliera Universitaria Pisana
58,united states of america,baltimore,39.2902778,-76.6125,610892,58,NCT02538094,Multiple Sclerosis,Progressive Multiple Sclerosis,Device,N/A,50,Johns Hopkins University
59,switzerland,valens,46.966581,9.477047,400,0,NCT02408367,Multiple Sclerosis,All,Behavioral,Phase 1,20,Kliniken-Valens
60,ireland,merrion,53.295,-6.2372222,2386,61,NCT02208050,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 4,80,St Vincent's University Hospital
61,ireland,dublin,53.3330556,-6.2488889,1024027,61,NCT02208050,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 4,80,St. Vincents University Hospital
62,united kingdom,london,51.514125,-0.093689,7421228,62,NCT02490046,Multiple Sclerosis,All,Other,Phase 1,20,The National Hospital for Neurology and Neurosurgery
63,united kingdom,bristol,51.45,-2.583333,430714,63,NCT01932593,Multiple Sclerosis,All,Stem Cells,Phase 1,6,North Bristol NHS Trust
64,france,lille,50.632971,3.058585,189746,0,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Lille Catholic University
65,france,caen,49.197188,-0.326822,115358,0,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hospitalier Universitaire de Caen
66,france,maubeuge,50.278499,3.974426,33017,1012,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hospitalier de Sambre-Avenois
67,france,raimbeaucourt,50.434656,3.093332,4335,0,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hélène Borel
68,france,tourcoing,50.723907,3.161168,93835,0,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hospitalier Dron de Tourcoing
69,france,douai,50.372362,3.088996,43404,0,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hospitalier de Douai
70,france,amiens,49.9,2.3,138816,0,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hospitalier Universitaire d'Amiens
71,united states of america,brookline,42.3316667,-71.1216667,56079,45,NCT02649985,Multiple Sclerosis,All,Drug,Phase 1-Phase 2,50,Brigham and Women's Hospital
72,germany,darmstadt,49.870556,8.649444,139757,33,NCT02064816,Multiple Sclerosis,RRMS,Drug,Phase 4,218,Merck KGaA
73,united states of america,seattle,47.6063889,-122.3308333,569369,73,NCT02106052,Multiple Sclerosis,All,Other,N/A,125,University of Washington
74,switzerland,bern,46.916667,7.466667,123018,0,NCT02440516,Multiple Sclerosis,All,Other,N/A,62,Department of Neurology - University Hospital Bern
75,switzerland,luzern,47.083333,8.266667,57269,0,NCT02440516,Multiple Sclerosis,All,Other,N/A,62,Department of Neurology - Cantonal hospital Luzern
76,italy,ferrara,44.833333,11.583333,131252,0,NCT01883310,Multiple Sclerosis,RRMS,Device,Phase 2,30,Ferrara University Hospital
77,united states of america,columbus,39.9611111,-82.9988889,736836,77,NCT02258217,Multiple Sclerosis,RRMS,Drug,Phase 3,30,The Ohio State University Wexner Medical Center
78,italy,verona,45.45,11,247082,0,NCT02459821,Multiple Sclerosis,All,Other,N/A,40,Azienta Ospedaliera - SSO Rehabilitation Unit - Verona
79,italy,verona,45.45,11,247082,0,NCT02459821,Multiple Sclerosis,All,Other,N/A,40,prof. Smania Nicola
80,united states of america,round rock,30.5080556,-97.6786111,88653,0,NCT02738775,Multiple Sclerosis,RRMS,Biological,Phase 2,40,TG Therapeutics Investigational Trial Site
81,united states of america,phoenix,33.4483333,-112.0733333,1428509,81,NCT02738775,Multiple Sclerosis,RRMS,Biological,Phase 2,40,TG Therapeutics Investigational Trial Site
82,united states of america,fort collins,40.5852778,-105.0838889,129252,286,NCT02738775,Multiple Sclerosis,RRMS,Biological,Phase 2,40,TG Therapeutics Investigational Trial Site
83,united states of america,san antonio,29.4238889,-98.4933333,1256810,83,NCT02738775,Multiple Sclerosis,RRMS,Biological,Phase 2,40,TG Therapeutics Investigational Trial Site
84,france,garches,48.842257,2.182317,18170,158,NCT01871818,Multiple Sclerosis,Progressive Multiple Sclerosis,Behavioral,Phase 3,240,Hôpital RAYMOND POINCARE
85,germany,muenster,51.966667,7.633333,302178,1655,NCT02361697,Multiple Sclerosis,CIS,Other,N/A,15,University Hospital Muenster
86,france,bordeaux,44.840439,-0.5805,219311,0,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de Neurologie - Hôpital Pellegrin - CHU de Bordeaux
87,france,clermont-ferrand,45.779657,3.086281,137364,0,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de neurologie - CHU de Clermont-Ferrand
88,france,dijon,47.316667,5.016667,153692,0,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,CHU de Dijon
89,france,lille,50.632971,3.058585,189746,0,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de Neurologie - CHRU de Lille
90,france,nancy,48.69211,6.187756,106857,0,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de Neurologie - CHU de nancy
91,france,nantes,47.216509,-1.552379,284677,0,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de neurologie - CHU de Nantes
92,france,strasbourg,48.600381,7.787355,273506,0,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de Neurologie - CHU de Strasbourg
93,united states of america,bethesda,38.9805556,-77.1005556,52801,43,NCT02423083,Multiple Sclerosis,RRMS,Drug,Phase 1,12,National Institute of Neurological Disorders and Stroke (NINDS)
94,united states of america,new york,40.7141667,-74.0063889,8107916,94,NCT02549703,Multiple Sclerosis,All,Other,N/A,45,Icahn School of Medicine at Mount Sinai
95,united states of america,portland,45.5236111,-122.675,540513,95,NCT02057159,Multiple Sclerosis,Progressive Multiple Sclerosis,Biological,Phase 2-Phase 3,200,Center Oregon Health & Science University
96,united states of america,portland,45.5236111,-122.675,540513,96,NCT02200718,Multiple Sclerosis,All,Biological,Phase 1,12,Center Oregon Health & Science University
97,france,rennes,48.111981,-1.674291,213334,0,NCT02652013,Multiple Sclerosis,All,Other,N/A,80,Pôle Saint Hélier
98,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT01698086,Multiple Sclerosis,All,Other,N/A,88,University of Colorado Denver
99,united states of america,houston,29.7630556,-95.3630556,2027712,99,NCT02519244,Multiple Sclerosis,All,Device,N/A,10,The University of Texas Health Science Center - Houston
100,united states of america,portland,45.5236111,-122.675,540513,100,NCT02133664,Multiple Sclerosis,All,Drug,Phase 1-Phase 2,53,Center Oregon Health & Science University
101,united states of america,phoenix,33.4483333,-112.0733333,1428509,101,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
102,united states of america,long beach,33.7669444,-118.1883333,482618,102,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
103,united states of america,centennial,39.5791667,-104.8763889,96930,286,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
104,united states of america,stamford,41.0533333,-73.5391667,121230,1,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
105,united states of america,patchogue,40.7655556,-73.0155556,12030,0,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
106,united states of america,charlotte,35.2269444,-80.8433333,598351,106,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
107,united states of america,indian land,35.002492,-80.856553,0,107,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
108,united states of america,knoxville,35.9605556,-83.9208333,172474,0,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
109,united states of america,houston,29.7630556,-95.3630556,2027712,109,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
110,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
111,united states of america,richmond,37.5536111,-77.4605556,190886,0,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
112,united states of america,west orange,40.7986111,-74.2394444,48131,1,NCT02301260,Multiple Sclerosis,All,Behavioral,N/A,100,Kessler Foundation
113,united states of america,new orleans,29.9544444,-90.075,459336,113,NCT02011451,Multiple Sclerosis,RRMS,Drug,Phase 2,48,LSU Health Sciences Center
114,germany,berlin,52.516667,13.4,3398362,114,NCT02740296,Multiple Sclerosis,RRMS,Other,N/A,200,Charité - Universitätsmedizin Berlin
115,united states of america,durham,35.9938889,-78.8988889,204734,0,NCT01776060,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,N/A,100,The Stedman Center on the Duke Center for Living Campus
116,united states of america,concord,35.4086111,-80.5797222,60592,106,NCT01776060,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,N/A,100,NE Neurology
117,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT01776060,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,N/A,100,Raleigh Neurology Associates
118,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02411838,Multiple Sclerosis,RRMS,Other,N/A,16,Washington University School of Medicine
119,united states of america,portland,45.5236111,-122.675,540513,119,NCT01970410,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Providence Multiple Sclerosis Center
120,united states of america,phoenix,33.4483333,-112.0733333,1428509,120,NCT01970410,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Phoenix Neurological Associates - Ltd
121,united states of america,latham,42.7469444,-73.7594444,20736,0,NCT01970410,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Multiple Sclerosis Center of Northeastern New York
122,united states of america,portland,45.5236111,-122.675,540513,122,NCT01909492,Multiple Sclerosis,RRMS,Other,N/A,30,Providence Multiple Sclerosis Center
123,cayman islands,george town,19.3,-81.3833333,27340,0,NCT02326935,Multiple Sclerosis,All,Stem Cells,Phase 1,100,The Da Vinci Center
124,united kingdom,sheffield,53.366667,-1.5,447048,124,NCT02702804,Multiple Sclerosis,All,Other,N/A,12,Sheffield Teaching Hospitals NHS FT
125,united kingdom,sheffield,53.366667,-1.5,447048,125,NCT02702804,Multiple Sclerosis,All,Other,N/A,12,Royal Hallamshire Hospital
126,israel,ramat gan,32.080556,34.814167,126864,1105,NCT02580435,Multiple Sclerosis,All,Other,N/A,520,Sheba Medical Center
127,united states of america,durham,35.9938889,-78.8988889,204734,0,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,The Stedman Center on the Duke Center for Living Campus
128,united states of america,concord,35.4086111,-80.5797222,60592,106,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,Carolinas Medical Center Northeast Medical Arts Building
129,united states of america,concord,35.4086111,-80.5797222,60592,106,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,NorthEast Neurology - Concord
130,united states of america,davidson,35.4991667,-80.8488889,10944,106,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,Ada Jenkins Center
131,united states of america,kannapolis,35.4872222,-80.6219444,38748,106,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,Kannapolis Internal Medicine
132,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,Raleigh Neurology Associates
133,germany,berlin,52.516667,13.4,3398362,133,NCT01371071,Multiple Sclerosis,CIS,Other,Phase 1,200,Department of Neurology - Charité - Universitätsmedizin Berlin
134,germany,berlin,52.516667,13.4,3398362,134,NCT01371071,Multiple Sclerosis,CIS,Other,Phase 1,200,NeuroCure Clinical Research Center - Charité - Universitätsmedizin Berlin
135,united states of america,portland,45.5236111,-122.675,540513,135,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,Providence St. Vincent Medical Center
136,united states of america,cullman,34.1747222,-86.8436111,14796,0,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,North Central Neurology Associates - PC
137,united states of america,medford,42.3266667,-122.8744444,69638,0,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,Providence Medical Group - Medford Neurology
138,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,Rocky Mountain Research Group
139,united states of america,seattle,47.6063889,-122.3308333,569369,139,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,Swedish Medical Center
140,united states of america,tacoma,47.2530556,-122.4430556,196957,73,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,MultiCare Health System -- Institute for Research and Innovation
141,united states of america,lutherville,39.4211111,-76.6263889,6504,5,NCT02633033,Multiple Sclerosis,RRMS,Drug,N/A,260,Mallinckrodt Investigational Site
142,united states of america,bala-cynwyd,40.0075,-75.2344444,9619,29,NCT02633033,Multiple Sclerosis,RRMS,Drug,N/A,260,Mallinckrodt Investigational Site
143,united states of america,knoxville,35.9605556,-83.9208333,172474,0,NCT02633033,Multiple Sclerosis,RRMS,Drug,N/A,260,Mallinckrodt Investigational Site
144,united states of america,west orange,40.7986111,-74.2394444,48131,1,NCT02496416,Multiple Sclerosis,All,Behavioral,N/A,15,Kessler Foundation
145,france,toulouse,43.599516,1.433188,411145,145,NCT02403947,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,12,Purpan Hospital
146,france,rennes,48.111981,-1.674291,213334,0,NCT02117375,Multiple Sclerosis,RRMS,Device,N/A,100,CHU Rennes
147,france,bordeaux,44.840439,-0.5805,219311,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Bordeaux
148,france,caen,49.197188,-0.326822,115358,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Caen
149,france,clermont-ferrand,45.779657,3.086281,137364,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Clermont-Ferrand
150,france,dijon,47.316667,5.016667,153692,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,Hôpital du Bocage
151,france,dunkerque,51.05,2.366667,90995,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CH de Dunkerque
152,france,lille,50.632971,3.058585,189746,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,Centre Hospitalier Saint Vincent de Paul
153,france,lille,50.632971,3.058585,189746,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,Hôpital Roger Salengro
154,france,marseille,43.285413,5.37606,792823,154,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Marseille
155,france,montpellier,43.61092,3.87723,238887,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU Montpellier
156,france,nancy,48.69211,6.187756,106857,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Nancy
157,france,nice,43.713644,7.25952,341621,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Nice
158,france,paris,48.866667,2.333333,2110694,158,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,Hôpital Tenon
159,france,poissy,48.92902,2.049521,35663,158,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,Hôpital de Poissy Saint Germain
160,france,reims,49.25,4.033333,192688,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Reims
161,france,strasbourg,48.600381,7.787355,273506,0,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Strasbourg
162,united states of america,bethesda,38.9805556,-77.1005556,52801,43,NCT01326715,Multiple Sclerosis,All,Drug,Phase 1,30,National Institutes of Health Clinical Center
163,sweden,stockholm,59.333333,18.05,1253309,163,NCT01730547,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,15,Karolinska Institute - Karolinska University Hospital Solna
164,france,nancy,48.69211,6.187756,106857,0,NCT01659593,Multiple Sclerosis,All,Other,Phase 2,140,University hospital Nancy
165,canada,ottawa,45.416667,-75.7,874433,165,NCT01891071,Multiple Sclerosis,All,Other,N/A,35,The Ottawa Hospital
166,canada,greenfield park,45.5,-73.483333,16969,747,NCT01891071,Multiple Sclerosis,All,Other,N/A,35,Hôpital Charles-LeMoyne
167,united states of america,stratford,39.8266667,-75.0158333,7040,29,NCT02227524,Multiple Sclerosis,All,Other,N/A,30,Rowan University School of Osteopathic Medicine
168,united states of america,centennial,39.5791667,-104.8763889,96930,286,NCT02601885,Multiple Sclerosis,All,Drug,Phase 1,60,Site Reference ID/Investigator# 141561
169,united states of america,baltimore,39.2902778,-76.6125,610892,169,NCT02601885,Multiple Sclerosis,All,Drug,Phase 1,60,Site Reference ID/Investigator# 141563
170,united states of america,boulder,40.015,-105.27,91521,286,NCT02152085,Multiple Sclerosis,All,Device,N/A,30,University of Colorado
171,germany,ulm,48.4,10,120745,768,NCT02671682,Multiple Sclerosis,CIS,Other,N/A,60,Department of Neurology - University of Ulm
172,germany,tubingen,48.533333,9.05,83815,768,NCT02686788,Multiple Sclerosis,RRMS,Drug,Phase 2,55,UKT - Universitätsklinikum Tübingen
173,germany,frankfurt,50.116667,8.683333,648034,173,NCT02686788,Multiple Sclerosis,RRMS,Drug,Phase 2,55,Goethe-Universität Frankfurt am Main
174,germany,munster,51.966667,7.633333,272452,1655,NCT02686788,Multiple Sclerosis,RRMS,Drug,Phase 2,55,Universitätsklinikum Münster - Klinik für Allgemeine Neurologie
175,germany,hamburg,53.55,10,1733846,175,NCT02686788,Multiple Sclerosis,RRMS,Drug,Phase 2,55,Universitätsklinikum Hamburg-Eppendorf - Neurologische Poliklinik - Multiple Sklerose Tagesklinik und Ambulanz
176,united states of america,bethesda,38.9805556,-77.1005556,52801,43,NCT02504840,Multiple Sclerosis,CIS,Other,N/A,1300,National Institutes of Health Clinical Center
177,india,pune,18.533333,73.866667,2935968,177,NCT01883661,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,15,Chaitanya Hospital
178,france,lomme,50.643579,2.987148,29084,0,NCT02726672,Multiple Sclerosis,All,Device,N/A,60,Hospital Group of the Catholic Institute of Lille
179,united states of america,lubbock,33.5777778,-101.8547222,211387,0,NCT02418897,Multiple Sclerosis,RRMS,Behavioral,N/A,40,Texas Tech University Health Sciences Center
180,united kingdom,irvine,55.6,-4.666667,32749,499,NCT02264704,Multiple Sclerosis,All,Other,N/A,63,Douglas Grant Rehabilitation Centre - Ayrshire Central Hospital
181,united states of america,birmingham,33.5205556,-86.8025,231621,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
182,united states of america,little rock,34.7463889,-92.2894444,184217,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
183,united states of america,los angeles,34.0522222,-118.2427778,3877129,183,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
184,united states of america,san francisco,37.775,-122.4183333,732072,184,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
185,united states of america,miami,25.7738889,-80.1938889,382894,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
186,united states of america,orlando,28.5380556,-81.3794444,207970,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
187,united states of america,tallahassee,30.4380556,-84.2808333,153583,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
188,united states of america,chicago,41.85,-87.65,2841952,188,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
189,united states of america,boston,42.3583333,-71.0602778,571281,189,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
190,united states of america,boston,42.3583333,-71.0602778,571281,190,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
191,united states of america,detroit,42.3313889,-83.0458333,884941,191,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
192,united states of america,new brunswick,40.4861111,-74.4522222,50633,1,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
193,united states of america,rochester,44.0216667,-92.4697222,96355,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
194,united states of america,stony brook,40.9255556,-73.1413889,13620,1,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
195,united states of america,chapel hill,35.9130556,-79.0561111,47529,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
196,united states of america,philadelphia,39.9522222,-75.1641667,1453268,196,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
197,united states of america,greenville,34.8525,-82.3941667,55559,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
198,united states of america,san antonio,29.4238889,-98.4933333,1256810,198,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
199,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
200,australia,melbourne,-37.813938,144.963425,3730212,200,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
201,austria,vienna,48.2,16.366667,1569315,201,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
202,belarus,minsk,53.9,27.5666667,1742123,202,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
203,brazil,belo horizonte,-19.916667,-43.933333,2373255,203,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
204,brazil,rio de janeiro,-22.9,-43.233333,6023742,204,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
205,brazil,sao paulo,-23.473293,-46.665803,10021437,205,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
206,brazil,goiania,-16.666667,-49.266667,1171209,206,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
207,bulgaria,sofia,42.6833333,23.3166667,1062065,207,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
208,canada,calgary,51.083333,-114.083333,968475,208,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
209,canada,ottawa,45.416667,-75.7,874433,209,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
210,croatia,osijek,45.5511111,18.6938889,88141,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
211,estonia,tallinn,59.4338889,24.7280556,394023,349,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
212,france,bordeaux,44.840439,-0.5805,219311,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
213,france,le kremlin-bicetre,48.814713,2.360728,27194,158,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
214,france,marseille,43.285413,5.37606,792823,214,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
215,france,montpellier,43.61092,3.87723,238887,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
216,france,toulouse,43.599516,1.433188,411145,216,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
217,germany,bochum,51.483333,7.216667,387061,17,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
218,germany,bonn,50.733333,7.1,314081,807,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
219,germany,dresden,51.05,13.75,480801,219,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
220,germany,erlangen,49.589722,11.003889,102781,777,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
221,germany,essen,51.45,7.016667,576914,221,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
222,germany,freiburg,48,7.85,213920,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
223,germany,gottingen,51.533333,9.933333,123570,1516,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
224,germany,hamburg,53.55,10,1733846,224,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
225,germany,munich,48.15,11.5833,1246133,225,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
226,germany,muenster,51.966667,7.633333,302178,1655,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
227,italy,bari,41.133333,16.85,303049,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
228,italy,montichiari,45.416667,10.383333,21041,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
229,italy,catania,37.5,15.1,307331,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
230,italy,milan,45.466667,9.2,1156903,230,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
231,italy,cefalu,38.033333,14.016667,14334,1523,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
232,italy,rome,41.9,12.483333,2643736,232,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
233,italy,gallarate,45.666667,8.783333,48529,7,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
234,italy,naples,40.833333,14.25,981284,234,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
235,latvia,riga,56.95,24.1,742570,235,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
236,lithuania,kaunas,54.9,23.9,374655,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
237,mexico,mexico,19.434167,-99.138611,8720916,237,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
238,mexico,mexico,19.434167,-99.138611,8720916,238,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
239,mexico,mexico,19.434167,-99.138611,8720916,239,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
240,mexico,mexico,19.434167,-99.138611,8720916,240,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
241,netherlands,rotterdam,51.916667,4.5,603851,241,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
242,poland,lodz,51.75,19.466667,715360,242,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
243,poland,lublin,51.25,22.566667,360044,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
244,poland,poznan,52.416667,16.966667,570352,244,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
245,poland,wroclaw,51.1,17.033333,634893,245,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
246,united states of america,santurce,18.1972222,-67.1405556,94067,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
247,romania,bucharest,44.433333,26.1,1877155,247,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
248,russia,moscow,55.752222,37.615556,10381288,248,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
249,russia,kazan,55.78874,49.122144,1104750,249,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
250,russia,moscow,55.752222,37.615556,10381288,250,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
251,russia,novosibirsk,55.0415,82.9346,1419016,251,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
252,russia,saint petersburg,59.894444,30.264167,4039751,252,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
253,serbia,belgrade,44.818611,20.468056,1115200,253,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
254,serbia,kragujevac,44.016667,20.916667,149275,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
255,serbia,novi sad,45.251667,19.836944,194405,253,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
256,slovakia,bratislava,48.15,17.1166667,423737,256,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
257,spain,malaga,36.726666,-4.434802,557875,257,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
258,spain,sevilla,37.382408,-5.976133,686647,258,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
259,spain,barcelona,41.398371,2.1741,1570378,259,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
260,spain,valencia,39.466667,-0.366667,769897,260,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
261,spain,bilboa,43.260919,-2.938764,345141,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
262,spain,madrid,40.408566,-3.69222,3102644,262,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
263,sweden,lund,55.7,13.183333,76263,37,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
264,turkey,ankara,39.911652,32.840305,3519177,264,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
265,turkey,ankara,39.911652,32.840305,3519177,265,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
266,turkey,samsun,41.286667,36.33,394261,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
267,turkey,balcova,38.388578,27.056201,77843,1122,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
268,turkey,istanbul,41.018611,28.964722,9797536,268,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
269,turkey,konak,38.4,27.1,390682,1122,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
270,ukraine,cherkasy,49.428536,32.06207,297566,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
271,ukraine,dnipropetrovsk,48.46298,35.039043,979046,271,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
272,ukraine,kharkiv,49.980814,36.252718,1430885,272,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
273,ukraine,kharkiv,49.980814,36.252718,1430885,273,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
274,ukraine,kiev,50.433333,30.516667,2514227,274,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
275,ukraine,lviv,49.840661,24.030451,729429,275,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
276,ukraine,odessa,46.463934,30.738551,1016515,276,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
277,ukraine,vinnytsya,49.232776,28.480968,352113,0,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
278,united kingdom,west midlands,52.5,-1.966667,2440986,278,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
279,united kingdom,edinburgh,55.95,-3.2,435794,279,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
280,united kingdom,london,51.514125,-0.093689,7421228,280,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
281,united states of america,kenmore,47.7575,-122.2427778,19284,73,NCT01703429,Multiple Sclerosis,All,Other,N/A,1000,Bastyr University Clinical Research Center
282,united states of america,cullman,34.1747222,-86.8436111,14796,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
283,united states of america,berkeley,37.8716667,-122.2716667,100158,39,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
284,united states of america,carlsbad,33.1580556,-117.3497222,91070,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
285,united states of america,pomona,34.0552778,-117.7513889,156183,26,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
286,united states of america,denver,39.7391667,-104.9841667,555981,286,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
287,united states of america,hollywood,26.0108333,-80.1497222,144821,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
288,united states of america,naples,26.1416667,-81.795,21498,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
289,united states of america,ormond beach,29.2855556,-81.0561111,38455,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
290,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
291,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
292,united states of america,northbrook,42.1275,-87.8288889,34322,44,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
293,united states of america,fort wayne,41.1305556,-85.1288889,229715,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
294,united states of america,indianapolis,39.7683333,-86.1580556,773283,294,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
295,united states of america,lenexa,38.9536111,-94.7333333,43331,1051,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
296,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
297,united states of america,albuquerque,35.0844444,-106.6505556,487378,297,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
298,united states of america,charlotte,35.2269444,-80.8433333,598351,298,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
299,united states of america,charlotte,35.2269444,-80.8433333,598351,299,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
300,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
301,united states of america,akron,41.0813889,-81.5191667,208414,51,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
302,united states of america,columbus,39.9611111,-82.9988889,736836,302,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
303,united states of america,dayton,39.7588889,-84.1916667,159134,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
304,united states of america,portland,45.5236111,-122.675,540513,304,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
305,united states of america,franklin,35.925,-86.8688889,49706,704,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
306,united states of america,knoxville,35.9605556,-83.9208333,172474,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
307,united states of america,san antonio,29.4238889,-98.4933333,1256810,307,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
308,united states of america,orem,40.2969444,-111.6938889,93060,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
309,united states of america,richland,46.2858333,-119.2833333,44869,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
310,argentina,buenos aires,-34.5875,-58.6725,3050728,310,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
311,argentina,buenos aires,-34.5875,-58.6725,3050728,311,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
312,argentina,buenos aires,-34.5875,-58.6725,3050728,312,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
313,argentina,godoy cruz,-32.928635,-68.835099,182977,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
314,belarus,grodno,53.6813889,23.8147222,356557,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
315,belarus,minsk,53.9,27.5666667,1742123,315,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
316,belarus,minsk,53.9,27.5666667,1742123,316,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
317,belarus,vitebsk,55.1925,30.1944444,366299,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
318,belarus,vitebsk,55.1925,30.1944444,366299,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
319,bosnia and herzegovina,sarajevo,43.85,18.3833333,696726,319,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
320,bosnia and herzegovina,sarajevo,43.85,18.3833333,696726,320,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
321,bosnia and herzegovina,tuzla,44.5427778,18.6694444,142484,319,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
322,bulgaria,pleven,43.4166667,24.6166667,132542,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
323,bulgaria,plovdiv,42.15,24.75,332088,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
324,bulgaria,sofia,42.6833333,23.3166667,1062065,324,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
325,bulgaria,sofia,42.6833333,23.3166667,1062065,325,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
326,bulgaria,sofia,42.6833333,23.3166667,1062065,326,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
327,bulgaria,sofia,42.6833333,23.3166667,1062065,327,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
328,bulgaria,sofia,42.6833333,23.3166667,1062065,328,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
329,bulgaria,sofia,42.6833333,23.3166667,1062065,329,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
330,bulgaria,varna,43.2166667,27.9166667,307952,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
331,canada,edmonton,53.55,-113.5,822319,331,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
332,canada,victoria,48.433333,-123.35,289625,869,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
333,canada,halifax,44.65,-63.6,266012,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
334,canada,ottawa,45.416667,-75.7,874433,334,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
335,canada,greenfield park,45.5,-73.483333,16969,747,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
336,canada,regina,50.45,-104.616667,176182,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
337,croatia,osijek,45.5511111,18.6938889,88141,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
338,croatia,zagreb,45.8,16,698967,338,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
339,croatia,zagreb,45.8,16,698967,339,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
340,czech republic,brno,49.2,16.633333,377407,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
341,czech republic,brno,49.2,16.633333,377407,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
342,czech republic,hradec kralove,50.207744,15.829455,97427,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
343,czech republic,jihlava,49.4,15.583333,50818,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
344,czech republic,ostrava,49.811852,18.255282,317136,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
345,czech republic,pardubice,50.027778,15.775833,90853,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
346,czech republic,prague,50.083333,14.466667,1154508,346,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
347,czech republic,prague,50.083333,14.466667,1154508,347,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
348,czech republic,teplice,50.646569,13.840138,50972,219,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
349,finland,helsinki,60.175556,24.934167,558457,349,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
350,finland,tampere,61.5,23.75,202688,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
351,finland,turku,60.45,22.283333,175944,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
352,france,bordeaux,44.840439,-0.5805,219311,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
353,france,clermont-ferrand,45.779657,3.086281,137364,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
354,france,montpellier,43.61092,3.87723,238887,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
355,france,nancy,48.69211,6.187756,106857,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
356,france,nantes,47.216509,-1.552379,284677,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
357,france,nice,43.713644,7.25952,341621,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
358,france,strasbourg,48.600381,7.787355,273506,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
359,georgia,tbilisi,41.725,44.7908333,1049516,359,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
360,georgia,tbilisi,41.725,44.7908333,1049516,360,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
361,georgia,tbilisi,41.725,44.7908333,1049516,361,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
362,georgia,tbilisi,41.725,44.7908333,1049516,362,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
363,germany,berlin,52.516667,13.4,3398362,363,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
364,germany,erfurt,50.983333,11.033333,196719,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
365,germany,leipzig,51.3,12.333333,492637,365,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
366,germany,mainz,50,8.271111,187940,33,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
367,germany,ulm,48.4,10,120745,768,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
368,germany,wiesbaden,50.083333,8.25,272337,33,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
369,greece,athens,37.9833333,23.7333333,729139,369,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
370,greece,athens,37.9833333,23.7333333,729139,370,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
371,greece,athens,37.9833333,23.7333333,729139,371,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
372,greece,athens,37.9833333,23.7333333,729139,372,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
373,hungary,budapest,47.5,19.083333,1708088,373,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
374,hungary,budapest,47.5,19.083333,1708088,374,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
375,hungary,esztergom,47.7928,18.741476,28785,373,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
376,hungary,gyor,47.687281,17.637616,129009,256,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
377,hungary,kistarcsa,47.542839,19.263312,9637,373,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
378,hungary,miskolc,48.1,20.783333,179430,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
379,israel,ashkelon,31.669256,34.57149,126819,1105,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
380,israel,haifa,32.815556,34.989167,269961,1105,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
381,israel,jerusalem,31.78,35.23,714685,381,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
382,israel,petah tikwah,32.088611,34.872222,225400,1105,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
383,israel,rishon le zion,31.964167,34.804444,235123,1105,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
384,israel,safed,32.965637,35.500491,30100,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
385,italy,cefalu,38.033333,14.016667,14334,1523,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
386,italy,genova,44.416667,8.95,588688,386,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
387,italy,l'aquila,42.366667,13.366667,70967,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
388,italy,montichiari,45.416667,10.383333,21041,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
389,italy,rome,41.9,12.483333,2643736,389,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
390,italy,rome,41.9,12.483333,2643736,390,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
391,latvia,riga,56.95,24.1,742570,391,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
392,latvia,riga,56.95,24.1,742570,392,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
393,latvia,riga,56.95,24.1,742570,393,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
394,lithuania,kaunas,54.9,23.9,374655,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
395,lithuania,klaipeda,55.7172222,21.1175,192314,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
396,lithuania,siauliai,55.9333333,23.3166667,130594,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
397,mexico,chihuahua,28.633333,-106.083333,708292,397,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
398,mexico,cuauhtemoc,19.417222,-99.156944,531831,398,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
399,mexico,leon,21.116667,-101.666667,1114662,399,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
400,mexico,mexico,19.434167,-99.138611,8720916,400,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
401,mexico,monterrey,25.666667,-100.316667,1122912,401,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
402,poland,bialystok,53.133333,23.15,291855,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
403,poland,bydgoszcz,53.127062,18.019987,366452,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
404,poland,gdansk,54.36085,18.658291,461865,404,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
405,poland,katowice,50.258415,19.027545,317316,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
406,poland,katowice,50.258415,19.027545,317316,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
407,poland,konstancin-jeziorna,52.093277,21.118037,16548,414,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
408,poland,ksawerow,51.692173,19.419126,3000,242,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
409,poland,lublin,51.25,22.566667,360044,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
410,poland,lublin,51.25,22.566667,360044,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
411,poland,poznan,52.416667,16.966667,570352,411,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
412,poland,poznan,52.416667,16.966667,570352,412,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
413,poland,poznan,52.416667,16.966667,570352,413,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
414,poland,warsaw,52.25,21,1651676,414,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
415,poland,wroclaw,51.1,17.033333,634893,415,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
416,portugal,almada,38.679018,-9.156904,34007,2011,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
417,portugal,amadora,38.759711,-9.239708,178856,2011,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
418,portugal,braga,41.550323,-8.420052,121393,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
419,portugal,coimbra,40.205642,-8.419551,106580,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
420,portugal,porto,41.149606,-8.610993,249630,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
421,romania,bucharest,44.433333,26.1,1877155,421,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
422,romania,bucharest,44.433333,26.1,1877155,422,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
423,romania,bucharest,44.433333,26.1,1877155,423,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
424,romania,cluj-napoca,46.766667,23.6,316749,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
425,romania,targu-mures,46.55,24.566667,146864,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
426,romania,timisoara,45.749444,21.227222,315055,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
427,russia,barnaul,53.360556,83.763611,599586,427,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
428,russia,arkhangelsk,64.5401,40.5433,344603,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
429,russia,belgorod,50.610743,36.580152,345293,272,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
430,russia,bryansk,53.252089,34.371666,427241,430,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
431,russia,ekaterinburg,56.8519,60.6122,1428042,431,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
432,russia,kazan,55.78874,49.122144,1104750,432,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
433,russia,kemerovo,55.333333,86.083333,477096,433,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
434,russia,kirov,58.596654,49.660068,457387,434,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
435,russia,krasnoyarsk,56.0091,92.8628,907460,435,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
436,russia,kursk,51.737329,36.187349,409435,436,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
437,russia,moscow,55.752222,37.615556,10381288,437,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
438,russia,moscow,55.752222,37.615556,10381288,438,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
439,russia,moscow,55.752222,37.615556,10381288,439,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
440,russia,moscow,55.752222,37.615556,10381288,440,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
441,russia,nizhniy novgorod,56.326944,44.0075,1284176,441,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
442,russia,nizhniy novgorod,56.326944,44.0075,1284176,442,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
443,russia,novgorod,42.652954,130.797066,218681,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
444,russia,novosibirsk,55.0415,82.9346,1419016,444,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
445,russia,novosibirsk,55.0415,82.9346,1419016,445,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
446,russia,penza,53.200656,45.004643,512607,446,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
447,russia,perm,58.009282,56.284063,982428,447,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
448,russia,pyatigorsk,44.048611,43.059444,142868,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
449,russia,rostov-on-don,47.23135,39.723284,1089261,449,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
450,russia,saint petersburg,59.894444,30.264167,4039751,450,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
451,russia,samara,53.1835,50.1182,1134742,451,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
452,russia,smolensk,54.7818,32.0401,320994,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
453,russia,saint petersburg,59.894444,30.264167,4039751,453,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
454,russia,saint petersburg,59.894444,30.264167,4039751,454,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
455,russia,saint petersburg,59.894444,30.264167,4039751,455,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
456,russia,saint petersburg,59.894444,30.264167,4039751,456,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
457,russia,tomsk,56.494167,84.974167,485523,457,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
458,russia,tver,56.860491,35.876027,400216,458,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
459,russia,yaroslavl,57.61977,39.85536,606735,459,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
460,serbia,belgrade,44.818611,20.468056,1115200,460,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
461,serbia,belgrade,44.818611,20.468056,1115200,461,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
462,serbia,belgrade,44.818611,20.468056,1115200,462,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
463,serbia,kragujevac,44.016667,20.916667,149275,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
464,serbia,nis,43.324722,21.903333,173775,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
465,spain,barcelona,41.398371,2.1741,1570378,465,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
466,spain,barcelona,41.398371,2.1741,1570378,466,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
467,spain,barcelona,41.398371,2.1741,1570378,467,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
468,spain,barcelona,41.398371,2.1741,1570378,468,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
469,spain,girona,41.984444,2.821111,85128,30,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
470,spain,madrid,40.408566,-3.69222,3102644,470,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
471,spain,madrid,40.408566,-3.69222,3102644,471,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
472,spain,majadahonda,40.4717,-3.869451,56060,262,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
473,spain,malaga,36.726666,-4.434802,557875,473,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
474,spain,santa cruz de tenerife,28.460238,-16.280616,193852,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
475,spain,sevilla,37.382408,-5.976133,686647,475,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
476,sweden,goteborg,57.716667,11.966667,515253,476,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
477,sweden,stockholm,59.333333,18.05,1253309,477,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
478,sweden,stockholm,59.333333,18.05,1253309,478,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
479,turkey,istanbul,41.018611,28.964722,9797536,479,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
480,turkey,trabzon,41.005,39.726944,244209,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
481,ukraine,chernihiv,51.505507,31.284875,307683,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
482,ukraine,chernihiv,51.505507,31.284875,307683,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
483,ukraine,ivanofrankivsk,48.921504,24.709716,229447,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
484,ukraine,ivanofrankivsk,48.921504,24.709716,229447,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
485,ukraine,kharkiv,49.980814,36.252718,1430885,485,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
486,ukraine,kharkiv,49.980814,36.252718,1430885,486,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
487,ukraine,kiev,50.433333,30.516667,2514227,487,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
488,ukraine,kiev,50.433333,30.516667,2514227,488,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
489,ukraine,lviv,49.840661,24.030451,729429,489,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
490,ukraine,lviv,49.840661,24.030451,729429,490,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
491,ukraine,odessa,46.463934,30.738551,1016515,491,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
492,ukraine,poltava,49.593727,34.540733,317845,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
493,ukraine,ternopil,49.555887,25.605565,218641,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
494,ukraine,vinnytsya,49.232776,28.480968,352113,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
495,ukraine,zaporizhzhya,47.822892,35.190314,796213,495,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
496,ukraine,zaporizhzhya,47.822892,35.190314,796213,496,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
497,ukraine,zhytomyr,50.264868,28.676691,282190,0,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
498,united kingdom,cardiff,51.5,-3.2,302142,25,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
499,united kingdom,glasgow,55.833333,-4.25,610271,499,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
500,united kingdom,lancashire,53.888996,-2.633778,1461400,500,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
501,united kingdom,salford,53.483333,-2.266667,70905,500,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
502,united kingdom,staffordshire,52.833333,-2,1098300,502,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
503,united states of america,boston,42.3583333,-71.0602778,571281,503,NCT01353547,Multiple Sclerosis,All,Other,N/A,5000,Brigham and Womens Hospital
504,united states of america,cambridge,42.375,-71.1061111,101382,45,NCT01013350,Multiple Sclerosis,All,Drug,Phase 3,1190,Outcome Sciences - Inc
505,united kingdom,glasgow,55.833333,-4.25,610271,505,NCT02737904,Multiple Sclerosis,All,Other,N/A,30,Queen Elizabeth University Hospital
506,united states of america,bethesda,38.9805556,-77.1005556,52801,43,NCT02659956,Multiple Sclerosis,All,Other,N/A,120,National Institutes of Health Clinical Center
507,united states of america,bethesda,38.9805556,-77.1005556,52801,43,NCT00001248,Multiple Sclerosis,All,Other,N/A,920,National Institutes of Health Clinical Center
512,sweden,umea,63.833333,20.25,74005,0,NCT01719159,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,30,Department of neurology - Umeå University Hospital
513,sweden,uppsala,59.85,17.633333,127734,163,NCT01719159,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,30,Dept of neurology - Uppsala University Hospital
514,israel,haifa,32.815556,34.989167,269961,1105,NCT01954823,Multiple Sclerosis,All,Device,N/A,100,Carmel Medical Center
515,united states of america,hartford,41.7636111,-72.6855556,124019,0,NCT02759211,Multiple Sclerosis,All,Other,Phase 1,16,Mandell Center for Multiple Sclerosis at the Mount Sinai Rehabilitation Hospital
516,united states of america,miami,25.7738889,-80.1938889,382894,0,NCT01848327,Multiple Sclerosis,RRMS,Other,Phase 2,158,University of Miami Miller School of Medicine
517,france,lomme,50.643579,2.987148,29084,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Groupe Hospitalier de l'Institut Catholique de Lille
518,france,bordeaux,44.840439,-0.5805,219311,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Bordeaux
519,france,caen,49.197188,-0.326822,115358,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire Caen
520,france,clermont-ferrand,45.779657,3.086281,137364,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Clermont-Ferrand
521,france,dijon,47.316667,5.016667,153692,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Dijon
522,france,lille,50.632971,3.058585,189746,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Régional Universitaire de Lille
523,france,lyon,45.748457,4.846711,463700,523,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Lyon
524,france,marseille,43.285413,5.37606,792823,524,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Hopital de la Timone
525,france,nancy,48.69211,6.187756,106857,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Universitée de Nancy
526,france,nantes,47.216509,-1.552379,284677,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Nantes
527,france,nice,43.713644,7.25952,341621,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Nice
528,france,poissy,48.92902,2.049521,35663,158,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Intercommunal Poissy-St-Germain
529,france,rouen,49.433333,1.083333,108101,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Univetrsitaire de Rouen
530,france,strasbourg,48.600381,7.787355,273506,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Régional Universitaire de Strasbourg
531,france,valenciennes,50.357065,3.527885,42941,0,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier de Valenciennes
532,united states of america,bethesda,38.9805556,-77.1005556,52801,43,NCT01617395,Multiple Sclerosis,All,Other,N/A,2050,National Institutes of Health Clinical Center
533,france,nimes,43.833778,4.359623,137532,0,NCT02636829,Multiple Sclerosis,All,Other,N/A,100,CHRU de Nîmes - Hôpital Universitaire Carémeau
534,united kingdom,london,51.514125,-0.093689,7421228,534,NCT02606630,Multiple Sclerosis,RRMS,Drug,Phase 1,24,Site Reference ID/Investigator# 141463
535,united kingdom,whitechapel,51.516667,-0.05,14862,62,NCT02606630,Multiple Sclerosis,RRMS,Drug,Phase 1,24,Site Reference ID/Investigator# 141461
536,france,rennes,48.111981,-1.674291,213334,0,NCT01065727,Multiple Sclerosis,RRMS,Other,Phase 2,250,CHU Rennes
537,france,brest,48.390756,-4.486165,150554,0,NCT01065727,Multiple Sclerosis,RRMS,Other,Phase 2,250,CHU Cavale Blanche
538,united kingdom,london,51.514125,-0.093689,7421228,538,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,The National hospital for Neurology and Neurosurgery - University College London
539,united kingdom,edinburgh,55.95,-3.2,435794,539,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Anne Rowling Regenerative Neurology Clinic - Royal Infirmary of Edinburgh
540,united kingdom,glasgow,55.833333,-4.25,610271,540,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Gartnavel Royal Hospital - 1055 Great Western Road
541,united kingdom,haywards heath,50.983333,-0.1,29660,62,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Brighton and Sussex University Hospitals
542,united kingdom,leeds,53.8,-1.583333,455124,542,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,St James's University Hospital
543,united kingdom,liverpool,53.416667,-3,468946,543,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,The Walton Centre
544,united kingdom,newcastle,54.988056,-1.619444,289835,0,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,The Royal Victoria Infirmary
545,united kingdom,nottingham,52.966667,-1.166667,246655,124,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Queens Medical Centre
546,united kingdom,oxford,51.75,-1.25,154567,0,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,John Radcliffe Hospital - Oxford University Hospitals NHS Trust
547,united kingdom,plymouth,50.396389,-4.138611,247298,1578,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Derriford Hospital
548,united kingdom,sheffield,53.366667,-1.5,447048,548,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Royal Hallamshire Hospital
549,united kingdom,stoke-on-trent,53,-2.183333,260420,502,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,University Hospital of North Staffordshire
550,united kingdom,truro,50.261667,-5.043333,22044,0,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Royal Cornwall Hospital
551,france,paris,48.866667,2.333333,2110694,551,NCT02424396,Multiple Sclerosis,RRMS,Drug,Phase 2,30,Centre d'investigation Clinique - Pitié salpêtrière
552,france,paris,48.866667,2.333333,2110694,552,NCT02424396,Multiple Sclerosis,RRMS,Drug,Phase 2,30,Centre d'investigation clinique Biothérapie Immunologie (CIC-BTi) - Groupe Hospitalier Pitié-Salpêtrière - AP-HP
553,france,paris,48.866667,2.333333,2110694,553,NCT02424396,Multiple Sclerosis,RRMS,Drug,Phase 2,30,Département des maladies du système nerveux et Centre d'investigation clinique - Groupe Hospitalier Pitié-Salpêtrière - AP-HP
562,united states of america,chicago,41.85,-87.65,2841952,562,NCT00273364,Multiple Sclerosis,CIS,Stem Cells,Phase 3,110,Northwestern University - Feinberg School of Medicine
563,france,nice,43.713644,7.25952,341621,0,NCT01866878,Multiple Sclerosis,All,Device,N/A,30,Hôpital Pasteur
564,united kingdom,glasgow,55.833333,-4.25,610271,564,NCT02136485,Multiple Sclerosis,All,Behavioral,N/A,50,NHS Centre for Integrative Care
565,united states of america,portland,45.5236111,-122.675,540513,565,NCT02583386,Multiple Sclerosis,All,Behavioral,N/A,94,VA Portland Health Care System
566,belgium,yvoir,50.333333,4.883333,8169,1012,NCT02266121,Multiple Sclerosis,RRMS,Device,N/A,100,Department of Neurology - CHU Dinant Godinne UcL Namur
567,chile,santiago,-33.45,-70.666667,4837248,567,NCT02273635,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 1-Phase 2,68,Multiple Sclerosis Centre - Pontificia Universidad Catolica de Chile
568,mexico,guadalajara,20.666667,-103.333333,1640649,568,NCT02769767,Multiple Sclerosis,All,Biological,N/A,500,Instituto Jalisciense de Cancerología
569,switzerland,basel,47.558395,7.573271,164474,0,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,University Hospital Basel
570,switzerland,aarau,47.389616,8.052354,15007,0,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,Cantonal Hospital Aarau
571,switzerland,bern,46.916667,7.466667,123018,0,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,University Hospital Berne
572,switzerland,geneva,46.195602,6.148113,181492,0,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,University Hospital Geneva
573,switzerland,saint gallen,47.42539,9.377615,75310,0,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,Cantonal Hospital St. Gallen
574,switzerland,lugano,46.006182,8.951142,26327,7,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,Regional Hospital Lugano
575,switzerland,lausanne,46.533333,6.666667,118015,0,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,University Hospital Lausanne
576,canada,calgary,51.083333,-114.083333,968475,576,NCT02087631,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,36,MS Clinic - Foothills Medical Centre  
577,united states of america,west orange,40.7986111,-74.2394444,48131,1,NCT02297932,Multiple Sclerosis,All,Behavioral,N/A,20,Kessler Foundation
578,united states of america,ann arbor,42.2708333,-83.7263889,113810,191,NCT02296346,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 1,66,University of Michigan Health Systems
579,iran,tehran,35.7261,51.3304,8846782,579,NCT02463318,Multiple Sclerosis,RRMS,Drug,Phase 2,34,Solaleh Emamgholipour
580,france,bron,45.740218,4.922415,36263,523,NCT02543788,Multiple Sclerosis,All,Other,N/A,60,Unité de Neuro-Ophtalmologie - Hôpital Neurologique - HOSPICES CIVILS DE LYON
581,united states of america,gilbert,33.3527778,-111.7883333,170829,81,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
582,united states of america,long beach,33.7669444,-118.1883333,482618,582,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
583,united states of america,ocala,29.1869444,-82.1402778,49558,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
584,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
585,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
586,united states of america,atlanta,33.7488889,-84.3880556,422908,586,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
587,united states of america,overland park,38.9822222,-94.6705556,166010,1051,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
588,united states of america,baltimore,39.2902778,-76.6125,610892,588,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
589,united states of america,traverse city,44.7630556,-85.6205556,14425,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
590,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
591,united states of america,spartanburg,34.9494444,-81.9322222,37992,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
592,united states of america,san antonio,29.4238889,-98.4933333,1256810,592,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
593,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
594,united states of america,tacoma,47.2530556,-122.4430556,196957,73,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
595,belgium,la louviere,50.466667,4.183333,76668,1012,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
596,bulgaria,pleven,43.4166667,24.6166667,132542,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
597,bulgaria,pleven,43.4166667,24.6166667,132542,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
598,bulgaria,sofia,42.6833333,23.3166667,1062065,598,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
599,bulgaria,sofia,42.6833333,23.3166667,1062065,599,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
600,croatia,vukovar,45.3433333,18.9997222,29584,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
601,croatia,zagreb,45.8,16,698967,601,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
602,lithuania,kaunas,54.9,23.9,374655,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
603,lithuania,klaipeda,55.7172222,21.1175,192314,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
604,lithuania,vilnius,54.6833333,25.3166667,542381,604,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
605,poland,katowice,50.258415,19.027545,317316,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
606,poland,katowice,50.258415,19.027545,317316,0,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
607,united states of america,portland,45.5236111,-122.675,540513,607,NCT02149706,Multiple Sclerosis,Progressive Multiple Sclerosis,Biological,Phase 2,150,OHSU MS Center
608,united states of america,baltimore,39.2902778,-76.6125,610892,608,NCT02253264,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 1,12,The Johns Hopkins Hospital
609,switzerland,lugano,46.006182,8.951142,26327,7,NCT02082002,Multiple Sclerosis,All,Behavioral,N/A,100,Ospedale Regionale di Lugano - Civico
610,united states of america,birmingham,33.5205556,-86.8025,231621,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
611,united states of america,gilbert,33.3527778,-111.7883333,170829,81,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
612,united states of america,phoenix,33.4483333,-112.0733333,1428509,612,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
613,united states of america,phoenix,33.4483333,-112.0733333,1428509,613,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
614,united states of america,phoenix,33.4483333,-112.0733333,1428509,614,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
615,united states of america,tucson,32.2216667,-110.9258333,518907,615,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
616,united states of america,fullerton,33.8702778,-117.9244444,135353,102,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
617,united states of america,loma linda,34.0483333,-117.2602778,20802,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
618,united states of america,newport beach,33.6188889,-117.9280556,78702,102,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
619,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
620,united states of america,denver,39.7391667,-104.9841667,555981,620,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
621,united states of america,danbury,41.3947222,-73.4544444,78565,1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
622,united states of america,dover,39.1580556,-75.5247222,33286,29,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
623,united states of america,newark,39.6836111,-75.75,30238,29,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
624,united states of america,washington,38.895,-77.0366667,552433,624,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
625,united states of america,washington,38.895,-77.0366667,552433,625,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
626,united states of america,lighthouse point,26.2752778,-80.0875,11237,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
627,united states of america,maitland,28.6275,-81.3633333,11686,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
628,united states of america,port charlotte,26.9758333,-82.0908333,49333,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
629,united states of america,sarasota,27.3361111,-82.5308333,53327,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
630,united states of america,saint petersburg,27.7705556,-82.6794444,246316,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
631,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
632,united states of america,atlanta,33.7488889,-84.3880556,422908,632,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
633,united states of america,augusta,33.4708333,-81.975,195844,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
634,united states of america,savannah,32.0833333,-81.1,126119,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
635,united states of america,chicago,41.85,-87.65,2841952,635,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
636,united states of america,chicago,41.85,-87.65,2841952,636,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
637,united states of america,peoria,40.6936111,-89.5888889,113004,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
638,united states of america,winfield,41.8616667,-88.1608333,9802,44,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
639,united states of america,elkhart,41.6819444,-85.9766667,51400,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
640,united states of america,des moines,41.6005556,-93.6088889,193180,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
641,united states of america,des moines,41.6005556,-93.6088889,193180,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
642,united states of america,lenexa,38.9536111,-94.7333333,43331,1051,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
643,united states of america,henderson,37.8361111,-87.59,27495,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
644,united states of america,louisville,38.2541667,-85.7594444,243639,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
645,united states of america,hammond,30.5041667,-90.4611111,17812,113,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
646,united states of america,new orleans,29.9544444,-90.075,459336,646,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
647,united states of america,rockport,44.1844444,-69.0766667,1318,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
648,united states of america,baltimore,39.2902778,-76.6125,610892,648,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
649,united states of america,baltimore,39.2902778,-76.6125,610892,649,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
650,united states of america,glen burnie,39.1625,-76.625,40317,5,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
651,united states of america,hagerstown,39.6416667,-77.7202778,37313,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
652,united states of america,rockville,39.0838889,-77.1530556,60646,43,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
653,united states of america,boston,42.3583333,-71.0602778,571281,653,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
654,united states of america,boston,42.3583333,-71.0602778,571281,654,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
655,united states of america,foxboro,42.0583333,-71.25,16693,45,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
656,united states of america,lexington,42.4472222,-71.225,30661,45,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
657,united states of america,worcester,42.2625,-71.8027778,177216,45,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
658,united states of america,detroit,42.3313889,-83.0458333,884941,658,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
659,united states of america,east lansing,42.7369444,-84.4838889,48371,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
660,united states of america,edina,44.8897222,-93.3497222,45945,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
661,united states of america,golden valley,45.0097222,-93.3488889,20325,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
662,united states of america,ocean springs,30.4111111,-88.8277778,17659,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
663,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
664,united states of america,lincoln,40.8,-96.6666667,242072,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
665,united states of america,lincoln,40.8,-96.6666667,242072,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
666,united states of america,las vegas,36.175,-115.1363889,540111,666,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
667,united states of america,flemington,40.5122222,-74.8597222,4581,29,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
668,united states of america,livingston,40.7958333,-74.3152778,27853,1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
669,united states of america,new brunswick,40.4861111,-74.4522222,50633,1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
670,united states of america,newark,40.7355556,-74.1727778,280123,1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
671,united states of america,stratford,39.8266667,-75.0158333,7040,29,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
672,united states of america,toms river,39.9536111,-74.1983333,119088,1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
673,united states of america,cedarhurst,40.6227778,-73.7247222,6592,1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
674,united states of america,east meadow,40.7138889,-73.5594444,37427,1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
675,united states of america,kingston,41.9269444,-73.9977778,23174,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
676,united states of america,new york,40.7141667,-74.0063889,8107916,676,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
677,united states of america,new york,40.7141667,-74.0063889,8107916,677,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
678,united states of america,patchogue,40.7655556,-73.0155556,12030,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
679,united states of america,plainview,40.7763889,-73.4677778,25174,1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
680,united states of america,syracuse,43.0480556,-76.1477778,141830,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
681,united states of america,asheville,35.6008333,-82.5541667,68795,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
682,united states of america,greensboro,36.0725,-79.7922222,231769,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
683,united states of america,pinehurst,35.1952778,-79.4697222,11523,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
684,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
685,united states of america,bismarck,46.8083333,-100.7833333,56706,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
686,united states of america,canton,40.7988889,-81.3786111,78160,51,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
687,united states of america,cleveland,41.4994444,-81.6955556,449514,687,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
688,united states of america,oklahoma city,35.4675,-97.5161111,532950,688,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
689,united states of america,oklahoma city,35.4675,-97.5161111,532950,689,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
690,united states of america,tulsa,36.1538889,-95.9925,382005,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
691,united states of america,portland,45.5236111,-122.675,540513,691,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
692,united states of america,portland,45.5236111,-122.675,540513,692,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
693,united states of america,allentown,40.6083333,-75.4905556,105519,29,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
694,united states of america,meadowbrook,40.1125,-75.0786111,18571,29,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
695,united states of america,monroeville,40.4211111,-79.7883333,28386,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
696,united states of america,philadelphia,39.9522222,-75.1641667,1453268,696,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
697,united states of america,pittsburgh,40.4405556,-79.9961111,319494,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
698,united states of america,tarentum,40.6013889,-79.76,4530,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
699,united states of america,willow grove,40.1438889,-75.1161111,16129,29,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
700,united states of america,columbia,34.0005556,-81.035,117722,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
701,united states of america,spartanburg,34.9494444,-81.9322222,37992,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
702,united states of america,knoxville,35.9605556,-83.9208333,172474,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
703,united states of america,knoxville,35.9605556,-83.9208333,172474,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
704,united states of america,nashville,36.1658333,-86.7844444,530852,704,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
705,united states of america,colleyville,32.8808333,-97.1547222,22325,53,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
706,united states of america,norfolk,36.8466667,-76.2855556,246216,1285,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
707,united states of america,norfolk,36.8466667,-76.2855556,246216,1285,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
708,united states of america,richmond,37.5536111,-77.4605556,190886,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
709,united states of america,kirkland,47.6816667,-122.2075,45778,73,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
710,united states of america,seattle,47.6063889,-122.3308333,569369,710,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
711,united states of america,tacoma,47.2530556,-122.4430556,196957,73,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
712,united states of america,green bay,44.5191667,-88.0197222,101012,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
713,united states of america,green bay,44.5191667,-88.0197222,101012,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
714,united states of america,green bay,44.5191667,-88.0197222,101012,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
715,united states of america,madison,43.0730556,-89.4011111,224625,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
716,united states of america,milwaukee,43.0388889,-87.9063889,579180,716,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
717,united states of america,milwaukee,43.0388889,-87.9063889,579180,717,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
718,united states of america,neenah,44.1858333,-88.4625,24810,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
719,australia,camperdown,-33.9,151.183333,7866,723,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
720,australia,concord,-33.866667,151.1,14150,723,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
721,australia,kogarah,-33.983333,151.116667,10984,723,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
722,australia,liverpool,-33.9,150.933333,24095,723,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
723,australia,sydney,-33.861481,151.205475,4394585,723,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
724,australia,new lambton,-32.933333,151.716667,9236,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
725,australia,randwick,-33.916667,151.241667,27740,723,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
726,australia,westmead,-33.816667,150.983333,14171,723,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
727,australia,brisbane,-27.47101,153.024292,1843459,727,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
728,australia,gold coast,-28.00029,153.430878,501175,728,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
729,australia,bedford park,-35.033333,138.566667,1837,730,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
730,australia,adelaide,-34.928661,138.598633,1074168,730,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
731,australia,box hill,-37.816667,145.133333,1173,200,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
732,australia,clayton,-37.916667,145.116667,15543,200,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
733,australia,geelong,-38.153461,144.358093,150438,200,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
734,australia,heidelberg,-37.75,145.066667,5714,200,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
735,australia,melbourne,-37.813938,144.963425,3730212,735,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
736,australia,melbourne,-37.813938,144.963425,3730212,736,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
737,australia,nedlands,-31.983333,115.808333,10184,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
738,canada,victoria,48.433333,-123.35,289625,869,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
739,canada,halifax,44.65,-63.6,266012,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
740,canada,sydney,46.15,-60.166667,32660,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
741,canada,cambridge,43.383333,-80.316667,126748,1220,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
742,canada,london,42.983333,-81.25,346774,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
743,canada,milton,43.516667,-79.883333,23472,1900,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
744,canada,scarborough,43.75,-79.2,625698,744,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
745,canada,thunder bay,48.4,-89.233333,99336,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
746,canada,gatineau,45.483333,-75.65,265349,165,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
747,canada,montreal,45.5,-73.583333,3268513,747,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
748,canada,regina,50.45,-104.616667,176182,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
749,czech republic,brno,49.2,16.633333,377407,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
750,czech republic,hradec kralove,50.207744,15.829455,97427,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
751,czech republic,jihlava,49.4,15.583333,50818,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
752,czech republic,olomouc,49.59404,17.25119,102792,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
753,czech republic,pardubice,50.027778,15.775833,90853,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
754,czech republic,prague,50.083333,14.466667,1154508,754,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
755,czech republic,teplice,50.646569,13.840138,50972,219,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
756,denmark,aarhus,56.153423,10.22553,264716,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
757,denmark,glostrup,55.666597,12.403768,22357,37,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
758,denmark,odense,55.393475,10.394935,145931,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
759,denmark,sonderborg,54.910634,9.792843,27033,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
760,germany,freiburg,48,7.85,213920,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
761,germany,heidelberg,49.416667,8.7,144703,33,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
762,germany,heidenheim,48.683333,10.15,50684,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
763,germany,ladenburg,49.475,8.606944,11621,33,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
764,germany,mannheim,49.488333,8.464722,309626,33,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
765,germany,ravensburg,47.783333,9.616667,48441,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
766,germany,singen,47.766667,8.833333,46386,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
767,germany,sinsheim,49.255278,8.877222,35740,768,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
768,germany,stuttgart,48.766667,9.183333,591688,768,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
769,germany,stuttgart,48.766667,9.183333,591688,769,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
770,germany,ulm,48.4,10,120745,768,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
771,germany,bogen,48.916667,12.683333,10458,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
772,germany,erlangen,49.589722,11.003889,102781,777,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
773,germany,landshut,48.533333,12.15,61131,225,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
774,germany,munich,48.15,11.5833,1246133,774,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
775,germany,neuburg,49.346667,12.384444,8099,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
776,germany,neusass,48.4,10.833333,21433,225,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
777,germany,nurnberg,49.447778,11.068333,501072,777,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
778,germany,nurnberg,49.447778,11.068333,501072,778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
779,germany,regensburg,49.015,12.095556,142292,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
780,germany,unterhaching,48.05,11.633333,20751,225,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
781,germany,wolfratshausen,47.916667,11.416667,17190,225,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
782,germany,wurzburg,49.787778,9.936111,134499,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
783,germany,butzbach,50.433333,8.683333,25804,33,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
784,germany,eltville,50.033333,8.116667,16858,33,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
785,germany,erbach,49.656111,8.996389,13501,33,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
786,germany,eschwege,51.183333,10.066667,21546,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
787,germany,frankfurt,50.116667,8.683333,648034,787,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
788,germany,frankfurt,50.116667,8.683333,648034,788,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
789,germany,frankfurt,50.116667,8.683333,648034,789,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
790,germany,gelnhausen,50.2,9.183333,21417,33,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
791,germany,gladenbach,50.766667,8.566667,12613,33,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
792,germany,kassel,51.316667,9.5,193117,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
793,germany,wiesbaden,50.083333,8.25,272337,33,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
794,germany,buchholz,53.416667,9.433333,37876,175,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
795,germany,gottingen,51.533333,9.933333,123570,1516,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
796,germany,oldenburg,53.166667,8.2,160347,1644,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
797,germany,aachen,50.770833,6.105278,251104,16,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
798,germany,aachen,50.770833,6.105278,251104,16,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
799,germany,honnef,50.633333,7.233333,25078,807,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
800,germany,bergisch gladbach,50.983333,7.133333,106611,807,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
801,germany,bielefeld,52.033333,8.533333,327198,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
802,germany,bochum,51.483333,7.216667,387061,17,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
803,germany,bonn,50.733333,7.1,314081,807,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
804,germany,dusseldorf,51.216667,6.766667,577139,804,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
805,germany,essen,51.45,7.016667,576914,805,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
806,germany,hagen,51.35,7.466667,199497,1655,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
807,germany,koln,50.933333,6.95,1046680,807,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
808,germany,koln,50.933333,6.95,1046680,808,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
809,germany,siegen,50.866667,8.033333,108228,1655,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
810,germany,willich,51.266667,6.55,52100,16,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
811,germany,wuppertal,51.266667,7.183333,363240,17,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
812,germany,kandel,49.089167,8.184167,8773,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
813,germany,katzenelnbogen,50.283333,7.95,2161,33,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
814,germany,trier,49.75,6.633333,100649,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
815,germany,halle,51.5,12,232452,365,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
816,germany,magdeburg,52.166667,11.666667,224428,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
817,germany,chemnitz,50.833333,12.916667,246654,365,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
818,germany,goerlitz,51.166667,15,54193,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
819,germany,leipzig,51.3,12.333333,492637,819,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
820,germany,wermsdorf,51.283333,12.95,5296,365,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
821,germany,kiel,54.333333,10.133333,235264,175,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
822,germany,eisenach,50.983333,10.316667,44399,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
823,germany,jena,50.933333,11.583333,99269,365,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
824,germany,berlin,52.516667,13.4,3398362,824,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
825,germany,berlin,52.516667,13.4,3398362,825,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
826,germany,berlin,52.516667,13.4,3398362,826,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
827,germany,berlin,52.516667,13.4,3398362,827,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
828,germany,berlin,52.516667,13.4,3398362,828,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
829,germany,hamburg,53.55,10,1733846,829,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
830,hungary,budapest,47.5,19.083333,1708088,830,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
831,hungary,budapest,47.5,19.083333,1708088,831,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
832,hungary,eger,47.9,20.383333,56302,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
833,hungary,esztergom,47.7928,18.741476,28785,373,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
834,netherlands,amsterdam,52.35,4.916667,745811,834,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
835,netherlands,breda,51.566667,4.8,168934,241,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
836,netherlands,eindhoven,51.45,5.466667,210498,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
837,netherlands,leeuwarden,53.20139,5.808588,92494,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
838,netherlands,leiden,52.176281,4.528154,116928,241,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
839,netherlands,geleen,50.965741,5.834752,33960,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
840,netherlands,tilburg,51.576922,5.106331,206858,241,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
841,netherlands,venray,51.524517,5.975006,40518,16,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
842,norway,bodo,67.283333,14.383333,33811,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
843,norway,namsos,64.483333,11.5,8946,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
844,united states of america,guaynabo,18.3594444,-66.1113889,81363,845,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
845,united states of america,san juan,18.4683333,-66.1061111,418140,845,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
846,slovakia,banska bystrica,48.7333333,19.15,82336,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
847,slovakia,nitra,48.3166667,18.0833333,86329,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
848,slovakia,ruzomberok,49.0833333,19.3166667,30806,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
849,united kingdom,bristol,51.45,-2.583333,430714,849,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
850,united kingdom,portadown,54.433333,-6.45,21617,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
851,united kingdom,exeter,50.7,-3.533333,113119,1578,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
852,united kingdom,plymouth,50.396389,-4.138611,247298,1578,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
853,united kingdom,torquay,50.45,-3.5,65389,1578,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
854,united kingdom,salford,53.483333,-2.266667,70905,500,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
855,united kingdom,basingstoke,51.266667,-1.083333,96349,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
856,united kingdom,leicester,52.633333,-1.133333,339240,864,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
857,united kingdom,edinburgh,55.95,-3.2,435794,857,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
858,united kingdom,liverpool,53.416667,-3,468946,858,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
859,united kingdom,norwich,52.633333,1.3,177636,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
860,united kingdom,nottingham,52.966667,-1.166667,246655,124,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
861,united kingdom,glasgow,55.833333,-4.25,610271,861,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
862,united kingdom,dundee,56.5,-2.966667,151593,279,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
863,united kingdom,newcastle,54.988056,-1.619444,289835,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
864,united kingdom,birmingham,52.466667,-1.916667,984336,864,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
865,united kingdom,leeds,53.8,-1.583333,455124,865,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
866,united kingdom,swansea,51.633333,-3.966667,170885,0,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
867,united states of america,cleveland,41.4994444,-81.6955556,449514,867,NCT01572714,Multiple Sclerosis,All,Behavioral,Phase 1,215,Case Western Reserve University
868,belgium,diepenbeek,50.9,5.4,17699,0,NCT02339675,Multiple Sclerosis,All,Other,N/A,300,Hasselt University
869,canada,vancouver,49.25,-123.133333,1837970,869,NCT01118130,Multiple Sclerosis,RRMS,Other,N/A,300,MS Clinic UBC Hospital
870,canada,halifax,44.65,-63.6,266012,0,NCT01118130,Multiple Sclerosis,RRMS,Other,N/A,300,Dalhousie MS Research Unit
871,canada,london,42.983333,-81.25,346774,0,NCT01118130,Multiple Sclerosis,RRMS,Other,N/A,300,London Health Sciences Centre MS clinic  
872,canada,montreal,45.5,-73.583333,3268513,872,NCT01118130,Multiple Sclerosis,RRMS,Other,N/A,300,Hôpital Notre-Dame MS clinic
873,canada,gatineau,45.483333,-75.65,265349,165,NCT02383550,Multiple Sclerosis,All,Other,Phase 4,47,Clinique Neuro-Outaouais
874,canada,montreal,45.5,-73.583333,3268513,874,NCT02137707,Multiple Sclerosis,RRMS,Drug,Phase 4,400,Montreal Neurological Institute
875,canada,edmonton,53.55,-113.5,822319,875,NCT02137707,Multiple Sclerosis,RRMS,Drug,Phase 4,400,University of Alberta
876,canada,vancouver,49.25,-123.133333,1837970,876,NCT02137707,Multiple Sclerosis,RRMS,Drug,Phase 4,400,University of British Columbia
877,canada,ottawa,45.416667,-75.7,874433,877,NCT02137707,Multiple Sclerosis,RRMS,Drug,Phase 4,400,Ottawa General Hospital
878,united states of america,west orange,40.7986111,-74.2394444,48131,1,NCT02301247,Multiple Sclerosis,All,Behavioral,N/A,48,Kessler Foundation
879,united states of america,kirkland,47.6816667,-122.2075,45778,73,NCT02086188,Multiple Sclerosis,All,Drug,Phase 4,40,EvergreenHealth MS Center
880,denmark,aarhus,56.153423,10.22553,264716,0,NCT02661555,Multiple Sclerosis,All,Other,N/A,85,Sport Science - Department of Public Health - Aarhus University
881,france,lille,50.632971,3.058585,189746,0,NCT02468765,Multiple Sclerosis,RRMS,Other,N/A,90,Hôpital Saint Vincent de Paul (GHICL)
882,united states of america,maitland,28.6275,-81.3633333,11686,0,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
883,united states of america,reston,38.9686111,-77.3413889,61076,43,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
884,australia,box hill,-37.816667,145.133333,1173,200,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
885,germany,bochum,51.483333,7.216667,387061,17,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
886,ireland,dublin,53.3330556,-6.2488889,1024027,886,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
887,italy,firenze,43.766667,11.25,382808,0,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
888,spain,malaga,36.726666,-4.434802,557875,888,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
889,united kingdom,salford,53.483333,-2.266667,70905,500,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
890,germany,berlin,52.516667,13.4,3398362,890,NCT01790269,Multiple Sclerosis,RRMS,Other,Phase 1,40,Charité Universitätsmedizin Berlin
891,united states of america,portland,45.5236111,-122.675,540513,891,NCT02424825,Multiple Sclerosis,All,Behavioral,N/A,15,Oregon Health & Science University Multiple Sclerosis Center
892,belgium,hasselt,50.933333,5.333333,69222,0,NCT02466165,Multiple Sclerosis,All,Behavioral,N/A,100,Jessa hospital
893,belgium,diepenbeek,50.9,5.4,17699,0,NCT02466165,Multiple Sclerosis,All,Behavioral,N/A,100,REVAL
894,united states of america,baltimore,39.2902778,-76.6125,610892,894,NCT02647502,Multiple Sclerosis,RRMS,Other,Phase 1,36,Johns Hopkins University
895,united states of america,west orange,40.7986111,-74.2394444,48131,1,NCT02081508,Multiple Sclerosis,All,Behavioral,N/A,72,Kessler Foundation
896,united kingdom,edinburgh,55.95,-3.2,435794,896,NCT02508961,Multiple Sclerosis,All,Behavioral,N/A,90,Anne Rowling Regenerative Neurology Clinic
897,united kingdom,irvine,55.6,-4.666667,32749,499,NCT02508961,Multiple Sclerosis,All,Behavioral,N/A,90,Douglas Grant Rehabilitation Centre
898,united kingdom,plymouth,50.396389,-4.138611,247298,1578,NCT02508961,Multiple Sclerosis,All,Behavioral,N/A,90,University of Plymouth
899,israel,jerusalem,31.78,35.23,714685,899,NCT02166021,Multiple Sclerosis,Progressive Multiple Sclerosis,Stem Cells,Phase 2,36,Hadassah Medical Center
900,france,nice,43.713644,7.25952,341621,0,NCT02587195,Multiple Sclerosis,All,Drug,Phase 3,11,CHU de Nice
901,france,besancon,47.248778,6.018152,120139,0,NCT02587195,Multiple Sclerosis,All,Drug,Phase 3,11,CHU de Besançon
902,france,lille,50.632971,3.058585,189746,0,NCT02587195,Multiple Sclerosis,All,Drug,Phase 3,11,CHU de Lille
903,france,montpellier,43.61092,3.87723,238887,0,NCT02587195,Multiple Sclerosis,All,Drug,Phase 3,11,CHU de Montpellier
904,france,strasbourg,48.600381,7.787355,273506,0,NCT02587195,Multiple Sclerosis,All,Drug,Phase 3,11,CHU de Strasbourg
905,canada,calgary,51.083333,-114.083333,968475,905,NCT02308137,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,62,Calgary MS Clinic at Foothills Medical Centre
906,united kingdom,london,51.514125,-0.093689,7421228,906,NCT02104661,Multiple Sclerosis,All,Drug,Phase 2,60,Barts Health NHS Trust
907,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT02588053,Multiple Sclerosis,RRMS,Drug,Phase 4,146,University of Colorado Anschutz
908,italy,ciserano,45.583333,9.6,5270,7,NCT02291107,Multiple Sclerosis,All,Device,N/A,17,HABILITA
909,spain,cordoba,37.89155,-4.772748,311186,0,NCT01745783,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,30,University Hospital Reina Sofia
910,spain,malaga,36.726666,-4.434802,557875,910,NCT01745783,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,30,University Regional Hospital Carlos Haya
911,spain,sevilla,37.382408,-5.976133,686647,911,NCT01745783,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,30,University Hospital Virgen Macarena
912,united states of america,urbana,40.1105556,-88.2072222,39511,0,NCT02274935,Multiple Sclerosis,All,Other,N/A,30,Motor control research lab
913,united states of america,baltimore,39.2902778,-76.6125,610892,913,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Johns Hopkins University School of Medicine
914,united states of america,san francisco,37.775,-122.4183333,732072,914,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,University of California - San Francisco
915,united states of america,stanford,37.4241667,-122.165,12574,39,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Stanford University
916,united states of america,new haven,41.3080556,-72.9286111,124922,0,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Yale University
917,united states of america,annapolis,38.9783333,-76.4925,36252,5,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Anne Arundel Health System Research Institute
918,united states of america,worcester,42.2625,-71.8027778,177216,45,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,University of Massachusetts
919,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Washington University St. Louis
920,united states of america,new york,40.7141667,-74.0063889,8107916,920,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Mount Sinai School of Medicine
921,united states of america,new york,40.7141667,-74.0063889,8107916,921,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Columbia University
922,united states of america,rochester,44.0216667,-92.4697222,96355,0,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,University of Rochester
923,united states of america,cleveland,41.4994444,-81.6955556,449514,923,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Cleveland Clinic
924,united states of america,portland,45.5236111,-122.675,540513,924,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Oregon Health Sciences University
925,united states of america,philadelphia,39.9522222,-75.1641667,1453268,925,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,University of Pennsylvania
926,united states of america,charlottesville,38.0291667,-78.4769444,34703,0,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,University of Virginia
927,united states of america,seattle,47.6063889,-122.3308333,569369,927,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Swedish Medical Center
928,germany,rostock,54.083333,12.133333,196833,0,NCT02275741,Multiple Sclerosis,RRMS,Biological,Phase 2,400,University of Rostock
929,germany,berlin,52.516667,13.4,3398362,929,NCT02509897,Multiple Sclerosis,RRMS,Other,N/A,48,Experimental & Clinical Research Center
930,united states of america,chicago,41.85,-87.65,2841952,930,NCT01824550,Multiple Sclerosis,All,Other,N/A,54,University of Illinois at Chicago
931,united states of america,new york,40.7141667,-74.0063889,8107916,931,NCT02746705,Multiple Sclerosis,All,Device,Phase 3,60,New York University Langone Medical Center
932,belgium,diepenbeek,50.9,5.4,17699,0,NCT02339688,Multiple Sclerosis,All,Other,N/A,300,Hasselt University
933,united states of america,long beach,33.7669444,-118.1883333,482618,933,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #12
934,united states of america,sacramento,38.5816667,-121.4933333,467898,934,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #3
935,united states of america,san francisco,37.775,-122.4183333,732072,935,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #7
936,united states of america,stanford,37.4241667,-122.165,12574,39,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #15
937,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #11
938,united states of america,centennial,39.5791667,-104.8763889,96930,286,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #16
939,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #14
940,united states of america,teaneck,40.8975,-74.0163889,40078,1,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #19
941,united states of america,rochester,44.0216667,-92.4697222,96355,0,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #10
942,united states of america,dallas,32.7833333,-96.8,1211704,942,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #18
943,united states of america,seattle,47.6063889,-122.3308333,569369,943,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #2
944,united states of america,seattle,47.6063889,-122.3308333,569369,944,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #6
945,australia,east gosford,-33.433333,151.35,3514,723,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
946,australia,kanwal,-33.266667,151.483333,3873,723,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
947,australia,liverpool,-33.9,150.933333,24095,723,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
948,australia,new lambton,-32.933333,151.716667,9236,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
949,australia,sydney,-33.861481,151.205475,4394585,949,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
950,australia,brisbane,-27.47101,153.024292,1843459,950,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
951,australia,adelaide,-34.928661,138.598633,1074168,951,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
952,australia,box hill,-37.816667,145.133333,1173,200,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
953,australia,fitzroy,-37.783333,144.983333,9430,200,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
954,australia,fitzroy,-37.783333,144.983333,9430,200,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
955,australia,melbourne,-37.813938,144.963425,3730212,955,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
956,australia,melbourne,-37.813938,144.963425,3730212,956,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
957,australia,nedlands,-31.983333,115.808333,10184,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
958,australia,bedford park,-35.033333,138.566667,1837,730,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
959,australia,brisbane,-27.47101,153.024292,1843459,959,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
960,australia,geelong,-38.153461,144.358093,150438,200,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
961,spain,ferrol,43.483213,-8.236893,78689,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
962,spain,cordoba,37.89155,-4.772748,311186,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
963,spain,granada,37.178354,-3.599201,248942,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
964,spain,malaga,36.726666,-4.434802,557875,964,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
965,spain,sevilla,37.382408,-5.976133,686647,965,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
966,spain,sevilla,37.382408,-5.976133,686647,966,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
967,spain,oviedo,43.363223,-5.853128,198250,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
968,spain,santander,43.464722,-3.804444,185209,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
969,spain,albacete,38.995845,-1.857773,155083,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
970,spain,valladolid,41.655181,-4.72372,315859,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
971,spain,leon,42.600031,-5.570316,127480,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
972,spain,badalona,41.447145,2.244789,222413,30,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
973,spain,barcelona,41.398371,2.1741,1570378,973,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
974,spain,barcelona,41.398371,2.1741,1570378,974,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
975,spain,tarragona,41.116667,1.25,128391,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
976,spain,valencia,39.466667,-0.366667,769897,976,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
977,spain,valencia,39.466667,-0.366667,769897,977,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
978,spain,valencia,39.466667,-0.366667,769897,978,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
979,spain,la coruna,43.366609,-8.406812,246056,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
980,spain,palma de mallorca,39.574337,2.655222,401270,980,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
981,spain,las palmas de gran canaria,28.099727,-15.41343,383308,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
982,spain,pamplona,42.814075,-1.641153,191549,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
983,spain,bilboa,43.260919,-2.938764,345141,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
984,spain,bilboa,43.260919,-2.938764,349270,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
985,spain,barcelona,41.398371,2.1741,1570378,985,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
986,spain,las palmas de gran canaria,28.099727,-15.41343,383308,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
987,spain,madrid,40.408566,-3.69222,3102644,987,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
988,spain,madrid,40.408566,-3.69222,3102644,988,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
989,spain,madrid,40.408566,-3.69222,3102644,989,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
990,spain,madrid,40.408566,-3.69222,3102644,990,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
991,spain,madrid,40.408566,-3.69222,3102644,991,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
992,spain,santa cruz de tenerife,28.460238,-16.280616,193852,0,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
993,united states of america,baltimore,39.2902778,-76.6125,610892,993,NCT01647321,Multiple Sclerosis,Progressive Multiple Sclerosis,Behavioral,Phase 1,20,Kennedy Krieger Institute / Johns Hopkins
994,united states of america,san bernardino,34.1083333,-117.2888889,202381,0,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
995,belgium,ghent,51.05,3.716667,257029,1012,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
996,bulgaria,sofia,42.6833333,23.3166667,1062065,996,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
997,czech republic,hradec kralove,50.207744,15.829455,97427,0,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
998,germany,munich,48.15,11.5833,1246133,998,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
999,germany,gottingen,51.533333,9.933333,123570,1516,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1000,kuwait,kuwait,29.369722,47.978333,4187161,1000,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1001,latvia,riga,56.95,24.1,742570,1001,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1002,lebanon,beirut,33.8719444,35.5097222,1252010,1002,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1003,poland,gdansk,54.36085,18.658291,461865,1003,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1004,poland,poznan,52.416667,16.966667,570352,1004,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1005,turkey,ankara,39.911652,32.840305,3519177,1005,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1006,france,paris,48.866667,2.333333,2110694,1006,NCT01651520,Multiple Sclerosis,RRMS,Drug,N/A,80,Pitié Salpêtrière Hospital
1007,united states of america,new haven,41.3080556,-72.9286111,124922,0,NCT02282878,Multiple Sclerosis,All,Other,N/A,25,Yale MS Center
1008,united states of america,cleveland,41.4994444,-81.6955556,449514,1008,NCT02391961,Multiple Sclerosis,All,Drug,Phase 2,30,Louis Stokes VA Medical Center - Cleveland - OH
1009,united kingdom,cambridge,52.2,0.116667,128489,62,NCT01712945,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,86,Addenbrooke's Hospital
1010,france,bordeaux,44.840439,-0.5805,219311,0,NCT02290587,Multiple Sclerosis,RRMS,Other,N/A,35,CHU de Bordeaux
1011,italy,pavia,45.166667,9.166667,71520,7,NCT02331654,Multiple Sclerosis,All,Other,N/A,60,IRCCS Fondazione Istituto Neurologico Nazionale C. Mondino
1012,belgium,brussels,50.833333,4.333333,1019022,1012,NCT02607020,Multiple Sclerosis,All,Other,N/A,100,Cliniques universitaires Saint-Luc
1013,france,bordeaux,44.840439,-0.5805,219311,0,NCT02708927,Multiple Sclerosis,RRMS,Other,N/A,90,CHU de Bordeaux
1014,france,dijon,47.316667,5.016667,153692,0,NCT02708927,Multiple Sclerosis,RRMS,Other,N/A,90,CHU de Dijon
1015,belgium,liege,50.633333,5.566667,182597,0,NCT02427776,Multiple Sclerosis,RRMS,Stem Cells,Phase 1-Phase 2,18,University Hospital of Liège
1016,belgium,brussels,50.833333,4.333333,1019022,1016,NCT02427776,Multiple Sclerosis,RRMS,Stem Cells,Phase 1-Phase 2,18,Cliniques universitaires Saint-Luc
1017,belgium,leuven,50.883333,4.7,92892,1012,NCT02427776,Multiple Sclerosis,RRMS,Stem Cells,Phase 1-Phase 2,18,University Hospital Leuven (Gasthuisberg)
1018,france,caen,49.197188,-0.326822,115358,0,NCT01805336,Multiple Sclerosis,RRMS,Other,N/A,60,Department of Neurologie - Caen Hospital University
1019,france,caen,49.197188,-0.326822,115358,0,NCT01805336,Multiple Sclerosis,RRMS,Other,N/A,60,Inserm Unit 1075 Comete - Caen Hospital University
1020,united kingdom,edinburgh,55.95,-3.2,435794,1020,NCT01914016,Multiple Sclerosis,All,Other,N/A,10,Slateford medical centre
1021,italy,ferrara,44.833333,11.583333,131252,0,NCT02421731,Multiple Sclerosis,All,Device,Phase 2,98,Ferrara University Hospital
1022,italy,ferrara,44.833333,11.583333,131252,0,NCT02421731,Multiple Sclerosis,All,Device,Phase 2,98,Ferrara University Hospital
1023,united states of america,aventura,25.9561111,-80.1394444,27892,0,NCT01453764,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,50,Ageless Regenerative Institute LLC
1024,israel,jerusalem,31.78,35.23,714685,1024,NCT02529839,Multiple Sclerosis,All,Stem Cells,N/A,20,Hadassah University Hospital
1025,united kingdom,london,51.514125,-0.093689,7421228,1025,NCT02542787,Multiple Sclerosis,All,Drug,Phase 2,160,The National Hospital for Neurology and Neurosurgery
1026,united kingdom,liverpool,53.416667,-3,468946,1026,NCT02542787,Multiple Sclerosis,All,Drug,Phase 2,160,The Neuroscience Research Centre - The Walton Centre NHS Foundation Trust
1027,united kingdom,london,51.514125,-0.093689,7421228,1027,NCT02542787,Multiple Sclerosis,All,Drug,Phase 2,160,The Royal London Hospital
1028,united kingdom,sheffield,53.366667,-1.5,447048,1028,NCT02542787,Multiple Sclerosis,All,Drug,Phase 2,160,Royal Hallamshire Hospital - Sheffield Teaching Hospital NHS Foundation Trust
1029,united states of america,jonesboro,35.8422222,-90.7041667,58619,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1030,united states of america,carmichael,38.6172222,-121.3272222,50992,934,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1031,united states of america,la jolla,32.8472222,-117.2733333,42808,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1032,united states of america,la mesa,32.7677778,-117.0222222,54087,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1033,united states of america,pomona,34.0552778,-117.7513889,156183,26,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1034,united states of america,simi valley,34.2694444,-118.7805556,119417,26,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1035,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1036,united states of america,colorado springs,38.8338889,-104.8208333,373072,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1037,united states of america,fairfield,41.1411111,-73.2641667,59052,1,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1038,united states of america,washington,38.895,-77.0366667,552433,1038,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1039,united states of america,jacksonville,30.3319444,-81.6558333,797557,1039,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1040,united states of america,naples,26.1416667,-81.795,21498,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1041,united states of america,ormond beach,29.2855556,-81.0561111,38455,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1042,united states of america,sunrise,26.1336111,-80.1133333,90993,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1043,united states of america,rome,34.2569444,-85.1647222,35452,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1044,united states of america,chicago,41.85,-87.65,2841952,1044,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1045,united states of america,flossmoor,41.5427778,-87.6847222,9462,44,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1046,united states of america,indianapolis,39.7683333,-86.1580556,773283,1046,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1047,united states of america,louisville,38.2541667,-85.7594444,243639,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1048,united states of america,scarborough,43.5780556,-70.3222222,27706,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1049,united states of america,farmington hills,42.4852778,-83.3772222,79955,191,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1050,united states of america,chesterfield,38.6630556,-90.5769444,47128,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1051,united states of america,kansas city,39.0997222,-94.5783333,442028,1051,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1052,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1053,united states of america,freehold,40.26,-74.2741667,11558,1,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1054,united states of america,amherst,42.9783333,-78.8,37819,744,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1055,united states of america,new york,40.7141667,-74.0063889,8107916,1055,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1056,united states of america,patchogue,40.7655556,-73.0155556,12030,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1057,united states of america,hendersonville,35.3186111,-82.4611111,11678,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1058,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1059,united states of america,sanford,35.4797222,-79.1805556,23473,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1060,united states of america,winston-salem,36.0997222,-80.2444444,193300,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1061,united states of america,dayton,39.7588889,-84.1916667,159134,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1062,united states of america,dayton,39.7588889,-84.1916667,159134,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1063,united states of america,uniontown,40.975,-81.4083333,2802,51,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1064,united states of america,oklahoma city,35.4675,-97.5161111,532950,1064,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1065,united states of america,portland,45.5236111,-122.675,540513,1065,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1066,united states of america,tualatin,45.3841667,-122.7627778,26476,95,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1067,united states of america,dickson city,41.4713889,-75.6080556,6070,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1068,united states of america,greensburg,40.3013889,-79.5391667,15309,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1069,united states of america,hershey,40.2858333,-76.6505556,13172,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1070,united states of america,wilkes-barre,41.2458333,-75.8816667,40736,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1071,united states of america,nashville,36.1658333,-86.7844444,530852,1071,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1072,united states of america,dallas,32.7833333,-96.8,1211704,1072,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1073,united states of america,round rock,30.5080556,-97.6786111,88653,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1074,united states of america,alexandria,38.8047222,-77.0472222,127273,43,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1075,united states of america,newport news,36.9786111,-76.4283333,183444,1285,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1076,united states of america,seattle,47.6063889,-122.3308333,569369,1076,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1077,united states of america,madison,43.0730556,-89.4011111,224625,0,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1078,turkey,ankara,39.911652,32.840305,3519177,1078,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1079,turkey,bursa,40.191667,29.061111,1413485,1079,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1080,turkey,istanbul,41.018611,28.964722,9797536,1080,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1081,turkey,istanbul,41.018611,28.964722,9797536,1081,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1082,turkey,kocaeli,40.766944,29.916944,196672,0,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1083,turkey,kutahya,39.424167,29.983333,185104,0,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1084,united states of america,buffalo,42.8863889,-78.8786111,279557,0,NCT02651545,Multiple Sclerosis,RRMS,Drug,Phase 4,60,Buffalo General Hospital
1085,spain,barcelona,41.398371,2.1741,1570378,1085,NCT02283671,Multiple Sclerosis,All,Drug,Phase 1,12,Hospital Clinic of Barcelona
1086,united states of america,minneapolis,44.98,-93.2636111,367773,0,NCT01950234,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,100,Clinical Neuroscience Research Unit - University of Minnesota
1087,united states of america,fargo,46.8772222,-96.7894444,92103,0,NCT01950234,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,100,Sanford Clinic Neuroscience
1088,united states of america,oklahoma city,35.4675,-97.5161111,532950,1088,NCT01950234,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,100,Oklahoma Medical Research Foundation Multiple Sclerosis Center of Excellence
1089,united states of america,milwaukee,43.0388889,-87.9063889,579180,1089,NCT01950234,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,100,Wheaton Franciscan Healthcare - St Francis Center for Neurological Disorders
1090,united states of america,cullman,34.1747222,-86.8436111,14796,0,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1091,united states of america,boston,42.3583333,-71.0602778,571281,1091,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1092,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1093,australia,melbourne,-37.813938,144.963425,3730212,1093,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1094,belgium,gent,51.05,3.716667,231493,1012,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1095,belgium,leuven,50.883333,4.7,92892,1012,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1096,canada,calgary,51.083333,-114.083333,968475,1096,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1097,estonia,tallinn,59.4338889,24.7280556,394023,349,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1098,france,le kremlin-bicetre,48.814713,2.360728,27194,158,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1099,france,lyon,45.748457,4.846711,463700,1099,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1100,france,marseille,43.285413,5.37606,792823,1100,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1101,france,rennes,48.111981,-1.674291,213334,0,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1102,greece,thessaloniki,40.6402778,22.9438889,354291,0,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1103,israel,jerusalem,31.78,35.23,714685,1103,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1104,israel,tel hashomer,32.053889,34.848056,1700,1105,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1105,israel,tel aviv,32.066667,34.766667,426138,1105,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1106,israel,ness ziona,31.926389,34.803333,38100,1105,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1107,lebanon,beirut,33.8719444,35.5097222,1252010,1107,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1108,lithuania,kaunas,54.9,23.9,374655,0,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1109,russia,moscow,55.752222,37.615556,10381288,1109,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1110,russia,nizhniy novgorod,56.326944,44.0075,1284176,1110,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1111,russia,novosibirsk,55.0415,82.9346,1419016,1111,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1112,russia,saint petersburg,59.894444,30.264167,4039751,1112,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1113,russia,saint petersburg,59.894444,30.264167,4039751,1113,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1114,spain,madrid,40.408566,-3.69222,3102644,1114,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1115,spain,murcia,37.987041,-1.130042,410364,1115,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1116,spain,sevilla,37.382408,-5.976133,686647,1116,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1117,turkey,ankara,39.911652,32.840305,3519177,1117,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1118,turkey,ankara,39.911652,32.840305,3519177,1118,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1119,turkey,istanbul,41.018611,28.964722,9797536,1119,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1120,turkey,istanbul,41.018611,28.964722,9797536,1120,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1121,turkey,istanbul,41.018611,28.964722,9797536,1121,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1122,turkey,izmir,38.412726,27.138376,2501895,1122,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1123,turkey,izmir,38.412726,27.138376,2501895,1123,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1124,turkey,trabzon,41.005,39.726944,244209,0,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1125,united kingdom,birmingham,52.466667,-1.916667,984336,1125,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1126,united kingdom,london,51.514125,-0.093689,7421228,1126,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1127,united kingdom,london,51.514125,-0.093689,7421228,1127,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1128,norway,bodo,67.283333,14.383333,33811,0,NCT02522962,Multiple Sclerosis,All,Behavioral,Phase 4,72,Physiotherapy department - Nordlandssykehuset HF
1129,austria,vienna,48.2,16.366667,1569315,1129,NCT01879202,Multiple Sclerosis,All,Drug,Phase 2,96,Medical University of Vienna - Department of Neurology
1130,united states of america,stony brook,40.9255556,-73.1413889,13620,1,NCT02606604,Multiple Sclerosis,All,Device,N/A,20,Stony Brook Univeristy
1131,israel,haifa,32.815556,34.989167,269961,1105,NCT02488343,Multiple Sclerosis,All,Behavioral,N/A,400,MS Clinic - Carmel Medical Center
1132,israel,tel hashomer,32.053889,34.848056,1700,1105,NCT02259361,Multiple Sclerosis,All,Drug,Phase 4,30,Multiple Sclerosis Center
1133,united states of america,el paso,31.7586111,-106.4863889,597181,1133,NCT02694666,Multiple Sclerosis,All,Device,N/A,440,Stanley E. Fulton Biomechanics Laboratory
1134,united states of america,la jolla,32.8472222,-117.2733333,42808,0,NCT02157064,Multiple Sclerosis,All,Stem Cells,N/A,100,StemGenex
1135,united states of america,fresno,36.7477778,-119.7713889,465183,1135,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Victoria Walton - MD
1136,united states of america,fullerton,33.8702778,-117.9244444,135353,102,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Fullerton Neurology and Headache Center
1137,united states of america,newport beach,33.6188889,-117.9280556,78702,102,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Multiple Sclerosis Center of California & Research
1138,united states of america,sacramento,38.5816667,-121.4933333,467898,1138,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Sutter Institute for Medical Research
1139,united states of america,san francisco,37.775,-122.4183333,732072,1139,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of California San Francisco
1140,united states of america,temecula,33.4936111,-117.1475,85145,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Viking Clinical Research Center
1141,united states of america,englewood,39.6477778,-104.9872222,32860,286,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Colorado Neurological Institute
1142,united states of america,newark,39.6836111,-75.75,30238,29,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Christiana Care Health Services
1143,united states of america,bradenton,27.4986111,-82.575,54608,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Brandenton Neurology - Inc.
1144,united states of america,hollywood,26.0108333,-80.1497222,144821,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Sunrise Clinical Research - Inc.
1145,united states of america,jacksonville,30.3319444,-81.6558333,797557,1145,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of Florida
1146,united states of america,maitland,28.6275,-81.3633333,11686,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurology Associates - PA
1147,united states of america,ormond beach,29.2855556,-81.0561111,38455,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurology Associates of Ormond Beach
1148,united states of america,pompano beach,26.2375,-80.125,89715,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurological Associates
1149,united states of america,port orange,29.1380556,-80.9958333,54209,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Progressive Medical Research
1150,united states of america,sarasota,27.3361111,-82.5308333,53327,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Roskamp Institute
1151,united states of america,saint petersburg,27.7705556,-82.6794444,246316,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Suncoast Neuroscience Associates - Inc
1152,united states of america,tallahassee,30.4380556,-84.2808333,153583,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,AMO Corporation
1153,united states of america,vero beach,27.6383333,-80.3975,17262,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,MS Center of Vero Beach
1154,united states of america,weston,26.1,-80.4,68254,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Cleveland Clinic Florida
1155,united states of america,decatur,33.7747222,-84.2963889,17458,586,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurostudies
1156,united states of america,honolulu,21.3069444,-157.8583333,384241,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Leo Maher - MD
1157,united states of america,flossmoor,41.5427778,-87.6847222,9462,44,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,South Suburban Neurology
1158,united states of america,merrillville,41.4827778,-87.3327778,31168,44,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neuroscience Institute
1159,united states of america,des moines,41.6005556,-93.6088889,193180,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Mercy Ruan Neurology Clinic Res Ct.
1160,united states of america,lenexa,38.9536111,-94.7333333,43331,1051,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Mid America Neuroscience Institute
1161,united states of america,topeka,39.0483333,-95.6777778,121570,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Precise Clinical Research
1162,united states of america,topeka,39.0483333,-95.6777778,121570,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Cotton O'Neil Clinical Research Institute
1163,united states of america,lexington,37.9886111,-84.4777778,314488,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Associates in Neurology
1164,united states of america,louisville,38.2541667,-85.7594444,243639,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Norton Healthcare - Inc.
1165,united states of america,baltimore,39.2902778,-76.6125,610892,1165,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of Maryland
1166,united states of america,bethesda,38.9805556,-77.1005556,52801,43,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Bethesda Neurology - LLC
1167,united states of america,boston,42.3583333,-71.0602778,571281,1167,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Caritas St. Elizabeth's Hospital
1168,united states of america,milford,42.1397222,-71.5166667,28631,45,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Milford Regional Medical Center
1169,united states of america,springfield,42.1013889,-72.5902778,152227,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Springfield Neurology Associates - LLC
1170,united states of america,worcester,42.2625,-71.8027778,177216,45,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Fallon Clinic at Worcester Medical Center
1171,united states of america,edina,44.8897222,-93.3497222,45945,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Minneapolis Clinic of Neurology
1172,united states of america,kansas city,39.0997222,-94.5783333,442028,1172,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Saint Luke's Hospital
1173,united states of america,springfield,37.2152778,-93.2980556,150443,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,St.John's Research Institute - Inc
1174,united states of america,great falls,47.5002778,-111.3,56075,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Benefis Physician Associates
1175,united states of america,newark,40.7355556,-74.1727778,280123,1,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,UMDNJ
1176,united states of america,albany,42.6525,-73.7566667,93794,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurological Associates of Albany - PC
1177,united states of america,latham,42.7469444,-73.7594444,20736,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Empire Neurology - PC
1178,united states of america,patchogue,40.7655556,-73.0155556,12030,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,South Shore Neurologic Associates
1179,united states of america,plainview,40.7763889,-73.4677778,25174,1,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Island Neurological Associates
1180,united states of america,rochester,44.0216667,-92.4697222,96355,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of Rochester Medical Center
1181,united states of america,charlotte,35.2269444,-80.8433333,598351,1181,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,The Neurological Institute - PA
1182,united states of america,dayton,39.7588889,-84.1916667,159134,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurology Specialists - Inc.
1183,united states of america,corvallis,44.5647222,-123.2608333,50701,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,The Corvallis Clinic - P.C.
1184,united states of america,portland,45.5236111,-122.675,540513,1184,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Providence Multiple Sclerosis Center
1185,united states of america,greensburg,40.3013889,-79.5391667,15309,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Westmoreland Neurology
1186,united states of america,philadelphia,39.9522222,-75.1641667,1453268,1186,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of Pennsylvania Health System
1187,united states of america,pittsburgh,40.4405556,-79.9961111,319494,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Research Protocol Management Solutions
1188,united states of america,dallas,32.7833333,-96.8,1211704,1188,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Baylor Research Institute
1189,united states of america,dallas,32.7833333,-96.8,1211704,1189,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of Texas Southwestern
1190,united states of america,round rock,30.5080556,-97.6786111,88653,0,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Central Texas Neurology Consultants - P.A.
1191,united states of america,san antonio,29.4238889,-98.4933333,1256810,1191,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Innovative Clinical Trials - Bexar Diagnostic Medicine Assoc.
1192,united states of america,sherman,33.6355556,-96.6086111,37108,53,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Texoma Neurology Associates
1193,united states of america,seattle,47.6063889,-122.3308333,569369,1193,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Swedish Neuroscience Institute
1194,united states of america,seattle,47.6063889,-122.3308333,569369,1194,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Pacific Medical Centers
1195,united states of america,tacoma,47.2530556,-122.4430556,196957,73,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,MultiCare Research Institute
1196,united states of america,guaynabo,18.3594444,-66.1113889,81363,845,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Caribbean Center for Clinical Research - Inc
1197,united states of america,new york,40.7141667,-74.0063889,8107916,1197,NCT02207075,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,N/A,26,Weill Cornell Medical College
1198,united states of america,new york,40.7141667,-74.0063889,8107916,1198,NCT01226654,Multiple Sclerosis,All,Device,N/A,160,NYU Langone Medical Center
1199,united states of america,fort collins,40.5852778,-105.0838889,129252,286,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1200,united states of america,cambridge,42.375,-71.1061111,101382,45,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1201,united states of america,voorhees,40.4811111,-74.4836111,29131,1,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1202,united states of america,grand forks,47.9252778,-97.0325,48426,0,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1203,united states of america,round rock,30.5080556,-97.6786111,88653,0,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1204,united states of america,norfolk,36.8466667,-76.2855556,246216,1285,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1205,australia,liverpool,-33.9,150.933333,24095,723,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1206,australia,woodville,-34.883333,138.55,2207,730,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1207,australia,box hill,-37.816667,145.133333,1173,200,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1208,austria,linz,48.3,14.3,181163,0,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1209,belgium,melsbroek,50.916667,4.483333,11935,1012,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1210,canada,saint-laurent,45.516667,-73.666667,93842,747,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1211,czech republic,ostrava,49.811852,18.255282,317136,0,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1212,denmark,aarhus,56.153423,10.22553,264716,0,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1213,germany,bochum,51.483333,7.216667,387061,17,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1214,norway,bergen,60.391111,5.324722,214154,0,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1215,switzerland,bern,46.916667,7.466667,123018,0,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1216,switzerland,lausanne,46.533333,6.666667,118015,0,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1217,switzerland,saint gallen,47.42539,9.377615,75310,0,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1218,united kingdom,liverpool,53.416667,-3,468946,1218,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1219,italy,orbassano,45.016667,7.533333,22805,1528,NCT02611401,Multiple Sclerosis,All,Behavioral,Phase 4,88,Clinical and Biological Sciences Department
1220,canada,hamilton,43.25,-79.833333,653637,1220,NCT02100020,Multiple Sclerosis,All,Other,N/A,130,McMaster University - Physical Activity Centre for Excellence
1221,belgium,diepenbeek,50.9,5.4,17699,0,NCT02688231,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,Phase 2,45,Hasselt University
1222,belgium,overpelt,51.216667,5.416667,13344,0,NCT02688231,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,Phase 2,45,Revalidatie en MS centrum
1223,france,clermont-ferrand,45.779657,3.086281,137364,0,NCT02769689,Multiple Sclerosis,RRMS,Drug,Phase 4,56,CHU Clermont-Ferrand
1224,germany,berlin,52.516667,13.4,3398362,1224,NCT02695394,Multiple Sclerosis,CIS,Other,N/A,60,Charité Unversitätsmedizin Berlin - NeuroCure Clinical Research Center NCRC  
1225,france,amiens,49.9,2.3,138816,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU d'Amiens - Hôpital Nord
1226,france,besancon,47.248778,6.018152,120139,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Besançon - Hôpital Jean Minjoz
1227,france,bron,45.740218,4.922415,36263,523,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Lyon - Hôpital Pierre Wertheimer
1228,france,caen,49.197188,-0.326822,115358,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Caen - Hôpital Côte de Nacre
1229,france,clermont-ferrand,45.779657,3.086281,137364,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Clermont Ferrand - Hôpital Gabriel-Montpied
1230,france,corbeil-essonnes,48.606034,2.487571,38760,158,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH Sud Francilien
1231,france,cornebarrieu,43.648951,1.324073,5635,145,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,Clinique des Cèdres - Capio
1232,france,dijon,47.316667,5.016667,153692,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Dijon
1233,france,fort-de-france,14.6,-61.0833333,89997,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Martinique - Hôpital Pierre Zobda-Quitman
1234,france,grenoble,45.171546,5.722387,154853,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Grenoble - Hôpital A Michallon
1235,france,lille,50.632971,3.058585,189746,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHRU de Lille - Hôpital Roger Salengro
1236,france,limoges,45.831534,1.257805,134549,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Limoges - Hôpital Dupuytren
1237,france,lomme,50.643579,2.987148,29084,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,Groupe Hospitalier de l'Institut Catholique de Lille
1238,france,montpellier,43.61092,3.87723,238887,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Montpellier - Hôpital Gui de Chauliac
1239,france,nancy,48.69211,6.187756,106857,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Nancy - Hôpital Central
1240,france,nantes,47.216509,-1.552379,284677,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Nantes - Hôtel-Dieu
1241,france,nice,43.713644,7.25952,341621,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Nice - Hôpital Pasteur
1242,france,nimes,43.833778,4.359623,137532,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Nîmes - Hôpital Universitaire Carémeau
1243,france,paris,48.866667,2.333333,2110694,1243,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,Fondation Ophtalmologique Adolphe Rothschild
1244,france,paris,48.866667,2.333333,2110694,1244,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,APHP - Hôpital Saint-Antoine
1245,france,pau,43.299999,-0.366667,77475,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Pau
1246,france,perpignan,42.696172,2.897098,104783,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Perpignan - Hôpital Saint Jean
1247,france,quimper,48,-4.1,66251,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Cornouaille - Site Quimper - Hôpital Laennec  
1248,france,reims,49.25,4.033333,192688,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Reims - Hôpital Maison Blanche
1249,france,rennes,48.111981,-1.674291,213334,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Rennes - Hôpital PontChaillou
1250,france,rouen,49.433333,1.083333,108101,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Rouen - Hôpital Charles Nicolle
1251,france,saint-germain-en-laye,48.904194,2.086688,38098,158,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Poissy - Saint-Germain-en-Laye
1252,france,saint-priest-en-jarez,45.475013,4.376136,6022,523,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Saint Etienne - Hôpital Nord
1253,france,saumur,47.256629,-0.075025,30036,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Saumur
1254,france,strasbourg,48.600381,7.787355,273506,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHRU de Strasbourg - Hôpital Civil
1255,france,toulouse,43.599516,1.433188,411145,1255,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHRU de Toulouse - Hôpital Purpan
1256,france,tours,47.394836,0.703977,135143,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHRU de Tours - Hôpital Bretonneau
1257,france,versailles,48.803593,2.134236,85134,158,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Versailles - Hôpital Mignot
1258,france,vichy,46.128264,3.423472,25900,0,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Vichy - Jacques Larin
1259,canada,london,42.983333,-81.25,346774,0,NCT02634567,Multiple Sclerosis,RRMS,Behavioral,N/A,30,London Health Sciences Centre
1260,france,pau,43.299999,-0.366667,77475,0,NCT02545959,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,12,Centre hospitalier F. Mitterrand
1261,turkey,istanbul,41.018611,28.964722,9797536,1261,NCT02373098,Multiple Sclerosis,RRMS,Drug,Phase 4,60,Novartis Investigative Site  
1262,turkey,istanbul,41.018611,28.964722,9797536,1262,NCT02373098,Multiple Sclerosis,RRMS,Drug,Phase 4,60,Novartis Investigative Site  
1263,turkey,istanbul,41.018611,28.964722,9797536,1263,NCT02373098,Multiple Sclerosis,RRMS,Drug,Phase 4,60,Novartis Investigative Site  
1264,united states of america,minneapolis,44.98,-93.2636111,367773,0,NCT02716701,Multiple Sclerosis,All,Behavioral,N/A,40,VA Medical Center
1265,united states of america,derby,41.3205556,-73.0894444,12717,0,NCT02679885,Multiple Sclerosis,RRMS,Drug,Phase 4,40,Multiple Sclerosis Treatment Center at Griffin Hospital
1266,united states of america,birmingham,33.5205556,-86.8025,231621,0,NCT01018537,Multiple Sclerosis,CIS,Other,N/A,50000,University of Alabama at Birmingham
1267,france,rennes,48.111981,-1.674291,213334,0,NCT02388334,Multiple Sclerosis,All,Other,N/A,730,Rennes University Hospital
1268,united states of america,urbana,40.1105556,-88.2072222,39511,0,NCT02314585,Multiple Sclerosis,All,Other,N/A,100,Motor control research lab
1269,italy,milan,45.466667,9.2,1156903,1269,NCT02587065,Multiple Sclerosis,RRMS,Drug,Phase 4,275,Novartis Investigative Site  
1270,italy,pozzilli,41.516667,14.066667,2402,234,NCT02587065,Multiple Sclerosis,RRMS,Drug,Phase 4,275,Novartis Investigative Site  
1271,united states of america,cullman,34.1747222,-86.8436111,14796,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1272,united states of america,carmichael,38.6172222,-121.3272222,50992,934,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1273,united states of america,atlanta,33.7488889,-84.3880556,422908,1273,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1274,united states of america,northbrook,42.1275,-87.8288889,34322,44,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1275,united states of america,foxboro,42.0583333,-71.25,16693,45,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1276,united states of america,golden valley,45.0097222,-93.3488889,20325,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1277,united states of america,golden valley,45.0097222,-93.3488889,20325,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1278,united states of america,las vegas,36.175,-115.1363889,540111,1278,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1279,united states of america,teaneck,40.8975,-74.0163889,40078,1,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1280,united states of america,lake success,40.7705556,-73.7180556,2934,1,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1281,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1282,united states of america,columbus,39.9611111,-82.9988889,736836,1282,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1283,united states of america,uniontown,40.975,-81.4083333,2802,51,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1284,united states of america,round rock,30.5080556,-97.6786111,88653,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1285,united states of america,virginia beach,36.8527778,-75.9783333,449386,1285,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1286,argentina,buenos aires,-34.5875,-58.6725,3050728,1286,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1287,argentina,buenos aires,-34.5875,-58.6725,3050728,1287,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1288,argentina,rosario,-32.946818,-60.639317,1218497,1288,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1289,austria,vienna,48.2,16.366667,1569315,1289,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1290,belgium,brussels,50.833333,4.333333,1019022,1290,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1291,belgium,edegem,51.15,4.45,21839,1012,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1292,croatia,rijeka,45.3430556,14.4091667,141173,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1293,croatia,slavonski brod,45.1602778,18.0155556,60742,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1294,croatia,split,43.5138889,16.4558333,176315,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1295,croatia,zagreb,45.8,16,698967,1295,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1296,croatia,zagreb,45.8,16,698967,1296,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1297,croatia,zagreb,45.8,16,698967,1297,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1298,croatia,zagreb,45.8,16,698967,1298,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1299,finland,tampere,61.5,23.75,202688,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1300,finland,turku,60.45,22.283333,175944,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1301,france,besancon,47.248778,6.018152,120139,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1302,france,bordeaux,44.840439,-0.5805,219311,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1303,france,bron,45.740218,4.922415,36263,523,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1304,france,clermont-ferrand,45.779657,3.086281,137364,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1305,france,lille,50.632971,3.058585,189746,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1306,france,lomme,50.643579,2.987148,29084,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1307,france,nancy,48.69211,6.187756,106857,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1308,france,nice,43.713644,7.25952,341621,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1309,france,nimes,43.833778,4.359623,137532,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1310,france,nimes,43.833778,4.359623,137532,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1311,france,poissy,48.92902,2.049521,35663,158,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1312,france,rennes,48.111981,-1.674291,213334,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1313,france,strasbourg,48.600381,7.787355,273506,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1314,france,toulouse,43.599516,1.433188,411145,1314,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1315,germany,bayreuth,49.948056,11.578333,74840,777,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1316,germany,dresden,51.05,13.75,480801,1316,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1317,germany,dresden,51.05,13.75,480801,1317,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1318,germany,hamburg,53.55,10,1733846,1318,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1319,germany,rostock,54.083333,12.133333,196833,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1320,germany,stuttgart,48.766667,9.183333,591688,1320,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1321,ireland,dublin,53.3330556,-6.2488889,1024027,1321,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1322,ireland,dublin,53.3330556,-6.2488889,1024027,1322,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1323,italy,ancona,43.633333,13.5,100982,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1324,italy,bari,41.133333,16.85,303049,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1325,italy,cagliari,39.216667,9.116667,157343,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1326,italy,genova,44.416667,8.95,588688,1326,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1327,italy,milan,45.466667,9.2,1156903,1327,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1328,italy,milan,45.466667,9.2,1156903,1328,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1329,italy,montichiari,45.416667,10.383333,21041,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1330,italy,naples,40.833333,14.25,981284,1330,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1331,italy,rome,41.9,12.483333,2643736,1331,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1332,italy,rome,41.9,12.483333,2643736,1332,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1333,italy,rome,41.9,12.483333,2643736,1333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1334,mexico,mexico,19.434167,-99.138611,8720916,1334,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1335,mexico,mexico,19.434167,-99.138611,8720916,1335,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1336,mexico,distrito federal,32.491389,-115.036944,8918653,1336,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1337,mexico,distrito federal,32.491389,-115.036944,8918653,1337,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1338,mexico,mexico,19.434167,-99.138611,8720916,1338,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1339,poland,bydgoszcz,53.127062,18.019987,366452,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1340,poland,gdansk,54.36085,18.658291,461865,1340,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1341,poland,katowice,50.258415,19.027545,317316,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1342,poland,kielce,50.833333,20.666667,208598,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1343,poland,konskie,51.191432,20.408217,20756,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1344,poland,lodz,51.75,19.466667,715360,1344,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1345,poland,lodz,51.75,19.466667,715360,1345,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1346,poland,lublin,51.25,22.566667,360044,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1347,poland,olsztyn,53.779949,20.494162,171803,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1348,poland,rybnik,50.092076,18.547479,142510,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1349,poland,rzeszow,50.037246,22.004949,158382,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1350,poland,warsaw,52.25,21,1651676,1350,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1351,united states of america,guaynabo,18.3594444,-66.1113889,81363,845,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1352,russia,kaluga,54.529302,36.275415,338982,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1353,russia,kazan,55.78874,49.122144,1104750,1353,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1354,russia,krasnoyarsk,56.0091,92.8628,907460,1354,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1355,russia,moscow,55.752222,37.615556,10381288,1355,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1356,russia,moscow,55.752222,37.615556,10381288,1356,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1357,russia,moscow,55.752222,37.615556,10381288,1357,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1358,russia,novosibirsk,55.0415,82.9346,1419016,1358,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1359,russia,perm,58.009282,56.284063,982428,1359,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1360,russia,saint petersburg,59.894444,30.264167,4039751,1360,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1361,russia,saint petersburg,59.894444,30.264167,4039751,1361,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1362,russia,tyumen,57.152222,65.527222,519124,1362,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1363,russia,volgograd,48.71939,44.501835,1010331,1363,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1364,russia,yaroslavl,57.61977,39.85536,606735,1364,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1365,spain,burgos,42.350221,-3.675273,168319,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1366,spain,madrid,40.408566,-3.69222,3102644,1366,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1367,spain,murcia,37.987041,-1.130042,410364,1367,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1368,spain,malaga,36.726666,-4.434802,557875,1368,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1369,spain,sevilla,37.382408,-5.976133,686647,1369,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1370,spain,valencia,39.466667,-0.366667,769897,1370,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1371,turkey,ankara,39.911652,32.840305,3519177,1371,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1372,turkey,istanbul,41.018611,28.964722,9797536,1372,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1373,turkey,istanbul,41.018611,28.964722,9797536,1373,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1374,turkey,izmit,40.766944,29.916944,196672,0,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1375,canada,gatineau,45.483333,-75.65,265349,165,NCT02623946,Multiple Sclerosis,All,Drug,N/A,10,Clinique Neuro-Outaouais
1376,israel,haifa,32.815556,34.989167,269961,1105,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,Carmel Medical Center
1377,israel,ashkelon,31.669256,34.57149,126819,1105,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,Barzilai Medical Center
1378,israel,jerusalem,31.78,35.23,714685,1378,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,Hadassah Ein-Kerem
1379,israel,tel aviv,32.066667,34.766667,426138,1379,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,TASMC
1380,israel,tel hashomer,32.053889,34.848056,1700,1105,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,Sheba MC
1381,israel,ness ziona,31.926389,34.803333,38100,1105,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,Assaf Harofeh MC
1382,united states of america,phoenix,33.4483333,-112.0733333,1428509,1382,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1383,united states of america,sarasota,27.3361111,-82.5308333,53327,0,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1384,united states of america,atlanta,33.7488889,-84.3880556,422908,1384,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1385,united states of america,northbrook,42.1275,-87.8288889,34322,44,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1386,united states of america,rochester,44.0216667,-92.4697222,96355,0,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1387,united states of america,patchogue,40.7655556,-73.0155556,12030,0,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1388,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1389,united states of america,franklin,35.925,-86.8688889,49706,704,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1390,united states of america,dallas,32.7833333,-96.8,1211704,1390,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1391,united states of america,kirkland,47.6816667,-122.2075,45778,73,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1392,germany,bonn,50.733333,7.1,314081,807,NCT02364986,Multiple Sclerosis,RRMS,Drug,Phase 1,50,Department of Neurology
1393,germany,bonn,50.733333,7.1,314081,807,NCT02364986,Multiple Sclerosis,RRMS,Drug,Phase 1,50,Phase I Unit
1394,united states of america,cullman,34.1747222,-86.8436111,14796,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1395,united states of america,gilbert,33.3527778,-111.7883333,170829,81,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1396,united states of america,phoenix,33.4483333,-112.0733333,1428509,1396,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1397,united states of america,phoenix,33.4483333,-112.0733333,1428509,1397,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1398,united states of america,tucson,32.2216667,-110.9258333,518907,1398,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1399,united states of america,carlsbad,33.1580556,-117.3497222,91070,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1400,united states of america,fullerton,33.8702778,-117.9244444,135353,102,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1401,united states of america,la jolla,32.8472222,-117.2733333,42808,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1402,united states of america,centennial,39.5791667,-104.8763889,96930,286,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1403,united states of america,englewood,39.6477778,-104.9872222,32860,286,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1404,united states of america,fort collins,40.5852778,-105.0838889,129252,286,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1405,united states of america,fairfield,41.1411111,-73.2641667,59052,1,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1406,united states of america,maitland,28.6275,-81.3633333,11686,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1407,united states of america,sunrise,26.1336111,-80.1133333,90993,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1408,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1409,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1410,united states of america,atlanta,33.7488889,-84.3880556,422908,1410,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1411,united states of america,chicago,41.85,-87.65,2841952,1411,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1412,united states of america,northbrook,42.1275,-87.8288889,34322,44,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1413,united states of america,avon,39.7627778,-86.3997222,12446,294,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1414,united states of america,indianapolis,39.7683333,-86.1580556,773283,1414,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1415,united states of america,lexington,37.9886111,-84.4777778,314488,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1416,united states of america,lexington,37.9886111,-84.4777778,314488,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1417,united states of america,boston,42.3583333,-71.0602778,571281,1417,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1418,united states of america,boston,42.3583333,-71.0602778,571281,1418,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1419,united states of america,boston,42.3583333,-71.0602778,571281,1419,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1420,united states of america,edina,44.8897222,-93.3497222,45945,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1421,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1422,united states of america,freehold,40.26,-74.2741667,11558,1,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1423,united states of america,newark,40.7355556,-74.1727778,280123,1,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1424,united states of america,teaneck,40.8975,-74.0163889,40078,1,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1425,united states of america,latham,42.7469444,-73.7594444,20736,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1426,united states of america,mineola,40.7491667,-73.6411111,19006,1,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1427,united states of america,patchogue,40.7655556,-73.0155556,12030,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1428,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1429,united states of america,akron,41.0813889,-81.5191667,208414,51,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1430,united states of america,columbus,39.9611111,-82.9988889,736836,1430,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1431,united states of america,oklahoma city,35.4675,-97.5161111,532950,1431,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1432,united states of america,portland,45.5236111,-122.675,540513,1432,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1433,united states of america,pittsburgh,40.4405556,-79.9961111,319494,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1434,united states of america,cordova,35.1555556,-89.7761111,78138,2240,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1435,united states of america,knoxville,35.9605556,-83.9208333,172474,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1436,united states of america,houston,29.7630556,-95.3630556,2027712,1436,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1437,united states of america,lubbock,33.5777778,-101.8547222,211387,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1438,united states of america,round rock,30.5080556,-97.6786111,88653,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1439,united states of america,san antonio,29.4238889,-98.4933333,1256810,1439,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1440,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1441,united states of america,richmond,37.5536111,-77.4605556,190886,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1442,united states of america,seattle,47.6063889,-122.3308333,569369,1442,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1443,united states of america,tacoma,47.2530556,-122.4430556,196957,73,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1444,canada,calgary,51.083333,-114.083333,968475,1444,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1445,canada,edmonton,53.55,-113.5,822319,1445,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1446,canada,montreal,45.5,-73.583333,3268513,1446,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1447,canada,montreal,45.5,-73.583333,3268513,1447,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1448,canada,trois-rivieres,46.35,-72.55,119693,0,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1449,canada,quebec,46.8,-71.25,645623,1449,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1450,belgium,brussels,50.833333,4.333333,1019022,1450,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1451,belgium,gent,51.05,3.716667,231493,1012,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1452,belgium,la louviere,50.466667,4.183333,76668,1012,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1453,czech republic,brno,49.2,16.633333,377407,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1454,czech republic,hradec kralove,50.207744,15.829455,97427,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1455,czech republic,jihlava,49.4,15.583333,50818,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1456,czech republic,ostrava,49.811852,18.255282,317136,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1457,denmark,kobenhavn,55.666667,12.583333,591481,1457,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1458,denmark,odense,55.393475,10.394935,145931,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1459,denmark,aarhus,56.153423,10.22553,264716,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1460,france,strasbourg,48.600381,7.787355,273506,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1461,france,dijon,47.316667,5.016667,153692,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1462,france,rennes,48.111981,-1.674291,213334,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1463,france,bron,45.740218,4.922415,36263,523,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1464,france,amiens,49.9,2.3,138816,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1465,france,lille,50.632971,3.058585,189746,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1466,hungary,budapest,47.5,19.083333,1708088,1466,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1467,hungary,budapest,47.5,19.083333,1708088,1467,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1468,italy,gallarate,45.666667,8.783333,48529,7,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1469,italy,como,45.783333,9.083333,78582,7,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1470,italy,genova,44.416667,8.95,588688,1470,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1471,italy,milan,45.466667,9.2,1156903,1471,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1472,italy,rome,41.9,12.483333,2643736,1472,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1473,poland,bialystok,53.133333,23.15,291855,0,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1474,poland,gdansk,54.36085,18.658291,461865,1474,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1475,poland,poznan,52.416667,16.966667,570352,1475,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1476,serbia,belgrade,44.818611,20.468056,1115200,1476,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1477,serbia,belgrade,44.818611,20.468056,1115200,1477,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1478,sweden,goteborg,57.716667,11.966667,515253,1478,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1479,sweden,stockholm,59.333333,18.05,1253309,1479,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1480,united kingdom,london,51.514125,-0.093689,7421228,1480,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1481,united kingdom,london,51.514125,-0.093689,7421228,1481,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1482,united kingdom,birmingham,52.466667,-1.916667,984336,1482,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1483,united states of america,new york,40.7141667,-74.0063889,8107916,1483,NCT02688985,Multiple Sclerosis,RRMS,Drug,Phase 3,99,Hoffmann-La Roche Investigational Site
1484,united states of america,columbus,39.9611111,-82.9988889,736836,1484,NCT02688985,Multiple Sclerosis,RRMS,Drug,Phase 3,99,Hoffmann-La Roche Investigational Site
1485,united states of america,oklahoma city,35.4675,-97.5161111,532950,1485,NCT02688985,Multiple Sclerosis,RRMS,Drug,Phase 3,99,Hoffmann-La Roche Investigational Site
1486,united states of america,latham,42.7469444,-73.7594444,20736,0,NCT02683863,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 4,20,Multiple Sclerosis Center of Northeastern New York
1487,united states of america,phoenix,33.4483333,-112.0733333,1428509,1487,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1488,united states of america,newport beach,33.6188889,-117.9280556,78702,102,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1489,united states of america,san francisco,37.775,-122.4183333,732072,1489,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1490,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1491,united states of america,northbrook,42.1275,-87.8288889,34322,44,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1492,united states of america,kansas city,39.0997222,-94.5783333,442028,1492,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1493,united states of america,lenexa,38.9536111,-94.7333333,43331,1051,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1494,united states of america,golden valley,45.0097222,-93.3488889,20325,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1495,united states of america,golden valley,45.0097222,-93.3488889,20325,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1496,united states of america,chesterfield,38.6630556,-90.5769444,47128,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1497,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1498,united states of america,new york,40.7141667,-74.0063889,8107916,1498,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1499,united states of america,charlotte,35.2269444,-80.8433333,598351,1499,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1500,united states of america,columbus,39.9611111,-82.9988889,736836,1500,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1501,united states of america,uniontown,40.975,-81.4083333,2802,51,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1502,canada,halifax,44.65,-63.6,266012,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1503,canada,montreal,45.5,-73.583333,3268513,1503,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1504,canada,calgary,51.083333,-114.083333,968475,1504,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1505,canada,ottawa,45.416667,-75.7,874433,1505,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1506,canada,quebec,46.8,-71.25,645623,1506,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1507,canada,toronto,43.666667,-79.416667,4612187,1507,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1508,germany,bad mergentheim,49.4925,9.773611,22072,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1509,germany,bamberg,49.866667,10.866667,70471,777,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1510,germany,berlin,52.516667,13.4,3398362,1510,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1511,germany,bochum,51.483333,7.216667,387061,17,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1512,germany,dresden,51.05,13.75,480801,1512,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1513,germany,dusseldorf,51.216667,6.766667,577139,1513,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1514,germany,gottingen,51.533333,9.933333,123570,1516,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1515,germany,hamburg,53.55,10,1733846,1515,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1516,germany,hanover,52.366667,9.716667,519144,1516,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1517,germany,munich,48.15,11.5833,1246133,1517,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1518,germany,munich,48.15,11.5833,1246133,1518,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1519,germany,rostock,54.083333,12.133333,196833,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1520,germany,trier,49.75,6.633333,100649,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1521,germany,ulm,48.4,10,120745,768,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1522,germany,wurzburg,49.787778,9.936111,134499,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1523,italy,palermo,38.116667,13.366667,669582,1523,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1524,italy,firenze,43.766667,11.25,382808,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1525,italy,varese,45.8,8.833333,84371,7,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1526,italy,genova,44.416667,8.95,588688,1526,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1527,italy,milan,45.466667,9.2,1156903,1527,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1528,italy,torino,45.05,7.666667,892649,1528,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1529,italy,padova,45.416667,11.883333,205247,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1530,italy,rome,41.9,12.483333,2643736,1530,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1531,italy,rome,41.9,12.483333,2643736,1531,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1532,netherlands,amsterdam,52.35,4.916667,745811,1532,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1533,netherlands,nijmegen,51.833333,5.866667,158707,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1534,netherlands,geleen,50.965741,5.834752,33960,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1535,poland,bialystok,53.133333,23.15,291855,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1536,poland,bydgoszcz,53.127062,18.019987,366452,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1537,poland,gdansk,54.36085,18.658291,461865,1537,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1538,poland,katowice,50.258415,19.027545,317316,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1539,poland,katowice,50.258415,19.027545,317316,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1540,poland,katowice,50.258415,19.027545,317316,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1541,poland,kielce,50.833333,20.666667,208598,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1542,poland,konskie,51.191432,20.408217,20756,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1543,poland,lublin,51.25,22.566667,360044,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1544,poland,olsztyn,53.779949,20.494162,171803,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1545,poland,warsaw,52.25,21,1651676,1545,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1546,russia,kaluga,54.529302,36.275415,338982,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1547,russia,kazan,55.78874,49.122144,1104750,1547,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1548,russia,kirov,58.596654,49.660068,457387,1548,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1549,russia,krasnoyarsk,56.0091,92.8628,907460,1549,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1550,russia,moscow,55.752222,37.615556,10381288,1550,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1551,russia,nizhniy novgorod,56.326944,44.0075,1284176,1551,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1552,russia,novosibirsk,55.0415,82.9346,1419016,1552,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1553,russia,perm,58.009282,56.284063,982428,1553,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1554,russia,saint petersburg,59.894444,30.264167,4039751,1554,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1555,russia,saint petersburg,59.894444,30.264167,4039751,1555,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1556,russia,saint petersburg,59.894444,30.264167,4039751,1556,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1557,spain,barcelona,41.398371,2.1741,1570378,1557,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1558,spain,barcelona,41.398371,2.1741,1570378,1558,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1559,spain,el palmar,39.3,-0.316667,775,260,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1560,spain,lleida,41.616667,0.633333,119320,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1561,spain,madrid,40.408566,-3.69222,3102644,1561,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1562,spain,malaga,36.726666,-4.434802,557875,1562,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1563,spain,pozuelo de alarcon,40.432931,-3.813375,83173,262,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1564,spain,san sebastian,28.091627,-17.113314,8699,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1565,spain,sevilla,37.382408,-5.976133,686647,1565,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1566,spain,valencia,39.466667,-0.366667,769897,1566,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1567,ukraine,dnipropetrovsk,48.46298,35.039043,979046,1567,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1568,ukraine,ivanofrankivsk,48.921504,24.709716,229447,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1569,ukraine,kharkiv,49.980814,36.252718,1430885,1569,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1570,ukraine,kiev,50.433333,30.516667,2514227,1570,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1571,ukraine,lutsk,50.759319,25.342436,217103,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1572,ukraine,lviv,49.840661,24.030451,729429,1572,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1573,ukraine,lviv,49.840661,24.030451,729429,1573,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1574,ukraine,zaporizhzhya,47.822892,35.190314,796213,1574,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1575,ukraine,zaporizhzhya,47.822892,35.190314,796213,1575,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1576,ukraine,zaporizhzhya,47.822892,35.190314,796213,1576,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1577,united kingdom,bristol,51.45,-2.583333,430714,1577,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1578,united kingdom,devonshire,50.75,-3.75,1135700,1578,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1579,united kingdom,edinburgh,55.95,-3.2,435794,1579,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1580,united kingdom,liverpool,53.416667,-3,468946,1580,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1581,united kingdom,london,51.514125,-0.093689,7421228,1581,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1582,united kingdom,nottingham,52.966667,-1.166667,246655,124,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1583,united kingdom,oxford,51.75,-1.25,154567,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1584,united kingdom,plymouth,50.396389,-4.138611,247298,1578,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1585,united kingdom,stoke-on-trent,53,-2.183333,260420,502,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1586,united kingdom,swansea,51.633333,-3.966667,170885,0,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1587,united states of america,new haven,41.3080556,-72.9286111,124922,0,NCT02118298,Multiple Sclerosis,All,Other,N/A,120,Yale University
1588,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02675413,Multiple Sclerosis,RRMS,Drug,Phase 4,45,Washington University (John L. Trotter MS Center)
1589,united states of america,seattle,47.6063889,-122.3308333,569369,1589,NCT02675413,Multiple Sclerosis,RRMS,Drug,Phase 4,45,Swedish Neuroscience Institute
1590,germany,ostfildern,48.716667,9.266667,34162,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1591,germany,aachen,50.770833,6.105278,251104,16,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1592,germany,aachen,50.770833,6.105278,251104,16,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1593,germany,aalen,48.833333,10.1,67593,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1594,germany,aalen,48.833333,10.1,67593,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1595,germany,abensberg,48.816667,11.85,12543,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1596,germany,achim,53.033333,9.016667,30117,1644,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1597,germany,aichach,48.466667,11.133333,20935,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1598,germany,altenburg,50.983333,12.45,38338,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1599,germany,altenholz,54.4,10.133333,9721,175,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1600,germany,alzenau,50.083333,9.066667,19083,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1601,germany,andernach,50.433333,7.4,29089,807,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1602,germany,asbach,49.816667,7.283333,171,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1603,germany,aschaffenburg,49.973889,9.149167,69248,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1604,germany,augsburg,48.366667,10.883333,261842,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1605,germany,bad hersfeld,50.866667,9.7,30630,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1606,germany,bad homburg,50.216667,8.616667,51923,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1607,germany,honnef,50.633333,7.233333,25078,807,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1608,germany,bad krozingen,47.916272,7.700622,16051,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1609,germany,bad mergentheim,49.4925,9.773611,22072,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1610,germany,bad saarow,52.283333,14.066667,5006,14,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1611,germany,bad wildbad,48.75,8.55,11411,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1612,germany,bamberg,49.866667,10.866667,70471,777,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1613,germany,bayreuth,49.948056,11.578333,74840,777,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1614,germany,berg,47.966667,11.35,8139,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1615,germany,bergisch gladbach,50.983333,7.133333,106611,807,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1616,germany,berlin,52.516667,13.4,3398362,1616,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1617,germany,berlin,52.516667,13.4,3398362,1617,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1618,germany,berlin,52.516667,13.4,3398362,1618,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1619,germany,berlin,52.516667,13.4,3398362,1619,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1620,germany,berlin,52.516667,13.4,3398362,1620,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1621,germany,berlin,52.516667,13.4,3398362,1621,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1622,germany,berlin,52.516667,13.4,3398362,1622,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1623,germany,berlin,52.516667,13.4,3398362,1623,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1624,germany,berlin,52.516667,13.4,3398362,1624,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1625,germany,berlin,52.516667,13.4,3398362,1625,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1626,germany,berlin,52.516667,13.4,3398362,1626,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1627,germany,berlin,52.516667,13.4,3398362,1627,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1628,germany,berlin,52.516667,13.4,3398362,1628,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1629,germany,berlin,52.516667,13.4,3398362,1629,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1630,germany,berlin,52.516667,13.4,3398362,1630,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1631,germany,berlin,52.516667,13.4,3398362,1631,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1632,germany,berlin,52.516667,13.4,3398362,1632,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1633,germany,bielefeld,52.033333,8.533333,327198,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1634,germany,bielefeld,52.033333,8.533333,327198,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1635,germany,bochum,51.483333,7.216667,387061,17,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1636,germany,bochum,51.483333,7.216667,387061,17,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1637,germany,bochum,51.483333,7.216667,387061,17,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1638,germany,bochum,51.483333,7.216667,387061,17,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1639,germany,bogen,48.916667,12.683333,10458,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1640,germany,bonn,50.733333,7.1,314081,807,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1641,germany,borna,51.116667,12.5,18504,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1642,germany,braunschweig,52.266667,10.533333,247227,1516,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1643,germany,braunschweig,52.266667,10.533333,247227,1516,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1644,germany,bremen,53.083333,8.8,546429,1644,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1645,germany,bruchsal,49.128056,8.583611,43615,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1646,germany,buchholz,53.416667,9.433333,37876,175,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1647,germany,buchholz,53.416667,9.433333,37876,175,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1648,germany,butzbach,50.433333,8.683333,25804,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1649,germany,boblingen,48.683333,9.016667,46830,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1650,germany,celle,52.616667,10.083333,71106,1516,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1651,germany,chemnitz,50.833333,12.916667,246654,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1652,germany,delbruck,51.766667,8.566667,30699,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1653,germany,dillingen,48.566667,10.483333,19013,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1654,germany,dillingen,48.566667,10.483333,19013,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1655,germany,dortmund,51.516667,7.45,594255,1655,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1656,germany,dortmund,51.516667,7.45,594255,1656,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1657,germany,dresden,51.05,13.75,480801,1657,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1658,germany,dresden,51.05,13.75,480801,1658,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1659,germany,dusseldorf,51.216667,6.766667,577139,1659,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1660,germany,dusseldorf,51.216667,6.766667,577139,1660,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1661,germany,duren,50.8,6.483333,92956,807,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1662,germany,dusseldorf,51.216667,6.766667,577139,1662,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1663,germany,dusseldorf,51.216667,6.766667,577139,1663,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1664,germany,eberswalde,52.833333,13.833333,41384,14,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1665,germany,eisenach,50.983333,10.316667,44399,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1666,germany,eltville,50.033333,8.116667,16858,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1667,germany,emden,52.233333,11.266667,49790,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1668,germany,emmendingen,48.133333,7.85,26820,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1669,germany,erbach,49.656111,8.996389,13501,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1670,germany,erfurt,50.983333,11.033333,196719,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1671,germany,erfurt,50.983333,11.033333,196719,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1672,germany,erlangen,49.589722,11.003889,102781,777,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1673,germany,eschwege,51.183333,10.066667,21546,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1674,germany,essen,51.45,7.016667,576914,1674,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1675,germany,essen,51.45,7.016667,576914,1675,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1676,germany,essen,51.45,7.016667,576914,1676,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1677,germany,essen,51.45,7.016667,576914,1677,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1678,germany,flensburg,54.783333,9.433333,85158,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1679,germany,frankfurt,50.116667,8.683333,648034,1679,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1680,germany,frankfurt,50.116667,8.683333,648034,1680,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1681,germany,frankfurt,50.116667,8.683333,648034,1681,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1682,germany,frankfurt,50.116667,8.683333,648034,1682,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1683,germany,freiburg,48,7.85,213920,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1684,germany,fulda,50.55,9.666667,63851,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1685,germany,geldern,51.516667,6.333333,34291,16,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1686,germany,gelnhausen,50.2,9.183333,21417,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1687,germany,gelsenkirchen,51.516667,7.05,271647,17,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1688,germany,gilching,48.116667,11.3,17204,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1689,germany,gladenbach,50.766667,8.566667,12613,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1690,germany,gottingen,51.533333,9.933333,123570,1516,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1691,germany,greifswald,54.1,13.383333,51935,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1692,germany,grevenbroich,51.083333,6.583333,64851,16,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1693,germany,griesheim,49.862778,8.575278,25432,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1694,germany,gutersloh,51.9,8.383333,96332,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1695,germany,gummersbach,51.033333,7.55,53244,1655,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1696,germany,gottingen,51.533333,9.933333,123570,1516,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1697,germany,haar,48.1,11.733333,17810,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1698,germany,hagen,51.35,7.466667,199497,1655,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1699,germany,halle,51.5,12,232452,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1700,germany,halle,51.5,12,232452,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1701,germany,hamburg,53.55,10,1733846,1701,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1702,germany,hamburg,53.55,10,1733846,1702,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1703,germany,hamburg,53.55,10,1733846,1703,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1704,germany,hamburg,53.55,10,1733846,1704,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1705,germany,hamburg,53.55,10,1733846,1705,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1706,germany,hamburg,53.55,10,1733846,1706,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1707,germany,hanover,52.366667,9.716667,519144,1707,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1708,germany,hanover,52.366667,9.716667,519144,1708,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1709,germany,hanover,52.366667,9.716667,519144,1709,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1710,germany,heidelberg,49.416667,8.7,144703,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1711,germany,heidenheim,48.683333,10.15,50684,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1712,germany,herford,52.133333,8.683333,65834,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1713,germany,herford,52.133333,8.683333,65834,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1714,germany,hildesheim,52.15,9.966667,102958,1516,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1715,germany,homburg,49.316667,7.333333,45010,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1716,germany,hoppegarten,52.483333,14.016667,16920,14,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1717,germany,ibbenburen,52.266667,7.733333,51305,1655,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1718,germany,idar-oberstein,49.7,7.3,32876,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1719,germany,itzehoe,53.916667,9.516667,33415,175,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1720,germany,jena,50.933333,11.583333,99269,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1721,germany,jena,50.933333,11.583333,99269,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1722,germany,julich,50.933333,6.366667,34888,16,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1723,germany,kaiserslautern,49.45,7.75,98947,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1724,germany,kaltenkirchen,53.833333,9.966667,19161,175,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1725,germany,kandel,49.089167,8.184167,8773,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1726,germany,karlstadt,49.960278,9.772222,15247,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1727,germany,kassel,51.316667,9.5,193117,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1728,germany,kiel,54.333333,10.133333,235264,175,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1729,germany,klingenmunster,49.140556,8.018611,2372,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1730,germany,koln,50.933333,6.95,1046680,1730,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1731,germany,koln,50.933333,6.95,1046680,1731,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1732,germany,korbach,51.283333,8.866667,24657,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1733,germany,krefeld,51.333333,6.566667,239908,16,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1734,germany,krefeld,51.333333,6.566667,239908,16,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1735,germany,koln,50.933333,6.95,1046680,1735,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1736,germany,konigsbruck,51.266667,13.9,4405,219,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1737,germany,landshut,48.533333,12.15,61131,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1738,germany,lappersdorf,49.056944,12.09,12817,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1739,germany,leipzig,51.3,12.333333,492637,1739,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1740,germany,leipzig,51.3,12.333333,492637,1740,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1741,germany,leipzig,51.3,12.333333,492637,1741,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1742,germany,leverkusen,51.016667,6.983333,159088,807,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1743,germany,lohr,49.993611,9.578333,16297,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1744,germany,ludwigshafen,49.481111,8.435278,162514,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1745,germany,ludwigshafen,49.481111,8.435278,162514,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1746,germany,eisleben,52.15,11.216667,24346,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1747,germany,luneburg,53.25,10.4,73252,175,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1748,germany,lunen,51.616667,7.516667,91912,1655,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1749,germany,magdeburg,52.166667,11.666667,224428,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1750,germany,magdeburg,52.166667,11.666667,224428,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1751,germany,mannheim,49.488333,8.464722,309626,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1752,germany,mannheim,49.488333,8.464722,309626,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1753,germany,mannheim,49.488333,8.464722,309626,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1754,germany,marburg,50.816667,8.766667,79300,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1755,germany,meisenheim,49.716667,7.666667,2795,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1756,germany,minden,52.283333,8.916667,83402,1516,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1757,germany,minden,52.283333,8.916667,83402,1516,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1758,germany,mittweida,50.983333,12.983333,16494,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1759,germany,muenster,51.966667,7.633333,302178,1655,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1760,germany,monchengladbach,51.2,6.433333,264969,16,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1761,germany,mulheim,51.433333,6.883333,172779,17,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1762,germany,munich,48.15,11.5833,1246133,1762,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1763,germany,munich,48.15,11.5833,1246133,1763,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1764,germany,munich,48.15,11.5833,1246133,1764,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1765,germany,munster,51.966667,7.633333,272452,1655,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1766,germany,nagold,48.55,8.716667,23486,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1767,germany,naumburg,51.15,11.816667,30040,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1768,germany,ulm,48.4,10,120745,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1769,germany,neuburg,49.346667,12.384444,8099,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1770,germany,neuruppin,52.933333,12.8,32173,14,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1771,germany,neustadt an der weinstrasse,49.356667,8.137778,52400,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1772,germany,neusass,48.4,10.833333,21433,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1773,germany,nurnberg,49.447778,11.068333,501072,1773,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1774,germany,offenbach,50.1,8.766667,120641,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1775,germany,oldenburg,53.166667,8.2,160347,1644,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1776,germany,oldenburg,53.166667,8.2,160347,1644,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1777,germany,osnabruck,52.266667,8.05,165372,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1778,germany,osnabruck,52.266667,8.05,165372,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1779,germany,osnabruck,52.266667,8.05,165372,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1780,germany,papenburg,53.066667,7.4,34715,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1781,germany,pforzheim,48.883333,8.7,120366,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1782,germany,potsdam,52.4,13.066667,145291,14,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1783,germany,prien,47.866667,12.333333,10264,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1784,germany,quakenbruck,52.683333,7.95,13170,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1785,germany,querfurt,51.383333,11.6,9436,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1786,germany,ravensburg,47.783333,9.616667,48441,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1787,germany,recklinghausen,51.616667,7.2,122727,17,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1788,germany,regensburg,49.015,12.095556,142292,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1789,germany,remscheid,51.183333,7.2,118230,17,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1790,germany,rostock,54.083333,12.133333,196833,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1791,germany,rudersdorf,52.45,13.783333,17943,14,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1792,germany,sande,53.5,8,9015,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1793,germany,schwalmstadt,50.933333,9.216667,20002,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1794,germany,schwerin,53.633333,11.383333,96329,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1795,germany,siegen,50.866667,8.033333,108228,1655,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1796,germany,singen,47.766667,8.833333,46386,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1797,germany,sinsheim,49.255278,8.877222,35740,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1798,germany,sankt ingbert,49.283333,7.116667,38654,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1799,germany,stade,53.6,9.483333,45419,175,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1800,germany,stadtroda,50.85,11.733333,5849,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1801,germany,stralsund,54.3,13.1,57959,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1802,germany,stuttgart,48.766667,9.183333,591688,1802,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1803,germany,stuttgart,48.766667,9.183333,591688,1803,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1804,germany,stuttgart,48.766667,9.183333,591688,1804,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1805,germany,stuttgart,48.766667,9.183333,591688,1805,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1806,germany,telgte,51.983333,7.783333,19739,1655,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1807,germany,teupitz,52.116667,13.616667,1785,14,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1808,germany,troisdorf,50.816667,7.166667,75641,807,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1809,germany,tubingen,48.533333,9.05,83815,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1810,germany,ulm,48.4,10,120745,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1811,germany,ulm,48.4,10,120745,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1812,germany,unterhaching,48.05,11.633333,20751,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1813,germany,wasserburg,48.066667,12.233333,12539,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1814,germany,wendlingen,48.683333,9.383333,16199,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1815,germany,wermsdorf,51.283333,12.95,5296,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1816,germany,westerstede,53.25,7.933333,22209,1644,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1817,germany,wiesbaden,50.083333,8.25,272337,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1818,germany,wiesbaden,50.083333,8.25,272337,33,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1819,germany,wolfratshausen,47.916667,11.416667,17190,225,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1820,germany,wuppertal,51.266667,7.183333,363240,17,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1821,germany,wuppertal,51.266667,7.183333,363240,17,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1822,germany,wurzburg,49.787778,9.936111,134499,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1823,germany,wurzburg,49.787778,9.936111,134499,0,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1824,germany,zwickau,50.733333,12.5,99343,365,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1825,germany,ohringen,49.201667,9.503889,23068,768,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1826,united states of america,seattle,47.6063889,-122.3308333,569369,1826,NCT02474940,Multiple Sclerosis,All,Behavioral,N/A,30,University of Washington - Ninth and Jefferson Building
1827,united states of america,tucson,32.2216667,-110.9258333,518907,1827,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1828,united states of america,fullerton,33.8702778,-117.9244444,135353,102,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1829,united states of america,la jolla,32.8472222,-117.2733333,42808,0,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1830,united states of america,maitland,28.6275,-81.3633333,11686,0,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1831,united states of america,miami,25.7738889,-80.1938889,382894,0,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1832,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1833,united states of america,farmington hills,42.4852778,-83.3772222,79955,191,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1834,united states of america,golden valley,45.0097222,-93.3488889,20325,0,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1835,united states of america,chesterfield,38.6630556,-90.5769444,47128,0,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1836,united states of america,albuquerque,35.0844444,-106.6505556,487378,1836,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1837,united states of america,new york,40.7141667,-74.0063889,8107916,1837,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1838,united states of america,charlotte,35.2269444,-80.8433333,598351,1838,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1839,united states of america,columbus,39.9611111,-82.9988889,736836,1839,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1840,united states of america,dayton,39.7588889,-84.1916667,159134,0,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1841,united states of america,willow grove,40.1438889,-75.1161111,16129,29,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1842,united states of america,cordova,35.1555556,-89.7761111,78138,2240,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1843,united states of america,round rock,30.5080556,-97.6786111,88653,0,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1844,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1845,united states of america,seattle,47.6063889,-122.3308333,569369,1845,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1846,united states of america,milwaukee,43.0388889,-87.9063889,579180,1846,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1847,canada,calgary,51.083333,-114.083333,968475,1847,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1848,canada,vancouver,49.25,-123.133333,1837970,1848,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1849,canada,montreal,45.5,-73.583333,3268513,1849,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1850,united states of america,kirkland,47.6816667,-122.2075,45778,73,NCT02490943,Multiple Sclerosis,RRMS,Other,Phase 1,28,Evergreen Health
1851,united states of america,portland,45.5236111,-122.675,540513,1851,NCT02340754,Multiple Sclerosis,All,Behavioral,N/A,60,National College of Natural Medicine
1852,united kingdom,glasgow,55.833333,-4.25,610271,1852,NCT02559765,Multiple Sclerosis,Progressive Multiple Sclerosis,Behavioral,N/A,1500,The University of Glasgow
1853,canada,montreal,45.5,-73.583333,3268513,1853,NCT02408380,Multiple Sclerosis,All,Drug,N/A,216,McGill University
1854,united states of america,new haven,41.3080556,-72.9286111,124922,0,NCT02218879,Multiple Sclerosis,RRMS,Drug,N/A,20,Yale University
1855,ireland,limerick,52.6647222,-8.6230556,90054,0,NCT02301442,Multiple Sclerosis,All,Behavioral,N/A,72,Department of Clinical Therapies - University of Limerick
1856,france,paris,48.866667,2.333333,2110694,1856,NCT02305264,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,N/A,65,Pitie Salpetriere Hospital
1857,finland,turku,60.45,22.283333,175944,0,NCT02139696,Multiple Sclerosis,All,Other,N/A,10,Turku University Hospital
1858,switzerland,basel,47.558395,7.573271,164474,0,NCT02142946,Multiple Sclerosis,All,Other,N/A,300,Lab for Exp Otoneurology - University Hospital Basel  
1859,united states of america,birmingham,33.5205556,-86.8025,231621,0,NCT02533882,Multiple Sclerosis,All,Behavioral,N/A,240,Lakeshore Foundation
1860,trinidad and tobago,san fernando,10.2833333,-61.4666667,56379,0,NCT02587715,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,69,Novo Cellular Medicine Institute
1861,switzerland,valens,46.966581,9.477047,400,0,NCT02571335,Multiple Sclerosis,All,Behavioral,N/A,80,Kliniken-Valens
1862,united states of america,new york,40.7141667,-74.0063889,8107916,1862,NCT02446886,Multiple Sclerosis,All,Drug,Phase 4,30,Weill Cornell Medical College
1863,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT02307877,Multiple Sclerosis,All,Drug,Phase 4,120,University of Colorado Hospital
1864,canada,hamilton,43.25,-79.833333,653637,1864,NCT01738347,Multiple Sclerosis,RRMS,Drug,Phase 1,30,St. Joseph Healthcare
1865,united states of america,oakland,37.8044444,-122.2697222,394579,39,NCT02743312,Multiple Sclerosis,All,Device,N/A,5,Samuel Merritt University - Motion Analysis Research Center
1866,czech republic,brno,49.2,16.633333,377407,0,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1867,czech republic,brno,49.2,16.633333,377407,0,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1868,czech republic,ceske budejovice,48.983333,14.466667,97530,0,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1869,czech republic,hradec kralove,50.207744,15.829455,97427,0,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1870,czech republic,jihlava,49.4,15.583333,50818,0,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1871,czech republic,olomouc,49.59404,17.25119,102792,0,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1872,czech republic,ostrava,49.811852,18.255282,317136,0,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1873,czech republic,pardubice,50.027778,15.775833,90853,0,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1874,czech republic,plzen,49.75,13.366667,165531,0,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1875,czech republic,prague,50.083333,14.466667,1154508,1875,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1876,czech republic,prague,50.083333,14.466667,1154508,1876,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1877,czech republic,prague,50.083333,14.466667,1154508,1877,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1878,czech republic,prague,50.083333,14.466667,1154508,1878,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1879,czech republic,teplice,50.646569,13.840138,50972,219,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1880,czech republic,zlin,49.216667,17.666667,81066,0,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1881,mexico,zapopan,20.716667,-103.4,987555,1881,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1882,mexico,monterrey,25.666667,-100.316667,1122912,1882,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1883,mexico,monterrey,25.666667,-100.316667,1122912,1883,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1884,mexico,aguascalientes,21.883333,-102.3,658193,1884,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1885,mexico,estado de mexico,18,-90.890278,16187608,1885,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1886,mexico,mexico,19.434167,-99.138611,8720916,1886,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1887,mexico,mexico,19.434167,-99.138611,8720916,1887,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1888,mexico,mexico,19.434167,-99.138611,8720916,1888,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1889,mexico,mexico,19.434167,-99.138611,8720916,1889,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1890,mexico,mexico,19.434167,-99.138611,8720916,1890,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1891,mexico,puebla,19.05,-98.2,1392137,1891,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1892,united states of america,new york,40.7141667,-74.0063889,8107916,1892,NCT02665221,Multiple Sclerosis,RRMS,Other,Phase 1,40,New York University School of Medicine
1893,united states of america,san francisco,37.775,-122.4183333,732072,1893,NCT02710214,Multiple Sclerosis,All,Drug,Phase 2,24,University of California - San Francisco
1894,united states of america,bethesda,38.9805556,-77.1005556,52801,43,NCT00794352,Multiple Sclerosis,All,Other,N/A,1200,National Institutes of Health Clinical Center - 9000 Rockville Pike
1895,germany,muenster,51.966667,7.633333,302178,1655,NCT02325440,Multiple Sclerosis,RRMS,Drug,Phase 4,15,Universitaetsklinikum Muenster - Department of Neurology
1896,argentina,buenos aires,-34.5875,-58.6725,3050728,1896,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1897,argentina,buenos aires,-34.5875,-58.6725,3050728,1897,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1898,argentina,buenos aires,-34.5875,-58.6725,3050728,1898,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1899,argentina,santiago del estero,-27.795112,-64.261489,407636,1899,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1900,canada,brampton,43.683333,-79.766667,523911,1900,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1901,canada,burnaby,49.25,-122.95,223218,869,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1902,canada,fredericton,45.95,-66.633333,52337,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1903,canada,london,42.983333,-81.25,346774,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1904,czech republic,hradec kralove,50.207744,15.829455,97427,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1905,czech republic,jihlava,49.4,15.583333,50818,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1906,czech republic,olomouc,49.59404,17.25119,102792,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1907,czech republic,ostrava,49.811852,18.255282,317136,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1908,czech republic,prague,50.083333,14.466667,1154508,1908,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1909,czech republic,teplice,50.646569,13.840138,50972,219,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1910,france,agen,44.199912,0.626641,30236,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1911,france,angers,47.473806,-0.54774,158585,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1912,france,bayonne,43.483333,-1.483333,40336,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1913,france,bois-guillaume,49.460197,1.12219,13395,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1914,france,bordeaux,44.840439,-0.5805,219311,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1915,france,caen,49.197188,-0.326822,115358,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1916,france,cahors,44.454598,1.43924,20336,145,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1917,france,cergy,49.036448,2.076133,60288,158,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1918,france,colmar,48.078708,7.355401,66637,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1919,france,dijon,47.316667,5.016667,153692,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1920,france,gonesse,48.986928,2.448922,26212,158,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1921,france,la seyne-sur-mer,43.098184,5.884715,61417,154,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1922,france,le mans,48.000386,0.204709,147413,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1923,france,lille,50.632971,3.058585,189746,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1924,france,limoges,45.831534,1.257805,134549,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1925,france,lisieux,49.147664,0.226625,23100,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1926,france,mantes-la-jolie,48.990163,1.70792,43439,158,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1927,france,marseille,43.285413,5.37606,792823,1927,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1928,france,annecy,45.906206,6.126699,51119,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1929,france,montauban,44.018194,1.364319,52818,145,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1930,france,montbeliard,47.510316,6.798629,26895,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1931,france,montpellier,43.61092,3.87723,238887,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1932,france,montpellier,43.61092,3.87723,238887,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1933,france,nancy,48.69211,6.187756,106857,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1934,france,nimes,43.833778,4.359623,137532,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1935,france,niort,46.323875,-0.461334,56715,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1936,france,nogent-sur-marne,48.838814,2.478642,30453,158,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1937,france,paris,48.866667,2.333333,2110694,1937,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1938,france,paris,48.866667,2.333333,2110694,1938,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1939,france,poitiers,46.583333,0.333333,86639,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1940,france,rambouillet,48.642276,1.831259,25429,158,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1941,france,reims,49.25,4.033333,192688,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1942,france,rennes,48.111981,-1.674291,213334,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1943,france,roanne,46.043291,4.068553,37144,523,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1944,france,rouen,49.433333,1.083333,108101,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1945,france,saint-denis,48.934172,2.354805,84027,158,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1946,france,saint malo,47.312574,3.267809,44620,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1947,france,toulouse,43.599516,1.433188,411145,1947,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1948,france,tourcoing,50.723907,3.161168,93835,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1949,germany,abensberg,48.816667,11.85,12543,225,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1950,germany,altenholz,54.4,10.133333,9721,175,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1951,germany,aschaffenburg,49.973889,9.149167,69248,33,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1952,germany,bad krozingen,47.916272,7.700622,16051,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1953,germany,bamberg,49.866667,10.866667,70471,777,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1954,germany,bayreuth,49.948056,11.578333,74840,777,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1955,germany,berlin,52.516667,13.4,3398362,1955,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1956,germany,bielefeld,52.033333,8.533333,327198,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1957,germany,bochum,51.483333,7.216667,387061,17,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1958,germany,boblingen,48.683333,9.016667,46830,768,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1959,germany,bogen,48.916667,12.683333,10458,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1960,germany,bonn,50.733333,7.1,314081,807,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1961,germany,butzbach,50.433333,8.683333,25804,33,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1962,germany,dresden,51.05,13.75,480801,1962,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1963,germany,eisenach,50.983333,10.316667,44399,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1964,germany,erbach,49.656111,8.996389,13501,33,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1965,germany,essen,51.45,7.016667,576914,1965,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1966,germany,frankfurt,50.116667,8.683333,648034,1966,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1967,germany,freiburg,48,7.85,213920,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1968,germany,gottingen,51.533333,9.933333,123570,1516,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1969,germany,grevenbroich,51.083333,6.583333,64851,16,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1970,germany,halle,51.5,12,232452,365,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1971,germany,hamburg,53.55,10,1733846,1971,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1972,germany,hemmoor,53.7,9.116667,8714,1644,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1973,germany,homburg,49.316667,7.333333,45010,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1974,germany,itzehoe,53.916667,9.516667,33415,175,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1975,germany,jena,50.933333,11.583333,99269,365,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1976,germany,kaltenkirchen,53.833333,9.966667,19161,175,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1977,germany,karlstadt,49.960278,9.772222,15247,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1978,germany,kirchberg,50.616667,12.533333,8429,365,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1979,germany,landshut,48.533333,12.15,61131,225,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1980,germany,lappersdorf,49.056944,12.09,12817,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1981,germany,leipzig,51.3,12.333333,492637,1981,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1982,germany,lengerich,52.183333,7.866667,22642,1655,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1983,germany,lohr,49.993611,9.578333,16297,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1984,germany,mannheim,49.488333,8.464722,309626,33,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1985,germany,muehlhausen,49.166667,11.45,33201,777,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1986,germany,ulm,48.4,10,120745,768,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1987,germany,neuburg,49.346667,12.384444,8099,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1988,germany,neusass,48.4,10.833333,21433,225,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1989,germany,oldenburg,53.166667,8.2,160347,1644,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1990,germany,osnabruck,52.266667,8.05,165372,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1991,germany,ostfildern,48.716667,9.266667,34162,768,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1992,germany,potsdam,52.4,13.066667,145291,14,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1993,germany,quakenbruck,52.683333,7.95,13170,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1994,germany,rosrath,50.9,7.2,27353,807,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1995,germany,singen,47.766667,8.833333,46386,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1996,germany,sinsheim,49.255278,8.877222,35740,768,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1997,germany,stade,53.6,9.483333,45419,175,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1998,germany,stadtroda,50.85,11.733333,5849,365,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1999,germany,stuttgart,48.766667,9.183333,591688,1999,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2000,germany,trier,49.75,6.633333,100649,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2001,germany,ulm,48.4,10,120745,768,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2002,germany,unterhaching,48.05,11.633333,20751,225,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2003,germany,wermsdorf,51.283333,12.95,5296,365,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2004,ireland,dublin,53.3330556,-6.2488889,1024027,2004,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2005,israel,ness ziona,31.926389,34.803333,38100,1105,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2006,israel,holon,32.011389,34.772222,182575,1105,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2007,norway,bergen,60.391111,5.324722,214154,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2008,norway,molde,62.733333,7.183333,18603,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2009,portugal,amadora,38.759711,-9.239708,178856,2011,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2010,portugal,braga,41.550323,-8.420052,121393,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2011,portugal,lisboa,38.716667,-9.133333,2666000,2011,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2012,portugal,porto,41.149606,-8.610993,249630,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2013,portugal,viana do castelo,41.693234,-8.832869,15555,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2014,spain,sant cugat del valles,41.471379,2.081834,65118,30,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2015,spain,terrassa,41.561111,2.008056,187770,30,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2016,spain,pamplona,42.814075,-1.641153,191549,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2017,spain,avila,40.657237,-4.699511,49408,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2018,spain,caceres,39.481877,-6.373222,90938,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2019,spain,girona,41.984444,2.821111,85128,30,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2020,spain,la coruna,43.366609,-8.406812,246056,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2021,spain,madrid,40.408566,-3.69222,3102644,2021,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2022,spain,malaga,36.726666,-4.434802,557875,2022,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2023,spain,palma de mallorca,39.574337,2.655222,401270,2023,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2024,spain,segovia,40.948083,-4.11839,55902,262,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2025,spain,valladolid,41.655181,-4.72372,315859,0,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2026,spain,zaragoza,41.64531,-0.884861,635509,2026,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2027,united states of america,homewood,33.4716667,-86.8008333,23815,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2028,united states of america,gilbert,33.3527778,-111.7883333,170829,81,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2029,united states of america,tucson,32.2216667,-110.9258333,518907,2029,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2030,united states of america,tucson,32.2216667,-110.9258333,518907,2030,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2031,united states of america,berkeley,37.8716667,-122.2716667,100158,39,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2032,united states of america,california city,35.1258333,-117.985,14780,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2033,united states of america,panorama city,34.2247222,-118.4488889,69817,26,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2034,united states of america,centennial,39.5791667,-104.8763889,96930,286,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2035,united states of america,englewood,39.6477778,-104.9872222,32860,286,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2036,united states of america,dover,39.1580556,-75.5247222,33286,29,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2037,united states of america,washington,38.895,-77.0366667,552433,2037,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2038,united states of america,washington,38.895,-77.0366667,552433,2038,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2039,united states of america,delray beach,26.4611111,-80.0730556,65511,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2040,united states of america,sarasota,27.3361111,-82.5308333,53327,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2041,united states of america,saint petersburg,27.7705556,-82.6794444,246316,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2042,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2043,united states of america,atlanta,33.7488889,-84.3880556,422908,2043,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2044,united states of america,flossmoor,41.5427778,-87.6847222,9462,44,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2045,united states of america,peoria,40.6936111,-89.5888889,113004,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2046,united states of america,indianapolis,39.7683333,-86.1580556,773283,2046,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2047,united states of america,iowa city,41.6611111,-91.53,64170,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2048,united states of america,louisville,38.2541667,-85.7594444,243639,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2049,united states of america,scarborough,43.5780556,-70.3222222,27706,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2050,united states of america,boston,42.3583333,-71.0602778,571281,2050,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2051,united states of america,boston,42.3583333,-71.0602778,571281,2051,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2052,united states of america,foxboro,42.0583333,-71.25,16693,45,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2053,united states of america,lexington,42.4472222,-71.225,30661,45,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2054,united states of america,worcester,42.2625,-71.8027778,177216,45,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2055,united states of america,farmington,42.4644444,-83.3763889,9989,191,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2056,united states of america,golden valley,45.0097222,-93.3488889,20325,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2057,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2058,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2059,united states of america,great falls,47.5002778,-111.3,56075,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2060,united states of america,lincoln,40.8,-96.6666667,242072,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2061,united states of america,lebanon,43.6422222,-72.2522222,12853,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2062,united states of america,freehold,40.26,-74.2741667,11558,1,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2063,united states of america,buffalo,42.8863889,-78.8786111,279557,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2064,united states of america,new hyde park,40.735,-73.6883333,9477,1,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2065,united states of america,new york,40.7141667,-74.0063889,8107916,2065,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2066,united states of america,charlotte,35.2269444,-80.8433333,598351,2066,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2067,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2068,united states of america,canton,40.7988889,-81.3786111,78160,51,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2069,united states of america,dayton,39.7588889,-84.1916667,159134,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2070,united states of america,dayton,39.7588889,-84.1916667,159134,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2071,united states of america,oklahoma city,35.4675,-97.5161111,532950,2071,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2072,united states of america,medford,42.3266667,-122.8744444,69638,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2073,united states of america,portland,45.5236111,-122.675,540513,2073,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2074,united states of america,pittsburgh,40.4405556,-79.9961111,319494,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2075,united states of america,port royal,32.3788889,-80.6927778,10678,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2076,united states of america,spartanburg,34.9494444,-81.9322222,37992,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2077,united states of america,knoxville,35.9605556,-83.9208333,172474,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2078,united states of america,houston,29.7630556,-95.3630556,2027712,2078,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2079,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2080,united states of america,richmond,37.5536111,-77.4605556,190886,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2081,united states of america,virginia beach,36.8527778,-75.9783333,449386,2081,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2082,united states of america,tacoma,47.2530556,-122.4430556,196957,73,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2083,united states of america,milwaukee,43.0388889,-87.9063889,579180,2083,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2084,united states of america,neenah,44.1858333,-88.4625,24810,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2085,australia,heidelberg,-37.75,145.066667,5714,200,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2086,denmark,esbjerg,55.470276,8.451869,72206,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2087,denmark,sonderborg,54.910634,9.792843,27033,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2088,germany,aalen,48.833333,10.1,67593,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2089,germany,freiburg,48,7.85,213920,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2090,germany,heidenheim,48.683333,10.15,50684,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2091,germany,ladenburg,49.475,8.606944,11621,33,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2092,germany,mannheim,49.488333,8.464722,309626,33,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2093,germany,pforzheim,48.883333,8.7,120366,768,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2094,germany,stuttgart,48.766667,9.183333,591688,2094,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2095,germany,bamberg,49.866667,10.866667,70471,777,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2096,germany,immenstadt im allgau,47.566667,10.216667,14027,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2097,germany,munich,48.15,11.5833,1246133,2097,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2098,germany,regensburg,49.015,12.095556,142292,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2099,germany,regensburg,49.015,12.095556,142292,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2100,germany,rudersdorf,52.45,13.783333,17943,14,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2101,germany,bad homburg,50.216667,8.616667,51923,33,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2102,germany,butzbach,50.433333,8.683333,25804,33,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2103,germany,frankfurt,50.116667,8.683333,648034,2103,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2104,germany,gelnhausen,50.2,9.183333,21417,33,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2105,germany,kassel,51.316667,9.5,193117,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2106,germany,emden,52.233333,11.266667,49790,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2107,germany,gottingen,51.533333,9.933333,123570,1516,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2108,germany,oldenburg,53.166667,8.2,160347,1644,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2109,germany,sande,53.5,8,9015,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2110,germany,stade,53.6,9.483333,45419,175,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2111,germany,aachen,50.770833,6.105278,251104,16,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2112,germany,dusseldorf,51.216667,6.766667,577139,2112,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2113,germany,essen,51.45,7.016667,576914,2113,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2114,germany,koln,50.933333,6.95,1046680,2114,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2115,germany,remscheid,51.183333,7.2,118230,17,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2116,germany,siegen,50.866667,8.033333,108228,1655,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2117,germany,kandel,49.089167,8.184167,8773,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2118,germany,katzenelnbogen,50.283333,7.95,2161,33,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2119,germany,ludwigshafen,49.481111,8.435278,162514,33,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2120,germany,chemnitz,50.833333,12.916667,246654,365,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2121,germany,leipzig,51.3,12.333333,492637,2121,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2122,germany,leipzig,51.3,12.333333,492637,2122,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2123,germany,itzehoe,53.916667,9.516667,33415,175,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2124,germany,kiel,54.333333,10.133333,235264,175,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2125,germany,altenburg,50.983333,12.45,38338,365,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2126,germany,erfurt,50.983333,11.033333,196719,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2127,germany,jena,50.933333,11.583333,99269,365,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2128,germany,stadtroda,50.85,11.733333,5849,365,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2129,germany,berlin,52.516667,13.4,3398362,2129,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2130,germany,berlin,52.516667,13.4,3398362,2130,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2131,germany,berlin,52.516667,13.4,3398362,2131,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2132,germany,berlin,52.516667,13.4,3398362,2132,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2133,germany,berlin,52.516667,13.4,3398362,2133,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2134,germany,hamburg,53.55,10,1733846,2134,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2135,germany,hamburg,53.55,10,1733846,2135,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2136,ireland,dublin,53.3330556,-6.2488889,1024027,2136,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2137,united kingdom,irvine,55.6,-4.666667,32749,499,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2138,united kingdom,inverness,57.466667,-4.233333,40755,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2139,united kingdom,glasgow,55.833333,-4.25,610271,2139,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2140,united kingdom,swansea,51.633333,-3.966667,170885,0,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2141,united states of america,houston,29.7630556,-95.3630556,2027712,2141,NCT02466074,Multiple Sclerosis,All,Drug,Phase 1-Phase 2,20,UTHealth
2142,france,besancon,47.248778,6.018152,120139,0,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Besançon
2143,france,bordeaux,44.840439,-0.5805,219311,0,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Bordeaux
2144,france,caen,49.197188,-0.326822,115358,0,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Caen
2145,france,lille,50.632971,3.058585,189746,0,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,Chu Lille
2146,france,marseille,43.285413,5.37606,792823,2146,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,Chu La Timone
2147,france,nancy,48.69211,6.187756,106857,0,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Nancy
2148,france,nantes,47.216509,-1.552379,284677,0,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Nantes
2149,france,nice,43.713644,7.25952,341621,0,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Nice
2150,france,nimes,43.833778,4.359623,137532,0,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Nîmes
2151,france,strasbourg,48.600381,7.787355,273506,0,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHRU Strasbourg
2152,germany,munster,51.966667,7.633333,272452,1655,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,Université de Muenter
2153,spain,barcelona,41.398371,2.1741,1570378,2153,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,Hôpital Vall D'Hebron
2154,norway,drammen,59.7425,10.211667,90692,2324,NCT01720849,Multiple Sclerosis,All,Drug,Phase 2,50,Vestre Viken Helseforetak
2155,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT02440126,Multiple Sclerosis,All,Drug,N/A,200,Rocky Mountain MS Research Group
2156,united states of america,columbus,39.9611111,-82.9988889,736836,2156,NCT02717429,Multiple Sclerosis,All,Behavioral,N/A,60,Department of Psychology - The Ohio State University
2157,united states of america,los angeles,34.0522222,-118.2427778,3877129,2157,NCT02740361,Multiple Sclerosis,All,Behavioral,N/A,400,Cedars-Sinai Medical Center
2158,united states of america,kansas city,39.0997222,-94.5783333,442028,2158,NCT02740361,Multiple Sclerosis,All,Behavioral,N/A,400,University of Missouri - Kansas City
2159,united states of america,state college,40.7933333,-77.8602778,41835,0,NCT02740361,Multiple Sclerosis,All,Behavioral,N/A,400,Penn State University
2160,germany,berlin,52.516667,13.4,3398362,2160,NCT02740361,Multiple Sclerosis,All,Behavioral,N/A,400,Charité University
2161,germany,hamburg,53.55,10,1733846,2161,NCT02740361,Multiple Sclerosis,All,Behavioral,N/A,400,Universitätsklinikum Hamburg-Eppendorf
2162,switzerland,basel,47.558395,7.573271,164474,0,NCT02277964,Multiple Sclerosis,RRMS,Drug,Phase 4,40,University Hospital Basel - Switzerland
2163,united states of america,homewood,33.4716667,-86.8008333,23815,0,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2164,united states of america,newport beach,33.6188889,-117.9280556,78702,102,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2165,united states of america,atlanta,33.7488889,-84.3880556,422908,2165,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2166,united states of america,buffalo,42.8863889,-78.8786111,279557,0,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2167,united states of america,patchogue,40.7655556,-73.0155556,12030,0,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2168,united states of america,huntersville,35.4105556,-80.8430556,40342,106,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2169,united states of america,seattle,47.6063889,-122.3308333,569369,2169,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2170,united states of america,milwaukee,43.0388889,-87.9063889,579180,2170,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2171,united states of america,cullman,34.1747222,-86.8436111,14796,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2172,united states of america,phoenix,33.4483333,-112.0733333,1428509,2172,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2173,united states of america,phoenix,33.4483333,-112.0733333,1428509,2173,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2174,united states of america,phoenix,33.4483333,-112.0733333,1428509,2174,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2175,united states of america,los angeles,34.0522222,-118.2427778,3877129,2175,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2176,united states of america,sacramento,38.5816667,-121.4933333,467898,2176,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2177,united states of america,torrance,33.8358333,-118.3397222,144963,102,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2178,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2179,united states of america,denver,39.7391667,-104.9841667,555981,2179,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2180,united states of america,loveland,40.3977778,-105.0744444,59618,286,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2181,united states of america,fairfield,41.1411111,-73.2641667,59052,1,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2182,united states of america,newark,39.6836111,-75.75,30238,29,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2183,united states of america,washington,38.895,-77.0366667,552433,2183,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2184,united states of america,jacksonville,30.3319444,-81.6558333,797557,2184,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2185,united states of america,maitland,28.6275,-81.3633333,11686,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2186,united states of america,ormond beach,29.2855556,-81.0561111,38455,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2187,united states of america,pompano beach,26.2375,-80.125,89715,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2188,united states of america,port charlotte,26.9758333,-82.0908333,49333,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2189,united states of america,sarasota,27.3361111,-82.5308333,53327,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2190,united states of america,sarasota,27.3361111,-82.5308333,53327,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2191,united states of america,tallahassee,30.4380556,-84.2808333,153583,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2192,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2193,united states of america,vero beach,27.6383333,-80.3975,17262,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2194,united states of america,west palm beach,26.715,-80.0536111,93620,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2195,united states of america,atlanta,33.7488889,-84.3880556,422908,2195,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2196,united states of america,elk grove village,42.0038889,-87.9702778,34261,44,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2197,united states of america,evanston,42.0411111,-87.69,75311,44,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2198,united states of america,flossmoor,41.5427778,-87.6847222,9462,44,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2199,united states of america,northbrook,42.1275,-87.8288889,34322,44,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2200,united states of america,indianapolis,39.7683333,-86.1580556,773283,2200,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2201,united states of america,west des moines,41.5772222,-93.7111111,55279,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2202,united states of america,kansas city,39.0997222,-94.5783333,442028,2202,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2203,united states of america,lenexa,38.9536111,-94.7333333,43331,1051,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2204,united states of america,louisville,38.2541667,-85.7594444,243639,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2205,united states of america,new orleans,29.9544444,-90.075,459336,2205,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2206,united states of america,boston,42.3583333,-71.0602778,571281,2206,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2207,united states of america,springfield,42.1013889,-72.5902778,152227,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2208,united states of america,detroit,42.3313889,-83.0458333,884941,2208,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2209,united states of america,grand rapids,42.9633333,-85.6680556,193852,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2210,united states of america,kansas city,39.0997222,-94.5783333,442028,2210,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2211,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2212,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2213,united states of america,great falls,47.5002778,-111.3,56075,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2214,united states of america,las vegas,36.175,-115.1363889,540111,2214,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2215,united states of america,freehold,40.26,-74.2741667,11558,1,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2216,united states of america,newark,40.7355556,-74.1727778,280123,1,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2217,united states of america,teaneck,40.8975,-74.0163889,40078,1,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2218,united states of america,albuquerque,35.0844444,-106.6505556,487378,2218,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2219,united states of america,albuquerque,35.0844444,-106.6505556,487378,2219,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2220,united states of america,amherst,42.9783333,-78.8,37819,744,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2221,united states of america,buffalo,42.8863889,-78.8786111,279557,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2222,united states of america,patchogue,40.7655556,-73.0155556,12030,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2223,united states of america,rochester,44.0216667,-92.4697222,96355,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2224,united states of america,stony brook,40.9255556,-73.1413889,13620,1,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2225,united states of america,syracuse,43.0480556,-76.1477778,141830,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2226,united states of america,chapel hill,35.9130556,-79.0561111,47529,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2227,united states of america,charlotte,35.2269444,-80.8433333,598351,2227,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2228,united states of america,winston-salem,36.0997222,-80.2444444,193300,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2229,united states of america,akron,41.0813889,-81.5191667,208414,51,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2230,united states of america,bellevue,41.2736111,-82.8416667,8202,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2231,united states of america,columbus,39.9611111,-82.9988889,736836,2231,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2232,united states of america,columbus,39.9611111,-82.9988889,736836,2232,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2233,united states of america,dayton,39.7588889,-84.1916667,159134,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2234,united states of america,toledo,41.6638889,-83.5552778,306974,191,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2235,united states of america,oklahoma city,35.4675,-97.5161111,532950,2235,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2236,united states of america,portland,45.5236111,-122.675,540513,2236,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2237,united states of america,philadelphia,39.9522222,-75.1641667,1453268,2237,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2238,united states of america,spartanburg,34.9494444,-81.9322222,37992,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2239,united states of america,knoxville,35.9605556,-83.9208333,172474,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2240,united states of america,memphis,35.1494444,-90.0488889,641608,2240,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2241,united states of america,nashville,36.1658333,-86.7844444,530852,2241,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2242,united states of america,dallas,32.7833333,-96.8,1211704,2242,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2243,united states of america,houston,29.7630556,-95.3630556,2027712,2243,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2244,united states of america,round rock,30.5080556,-97.6786111,88653,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2245,united states of america,san antonio,29.4238889,-98.4933333,1256810,2245,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2246,united states of america,sherman,33.6355556,-96.6086111,37108,53,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2247,united states of america,alexandria,38.8047222,-77.0472222,127273,43,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2248,united states of america,charlottesville,38.0291667,-78.4769444,34703,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2249,united states of america,richmond,37.5536111,-77.4605556,190886,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2250,united states of america,issaquah,47.5302778,-122.0313889,16853,73,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2251,united states of america,seattle,47.6063889,-122.3308333,569369,2251,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2252,united states of america,milwaukee,43.0388889,-87.9063889,579180,2252,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2253,argentina,buenos aires,-34.5875,-58.6725,3050728,2253,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2254,argentina,buenos aires,-34.5875,-58.6725,3050728,2254,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2255,brazil,belo horizonte,-19.916667,-43.933333,2373255,2255,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2256,brazil,porto alegre,-30.033333,-51.2,1372763,2256,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2257,brazil,joinville,-26.3,-48.833333,461312,2257,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2258,brazil,sao paulo,-23.473293,-46.665803,10021437,2258,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2259,brazil,sao paulo,-23.473293,-46.665803,10021437,2259,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2260,brazil,campina grande do sul,-25.3,-49.083333,31112,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2261,brazil,goiania,-16.666667,-49.266667,1171209,2261,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2262,brazil,passo fundo,-28.266667,-52.4,179532,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2263,brazil,rio de janeiro,-22.9,-43.233333,6023742,2263,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2264,canada,edmonton,53.55,-113.5,822319,2264,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2265,canada,burnaby,49.25,-122.95,223218,869,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2266,canada,ottawa,45.416667,-75.7,874433,2266,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2267,canada,chicoutimi,48.433333,-71.066667,66547,0,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2268,canada,montreal,45.5,-73.583333,3268513,2268,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2269,canada,montreal,45.5,-73.583333,3268513,2269,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2270,chile,santiago,-33.45,-70.666667,4837248,2270,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2271,chile,santiago,-33.45,-70.666667,4837248,2271,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2272,mexico,mexico,19.434167,-99.138611,8720916,2272,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2273,mexico,tlalnepantla,19.526944,-99.221667,715798,2273,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2274,mexico,monterrey,25.666667,-100.316667,1122912,2274,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2275,mexico,san luis potosi,22.15,-100.983333,677726,2275,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2276,mexico,aguascalientes,21.883333,-102.3,658193,2276,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2277,mexico,chihuahua,28.633333,-106.083333,708292,2277,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2278,mexico,mexico,19.434167,-99.138611,8720916,2278,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2279,mexico,monterrey,25.666667,-100.316667,1122912,2279,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2280,united states of america,guaynabo,18.3594444,-66.1113889,81363,845,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2281,france,nimes,43.833778,4.359623,137532,0,NCT02664623,Multiple Sclerosis,All,Other,N/A,182,CHRU de Nîmes - Hôpital Universitaire Carémeau
2282,france,ales,44.131126,4.087188,38661,0,NCT02664623,Multiple Sclerosis,All,Other,N/A,182,CH d'Alès
2283,united states of america,new york,40.7141667,-74.0063889,8107916,2283,NCT01900093,Multiple Sclerosis,RRMS,Drug,Phase 2,10,Icahn School of Medicine at Mount Sinai
2284,united states of america,ann arbor,42.2708333,-83.7263889,113810,191,NCT02544373,Multiple Sclerosis,All,Other,N/A,175,University of Michigan Medical Center
2285,united states of america,urbana,40.1105556,-88.2072222,39511,0,NCT02318576,Multiple Sclerosis,All,Other,N/A,30,Motor control research lab
2286,canada,ottawa,45.416667,-75.7,874433,2286,NCT02239393,Multiple Sclerosis,All,Stem Cells,Phase 2,40,Ottawa Hospital - General Campus
2287,canada,winnipeg,49.883333,-97.166667,632069,2287,NCT02239393,Multiple Sclerosis,All,Stem Cells,Phase 2,40,Health Sciences Centre
2288,belgium,gent,51.05,3.716667,231493,1012,NCT02232061,Multiple Sclerosis,All,Drug,Phase 4,40,Novartis Investigative Site
2289,belgium,hasselt,50.933333,5.333333,69222,0,NCT02232061,Multiple Sclerosis,All,Drug,Phase 4,40,Novartis Investigative Site
2290,germany,ravensburg,47.783333,9.616667,48441,0,NCT02232061,Multiple Sclerosis,All,Drug,Phase 4,40,Novartis Investigative Site
2291,germany,trier,49.75,6.633333,100649,0,NCT02232061,Multiple Sclerosis,All,Drug,Phase 4,40,Novartis Investigative Site
2292,italy,naples,40.833333,14.25,981284,2292,NCT02232061,Multiple Sclerosis,All,Drug,Phase 4,40,Novartis Investigative Site
2293,germany,munster,51.966667,7.633333,272452,1655,NCT02419378,Multiple Sclerosis,RRMS,Drug,Phase 4,15,Universitätsklinikum Münster - Klinik für Allgemeine Neurologie
2294,united states of america,seattle,47.6063889,-122.3308333,569369,2294,NCT01800604,Multiple Sclerosis,All,Behavioral,N/A,144,University of Washington - Ninth and Jefferson Building
2295,switzerland,aarau,47.389616,8.052354,15007,0,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2296,switzerland,bern,46.916667,7.466667,123018,0,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2297,switzerland,lugano,46.006182,8.951142,26327,7,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2298,switzerland,luzern,47.083333,8.266667,57269,0,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2299,switzerland,munsterlingen,47.630892,9.234947,3177,0,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2300,switzerland,saint gallen,47.42539,9.377615,75310,0,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2301,switzerland,wohlen,47.352359,8.278768,14163,0,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2302,switzerland,zurich,47.366667,8.55,346185,0,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2303,united states of america,kirkland,47.6816667,-122.2075,45778,73,NCT02736279,Multiple Sclerosis,All,Drug,Phase 4,25,EvergreenHealth MS Center
2304,canada,london,42.983333,-81.25,346774,0,NCT02676739,Multiple Sclerosis,All,Drug,Phase 2-Phase 3,180,London Health Sciences Centre
2305,united kingdom,truro,50.261667,-5.043333,22044,0,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2306,united kingdom,swansea,51.633333,-3.966667,170885,0,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2307,united kingdom,romford,51.583333,0.2,95894,62,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2308,united kingdom,basingstoke,51.266667,-1.083333,96349,0,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2309,united kingdom,edinburgh,55.95,-3.2,435794,2309,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2310,united kingdom,glasgow,55.833333,-4.25,610271,2310,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2311,united kingdom,leicester,52.633333,-1.133333,339240,864,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2312,united kingdom,liverpool,53.416667,-3,468946,2312,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2313,united kingdom,london,51.514125,-0.093689,7421228,2313,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2314,united kingdom,london,51.514125,-0.093689,7421228,2314,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2315,united kingdom,london,51.514125,-0.093689,7421228,2315,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2316,united kingdom,london,51.514125,-0.093689,7421228,2316,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2317,united kingdom,norwich,52.633333,1.3,177636,0,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2318,united kingdom,nottingham,52.966667,-1.166667,246655,124,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2319,norway,drammen,59.7425,10.211667,90692,2324,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2320,norway,haukeland,60.363333,5.451389,1100,0,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2321,norway,lillehammer,61.133333,10.5,19223,0,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2322,norway,strommen,59.95,11,12000,2324,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2323,norway,molde,62.733333,7.183333,18603,0,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2324,norway,oslo,59.916667,10.75,808690,2324,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2325,norway,stavanger,58.966667,5.75,173535,0,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2326,united states of america,baltimore,39.2902778,-76.6125,610892,2326,NCT02506751,Multiple Sclerosis,All,Drug,Phase 1,20,The Johns Hopkins Hospital
2327,france,caen,49.197188,-0.326822,115358,0,NCT02518776,Multiple Sclerosis,All,Behavioral,N/A,80,Department of Neurologie - Caen Hospital University
2328,trinidad and tobago,san fernando,10.2833333,-61.4666667,56379,0,NCT02587806,Multiple Sclerosis,RRMS,Stem Cells,Phase 1-Phase 2,69,Novo Cellular Medicine Institute
2329,united states of america,dallas,32.7833333,-96.8,1211704,2329,NCT02739542,Multiple Sclerosis,All,Drug,Phase 4,210,UT Southwestern Medical Center
2330,belgium,overpelt,51.216667,5.416667,13344,0,NCT02677077,Multiple Sclerosis,RRMS,Drug,Phase 4,300,Biogen Investigative Site
2331,united states of america,cullman,34.1747222,-86.8436111,14796,0,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2332,united states of america,boca raton,26.3583333,-80.0833333,80689,0,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2333,united states of america,new port richey,28.2438889,-82.7194444,17154,0,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2334,united states of america,tampa,27.9472222,-82.4586111,324465,0,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2335,united states of america,fulton,39.1508333,-76.9233333,2049,43,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2336,united states of america,foxboro,42.0583333,-71.25,16693,45,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2337,united states of america,deckerville,43.5266667,-82.7352778,830,0,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2338,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2339,united states of america,stratford,39.8266667,-75.0158333,7040,29,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2340,united states of america,teaneck,40.8975,-74.0163889,40078,1,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2341,united states of america,new york,40.7141667,-74.0063889,8107916,2341,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2342,united states of america,bala-cynwyd,40.0075,-75.2344444,9619,29,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2343,united states of america,lititz,40.1572222,-76.3072222,9029,0,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2344,united states of america,franklin,35.925,-86.8688889,49706,704,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2345,united states of america,memphis,35.1494444,-90.0488889,641608,2345,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2346,united states of america,nashville,36.1658333,-86.7844444,530852,2346,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2347,united states of america,lubbock,33.5777778,-101.8547222,211387,0,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2348,united states of america,round rock,30.5080556,-97.6786111,88653,0,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2349,united states of america,fairfax,38.8461111,-77.3066667,22162,43,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2350,united states of america,portland,45.5236111,-122.675,540513,2350,NCT02263339,Multiple Sclerosis,All,Behavioral,N/A,14,Oregon Health & Science University
2351,united kingdom,leeds,53.8,-1.583333,455124,2351,NCT02641041,Multiple Sclerosis,All,Drug,Phase 1,24,Biogen Research Site
2352,germany,bamberg,49.866667,10.866667,70471,777,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2353,germany,bochum,51.483333,7.216667,387061,17,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2354,germany,bonn,50.733333,7.1,314081,807,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2355,germany,dresden,51.05,13.75,480801,2355,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2356,germany,dusseldorf,51.216667,6.766667,577139,2356,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2357,germany,hanover,52.366667,9.716667,519144,2357,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2358,germany,heidelberg,49.416667,8.7,144703,33,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2359,germany,rostock,54.083333,12.133333,196833,0,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2360,germany,ulm,48.4,10,120745,768,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2361,germany,wermsdorf,51.283333,12.95,5296,365,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2362,switzerland,zurich,47.366667,8.55,346185,0,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2363,germany,berlin,52.516667,13.4,3398362,2363,NCT01647880,Multiple Sclerosis,CIS,Drug,Phase 2-Phase 3,88,Charité-Universitätsmedizin Berlin
2364,germany,potsdam,52.4,13.066667,145291,14,NCT01647880,Multiple Sclerosis,CIS,Drug,Phase 2-Phase 3,88,Sankt Josefs Krankenhaus Potsdam Neurologie
2365,united states of america,dallas,32.7833333,-96.8,1211704,2365,NCT01623076,NMOSD,NMOSD,Other,Phase 1,150,The University of Texas Southwestern Medical Center
2366,china,tianjin,39.142222,117.176667,3766207,2366,NCT02249676,NMOSD,NMOSD,Stem Cells,Phase 2,15,Tianjin Medical University General Hospital
2367,united states of america,baltimore,39.2902778,-76.6125,610892,2367,NCT02276963,NMOSD,NMOSD,Drug,Phase 1,5,Johns Hopkins University School of Medicine
2368,japan,osaka,35.95,137.266667,2668586,2368,NCT01845584,NMOSD,NMOSD,Drug,Phase 2,7,Nihon Investigative Site
2369,united states of america,birmingham,33.5205556,-86.8025,231621,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2370,united states of america,sacramento,38.5816667,-121.4933333,467898,2370,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2371,united states of america,san francisco,37.775,-122.4183333,732072,2371,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2372,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2373,united states of america,maitland,28.6275,-81.3633333,11686,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2374,united states of america,chicago,41.85,-87.65,2841952,2374,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2375,united states of america,kansas city,39.0997222,-94.5783333,442028,2375,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2376,united states of america,baltimore,39.2902778,-76.6125,610892,2376,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2377,united states of america,detroit,42.3313889,-83.0458333,884941,2377,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2378,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2379,united states of america,raleigh,35.7719444,-78.6388889,338759,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2380,united states of america,cleveland,41.4994444,-81.6955556,449514,2380,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2381,united states of america,dallas,32.7833333,-96.8,1211704,2381,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2382,united states of america,houston,29.7630556,-95.3630556,2027712,2382,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2383,australia,melbourne,-37.813938,144.963425,3730212,2383,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2384,bulgaria,sofia,42.6833333,23.3166667,1062065,2384,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2385,bulgaria,varna,43.2166667,27.9166667,307952,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2386,canada,vancouver,49.25,-123.133333,1837970,2386,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2387,canada,montreal,45.5,-73.583333,3268513,2387,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2388,colombia,barranquilla,10.963889,-74.796389,1380437,2388,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2389,colombia,bogota,4.649178,-74.062827,7102602,2389,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2390,colombia,bogota,4.649178,-74.062827,7102602,2390,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2391,colombia,cali,3.437222,-76.5225,2392897,2391,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2392,czech republic,olomouc,49.59404,17.25119,102792,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2393,czech republic,prague,50.083333,14.466667,1154508,2393,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2394,czech republic,teplice,50.646569,13.840138,50972,219,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2395,estonia,tallinn,59.4338889,24.7280556,394023,349,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2396,estonia,tartu,58.3661111,26.7361111,101092,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2397,germany,berlin,52.516667,13.4,3398362,2397,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2398,germany,dresden,51.05,13.75,480801,2398,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2399,germany,dusseldorf,51.216667,6.766667,577139,2399,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2400,germany,leipzig,51.3,12.333333,492637,2400,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2401,germany,marburg,50.816667,8.766667,79300,33,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2402,germany,munster,51.966667,7.633333,272452,1655,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2403,germany,rostock,54.083333,12.133333,196833,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2404,germany,tubingen,48.533333,9.05,83815,768,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2405,hong kong s.a.r.,hong kong,22.2833333,114.15,7234800,2405,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2406,hong kong s.a.r.,hong kong,22.2833333,114.15,7234800,2406,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2407,hong kong s.a.r.,sha tin,22.3833333,114.1833333,630273,2407,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2408,japan,aomori-shi,40.824445,140.74,288029,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2409,japan,kyoto-shi,35.021389,135.755556,1474570,2409,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2410,japan,sendai,31.816667,130.3,73133,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2411,japan,tokyo,35.685,139.751389,31480498,2411,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2412,japan,tsukuba,36.083333,140.116667,175593,2510,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2413,japan,ube,33.943056,131.251111,173735,2517,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2414,south korea,daegu,35.870278,128.591111,2492994,2414,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2415,south korea,seoul,37.5985,126.9783,10323448,2415,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2416,south korea,seoul,37.5985,126.9783,10323448,2416,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2417,south korea,seoul,37.5985,126.9783,10323448,2417,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2418,mexico,mexico,19.434167,-99.138611,8720916,2418,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2419,mexico,mexico,19.434167,-99.138611,8720916,2419,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2420,mexico,monterrey,25.666667,-100.316667,1122912,2420,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2421,mexico,san luis potosi,22.15,-100.983333,677726,2421,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2422,moldova,chisinau,47.005556,28.8575,713805,2422,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2423,new zealand,auckland,-36.866667,174.766667,417910,2423,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2424,new zealand,christchurch,-43.533333,172.633333,363925,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2425,peru,bellavista,-12.0666667,-77.1333333,72761,2426,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2426,peru,lima,-12.05,-77.05,7646786,2426,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2427,poland,katowice,50.258415,19.027545,317316,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2428,poland,krakow,50.083333,19.916667,762508,2428,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2429,poland,lublin,51.25,22.566667,360044,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2430,poland,lodz,51.75,19.466667,715360,2430,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2431,poland,olsztyn,53.779949,20.494162,171803,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2432,poland,warsaw,52.25,21,1651676,2432,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2433,russia,belgorod,50.610743,36.580152,345293,272,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2434,russia,kazan,55.78874,49.122144,1104750,2434,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2435,russia,khabarovsk,48.480833,135.092778,578307,2435,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2436,russia,moscow,55.752222,37.615556,10381288,2436,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2437,russia,nizhniy novgorod,56.326944,44.0075,1284176,2437,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2438,russia,novosibirsk,55.0415,82.9346,1419016,2438,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2439,russia,omsk,55,73.4,1129289,2439,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2440,russia,saint petersburg,59.894444,30.264167,4039751,2440,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2441,russia,ufa,54.785167,56.045621,1033350,2441,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2442,south africa,cape town,-33.925839,18.423218,3433504,2442,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2443,spain,madrid,40.408566,-3.69222,3102644,2443,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2444,taiwan,changhua,24.08,120.5425,235022,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2445,taiwan,hualien,23.9833333,121.6,333392,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2446,taiwan,tainan,22.9933333,120.2036111,734314,2446,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2447,thailand,bangkok,13.753979,100.501444,5104475,2447,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2448,thailand,amphoe ban muang,17.850796,103.569389,67196,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2449,turkey,istanbul,41.018611,28.964722,9797536,2449,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2450,turkey,izmir,38.412726,27.138376,2501895,2450,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2451,turkey,samsun,41.286667,36.33,394261,0,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2452,ukraine,dnipropetrovsk,48.46298,35.039043,979046,2452,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2453,united states of america,scottsdale,33.5091667,-111.8983333,225796,81,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Mayo Clinic Arizona
2454,united states of america,oceanside,33.1958333,-117.3786111,170340,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,The Research Center of Southern California
2455,united states of america,newark,39.6836111,-75.75,30238,29,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Christiana Care Neurology Spec -
2456,united states of america,orlando,28.5380556,-81.3794444,207970,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Neurological Services of Orlando
2457,united states of america,fort wayne,41.1305556,-85.1288889,229715,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Allied Physicians Inc. of Fort Wayne
2458,united states of america,kansas city,39.0997222,-94.5783333,442028,2458,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Kansas Medical Center
2459,united states of america,louisville,38.2541667,-85.7594444,243639,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Community Medical Associates - Inc. -
2460,united states of america,baltimore,39.2902778,-76.6125,610892,2460,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Maryland Medical Center
2461,united states of america,baltimore,39.2902778,-76.6125,610892,2461,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,John Hopkins University School of Medicine
2462,united states of america,rochester,44.0216667,-92.4697222,96355,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Mayo Clinic - Rochester
2463,united states of america,saint louis,38.6272222,-90.1977778,320916,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Washington University School of Medicine
2464,united states of america,new york,40.7141667,-74.0063889,8107916,2464,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Multiple Sclerosis Comprehensive Care Center NYU Langone Medical Center
2465,united states of america,new york,40.7141667,-74.0063889,8107916,2465,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Mount Sinai School of Medicine
2466,united states of america,rochester,44.0216667,-92.4697222,96355,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Rochester Medical Center
2467,united states of america,durham,35.9938889,-78.8988889,204734,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Duke University Health System
2468,united states of america,columbus,39.9611111,-82.9988889,736836,2468,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Ohio Health Reserach Institute
2469,united states of america,columbus,39.9611111,-82.9988889,736836,2469,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Ohio State University Medical Center
2470,united states of america,philadelphia,39.9522222,-75.1641667,1453268,2470,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Pennsylvania School of Medicine
2471,united states of america,pittsburgh,40.4405556,-79.9961111,319494,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Pittsburgh
2472,united states of america,salt lake city,40.7608333,-111.8902778,178026,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Utah
2473,united states of america,seattle,47.6063889,-122.3308333,569369,2473,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Swedish Medical Center
2474,argentina,pilar,-34.457607,-58.913845,299077,310,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario Austral
2475,argentina,rosario,-32.946818,-60.639317,1218497,2475,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Fundacion Rosarina de Neuro Rehabilitacion
2476,argentina,rosario,-32.946818,-60.639317,1218497,2476,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Departamento de Investigaciones Clinicas Sanatorio Norte
2477,argentina,buenos aires,-34.5875,-58.6725,3050728,2477,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,ALPI-Inst. de Rehabilitacion Marcelo Fitte
2478,australia,camperdown,-33.9,151.183333,7866,723,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Brain and Mind Research Institute
2479,australia,liverpool,-33.9,150.933333,24095,723,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Liverpool Hospital
2480,australia,gold coast,-28.00029,153.430878,501175,2480,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Griffith University
2481,australia,fitzroy,-37.783333,144.983333,9430,200,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,St. Vincent's Hospital
2482,austria,graz,47.066667,15.45,222326,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,LKH Graz
2483,austria,innsbruck,47.266667,11.4,112467,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Klinik Innsbruck
2484,canada,ottawa,45.416667,-75.7,874433,2484,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,The Ottawa Hospital
2485,canada,montreal,45.5,-73.583333,3268513,2485,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Montreal Neurological Institute and Hospital
2486,colombia,floridablanca,7.062222,-73.08644,252271,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Fundacion Cardiovascular de Colombia
2487,czech republic,teplice,50.646569,13.840138,50972,219,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Krajska zdravotni - a.s. - Nemocnice
2488,denmark,aarhus,56.153423,10.22553,264716,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Århus Universitetshospital
2489,france,strasbourg,48.600381,7.787355,273506,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,CHU Hautepierre
2490,france,nimes,43.833778,4.359623,137532,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,CHU de Nimes
2491,france,montpellier,43.61092,3.87723,238887,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hôpital Gui de Chauliac
2492,france,bron,45.740218,4.922415,36263,523,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hopital Neurologique Pierre Wertheimer
2493,germany,heidelberg,49.416667,8.7,144703,33,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University Hospital Heidelberg
2494,germany,munich,48.15,11.5833,1246133,2494,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Neurologische Klinik und Poliklinik
2495,germany,regensburg,49.015,12.095556,142292,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University Hospital Regensburg
2496,germany,bochum,51.483333,7.216667,387061,17,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Bochum - Nordrhein Westfalen - Germany - 44791
2497,germany,dusseldorf,51.216667,6.766667,577139,2497,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Dusseldorf - Nordrhein Westfalen - Germany - 40225
2498,germany,berlin,52.516667,13.4,3398362,2498,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Berlin - Germany - 10117
2499,germany,hanover,52.366667,9.716667,519144,2499,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hannover - Germany - 30625
2500,germany,rostock,54.083333,12.133333,196833,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Rostock - Germany - 18147
2501,hong kong s.a.r.,hong kong,22.2833333,114.15,7234800,2501,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Hong Kong - Queen Mary Hospital
2502,hong kong s.a.r.,sha tin,22.3833333,114.1833333,630273,2502,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Prince of Wales Hospital
2503,italy,palermo,38.116667,13.366667,669582,2503,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Fondazione Istituto San Raffaele - G.Giglio di Cefalù
2504,italy,catania,37.5,15.1,307331,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Policlinico di Catania
2505,italy,naples,40.833333,14.25,981284,2505,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Azienda Ospedaliera Universitaria
2506,italy,padova,45.416667,11.883333,205247,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Azienda Ospedaliera di Padova
2507,italy,pavia,45.166667,9.166667,71520,7,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Fondazione Instituto Neurologico Casimiro Mondino
2508,italy,rome,41.9,12.483333,2643736,2508,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Azienda Ospedaliera San Camillo Forlanini
2509,italy,rome,41.9,12.483333,2643736,2509,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Azienda Ospedaliera Sant'Andrea-Università di Roma La Sapienza
2510,japan,chiba-shi,35.604722,140.123334,972861,2510,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Chiba University Hospital
2511,japan,kyoto-shi,35.021389,135.755556,1474570,2511,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Kyoto Min-iren Chuo Hospital
2512,japan,sendai,31.816667,130.3,73133,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Tohoku University Hospital
2513,japan,ginowan,26.26265,127.761472,91801,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,NHO Okinawa National Hospital
2514,japan,tokyo,35.685,139.751389,31480498,2514,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Tokyo Medical and Dental University
2515,japan,tokyo,35.685,139.751389,31480498,2515,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Musashino Red Cross Hospital
2516,japan,ube,33.943056,131.251111,173735,2517,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Yamaguchi University Hospital
2517,japan,fukuoka-shi,33.606389,130.418056,1483052,2517,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Kyushu University Hospital
2518,japan,nagasaki,34.338333,133.14,446007,2518,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,NHO Nagasaki Kawatana Medical Center
2519,japan,niigata,37.902222,139.023611,505276,2519,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Niigata University Medical & Dental Hospital
2520,south korea,seoul,37.5985,126.9783,10323448,2520,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,National Cancer Center
2521,south korea,seoul,37.5985,126.9783,10323448,2521,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Korea University Anam Hospital
2522,south korea,seoul,37.5985,126.9783,10323448,2522,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Samsung Medical Center
2523,south korea,seoul,37.5985,126.9783,10323448,2523,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Seoul University National Hospital
2524,south korea,seoul,37.5985,126.9783,10323448,2524,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Severance Hospital - Yonsei University
2525,south korea,seoul,37.5985,126.9783,10323448,2525,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Asan Medical Center
2526,russia,kazan,55.78874,49.122144,1104750,2526,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Republican Clinical Hospital for Rehabilitation of Healthcare Ministry of Republic of Tatarstan
2527,russia,krasnoyarsk,56.0091,92.8628,907460,2527,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,"SBEI ""Krasnoyarsk SMU n.a. Prof. V.F. Voyno-Yasenetsky"""
2528,russia,moscow,55.752222,37.615556,10381288,2528,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,"State Healthcare Institution of city of Moscow ""City Clinical Hospital #11"""
2529,russia,novosibirsk,55.0415,82.9346,1419016,2529,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Federal State Budget Institution of Healthcare - Siberian District Medical Center of FMBA of Russia
2530,russia,rostov-on-don,47.23135,39.723284,1089261,2530,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,"SEIHPE ""Rostov SMU of MoH of RF"""
2531,russia,saint petersburg,59.894444,30.264167,4039751,2531,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,First Pavlov State Medical University of St.Petersburg
2532,russia,saint petersburg,59.894444,30.264167,4039751,2532,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,"Saint-Petersburg SHI ""City Clinical Hospital #31"""
2533,singapore,singapore,1.2930556,103.8558333,3547809,2533,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,National University Hospital
2534,singapore,singapore,1.2930556,103.8558333,3547809,2534,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,National Neuroscience Institute
2535,spain,zaragoza,41.64531,-0.884861,635509,2535,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario Miguel Servet
2536,spain,bilboa,43.260919,-2.938764,345141,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital de Cruces
2537,spain,cordoba,37.89155,-4.772748,311186,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario Reina Sofia
2538,spain,madrid,40.408566,-3.69222,3102644,2538,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario de la Princesa
2539,spain,madrid,40.408566,-3.69222,3102644,2539,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario Clinico San Carlos
2540,spain,sevilla,37.382408,-5.976133,686647,2540,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario Virgen Macarena
2541,taiwan,taipei,25.0391667,121.525,2514794,2541,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Cheng Hsin General Hospital
2542,taiwan,taipei,25.0391667,121.525,2514794,2542,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,National Taiwan University Hospital
2543,turkey,ankara,39.911652,32.840305,3519177,2543,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hacettepe University Medical Faculty
2544,turkey,edirne,41.675745,26.558665,126535,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Trakya University Medical Faculty
2545,turkey,istanbul,41.018611,28.964722,9797536,2545,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Istanbul Bilim Universty Medical Fac.
2546,turkey,istanbul,41.018611,28.964722,9797536,2546,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Istanbul University Cerrahpasa Medical Faculty
2547,turkey,istanbul,41.018611,28.964722,9797536,2547,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Istanbul University Istanbul Medical Faculty
2548,turkey,izmir,38.412726,27.138376,2501895,2548,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Dokuz Eylul University Medicine Faculty
2549,turkey,kocaeli,40.766944,29.916944,196672,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Kocaeli University Medical Faculty
2550,turkey,samsun,41.286667,36.33,394261,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Ondokuz Mayis Univ. Med. Fac.
2551,turkey,trabzon,41.005,39.726944,244209,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Karadeniz Tecnical Uni. Med. Fac.
2552,united kingdom,liverpool,53.416667,-3,468946,2552,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,The Walton Centre
2553,united kingdom,london,51.514125,-0.093689,7421228,2553,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Royal Free Hospital
2554,united kingdom,oxford,51.75,-1.25,154567,0,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,John Radcliffe Hospital
2555,united states of america,chicago,41.85,-87.65,2841952,2555,NCT00787722,NMOSD,NMOSD,Stem Cells,Phase 1,10,Northwestern University - Feinberg School of Medicine
2556,spain,barcelona,41.398371,2.1741,1570378,2556,NCT02283671,Multiple Sclerosis,All,Drug,Phase 1,12,Hospital Clinic of Barcelona
2557,japan,osaka,35.95,137.266667,2668586,2557,NCT02028884,NMOSD,NMOSD,Drug,Phase 3,70,Chugai Investigative Site
2558,united states of america,orange,33.7877778,-117.8522222,133874,102,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,UC Irvine Institute for Clinical and Translational Science
2559,united states of america,sacramento,38.5816667,-121.4933333,467898,2559,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,UC Davis Medical Center
2560,united states of america,aurora,39.7294444,-104.8313889,299780,286,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Colorado Denver
2561,united states of america,washington,38.895,-77.0366667,552433,2561,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,The George Washington University Medical Faculty Associates
2562,united states of america,miami,25.7738889,-80.1938889,382894,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Neurology Associate Group
2563,united states of america,miami,25.7738889,-80.1938889,382894,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,JDH Medical Group
2564,united states of america,miami,25.7738889,-80.1938889,382894,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Miami
2565,united states of america,sarasota,27.3361111,-82.5308333,53327,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Negroski - Sutherland & Hanes Neurology - LLP
2566,united states of america,vero beach,27.6383333,-80.3975,17262,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Vero Neurology
2567,united states of america,columbus,39.9611111,-82.9988889,736836,2567,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Columbus Research & Wellness Clinic
2568,united states of america,chicago,41.85,-87.65,2841952,2568,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Northwestern University
2569,united states of america,chicago,41.85,-87.65,2841952,2569,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Chicago Medical Center
2570,united states of america,northbrook,42.1275,-87.8288889,34322,44,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Consultants in Neurology - Ltd.
2571,united states of america,peoria,40.6936111,-89.5888889,113004,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Illinois College of Medicine / Illinois Neurologic Institute
2572,united states of america,kansas city,39.0997222,-94.5783333,442028,2572,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Kansas Medical Center
2573,united states of america,lenexa,38.9536111,-94.7333333,43331,1051,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Rowe Neurology Institute
2574,united states of america,baltimore,39.2902778,-76.6125,610892,2574,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,The Johns Hopkins Hospital
2575,united states of america,ann arbor,42.2708333,-83.7263889,113810,191,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Michigan
2576,united states of america,detroit,42.3313889,-83.0458333,884941,2576,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Wayne State University
2577,united states of america,new york,40.7141667,-74.0063889,8107916,2577,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,New York Eye and Ear Infirmary of Mount Sinai
2578,united states of america,new york,40.7141667,-74.0063889,8107916,2578,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Weill Cornell Medical College
2579,united states of america,patchogue,40.7655556,-73.0155556,12030,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,South Shore Neurologic Associates
2580,united states of america,rochester,44.0216667,-92.4697222,96355,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Rochester Multiple Sclerosis Ct / Strong Neurology
2581,united states of america,chapel hill,35.9130556,-79.0561111,47529,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of North Carolina at Chapel Hill
2582,united states of america,charlotte,35.2269444,-80.8433333,598351,2582,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,The Neurological Institute
2583,united states of america,cincinnati,39.1619444,-84.4569444,306382,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Cincinnati
2584,united states of america,columbus,39.9611111,-82.9988889,736836,2584,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Ohio Health Neurological Physicians
2585,united states of america,oklahoma city,35.4675,-97.5161111,532950,2585,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,OMRF Multiple Sclerosis Center of Excellence
2586,united states of america,tualatin,45.3841667,-122.7627778,26476,95,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Legacy Health Systems / Oregon Neurology - PC
2587,united states of america,philadelphia,39.9522222,-75.1641667,1453268,2587,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Thomas Jefferson University - The Comprehensive MS Center
2588,united states of america,dallas,32.7833333,-96.8,1211704,2588,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Texas Southwestern Medical School
2589,united states of america,round rock,30.5080556,-97.6786111,88653,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Central Texas Neurology Consultants
2590,united states of america,san antonio,29.4238889,-98.4933333,1256810,2590,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,UT Medicine San Antonio
2591,united states of america,richmond,37.5536111,-77.4605556,190886,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Virginia Commonwealth University - Medical Center
2592,united states of america,milwaukee,43.0388889,-87.9063889,579180,2592,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Wheaton Franciscan Healthcare
2593,canada,vancouver,49.25,-123.133333,1837970,2593,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of British Columbia
2594,canada,kingston,44.233333,-76.483333,114243,0,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Kingston General Hospital
2595,canada,greenfield park,45.5,-73.483333,16969,747,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Recherche Sepmus - Inc
2596,canada,montreal,45.5,-73.583333,3268513,2596,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,CHUM-Hôpital Notre-Dame
2597,united states of america,guaynabo,18.3594444,-66.1113889,81363,845,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Caribbean Neurological Center Centro Internacional de Mercadeo
2598,germany,freiburg,48,7.85,213920,0,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Medical Center - University of Freiburg - Eye Hospital
2599,germany,heidelberg,49.416667,8.7,144703,33,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Heidelberg University Hospital - Department of Neurooncology
2600,germany,tubingen,48.533333,9.05,83815,768,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Tuebingen University Hospital
2601,germany,erlangen,49.589722,11.003889,102781,777,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Hospital Erlangen
2602,germany,munich,48.15,11.5833,1246133,2602,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Hospital of Munich
2603,germany,munich,48.15,11.5833,1246133,2603,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Hospital Klinikum rechts der Isar - Munich
2604,germany,gottingen,51.533333,9.933333,123570,1516,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Medical Center Goettingen
2605,germany,hanover,52.366667,9.716667,519144,2605,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Hannover Medical School
2606,germany,dusseldorf,51.216667,6.766667,577139,2606,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Duesseldorf University Hospital
2607,germany,essen,51.45,7.016667,576914,2607,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Essen University Hospital
2608,germany,mainz,50,8.271111,187940,33,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Medical Center of the Johannes Gutenberg University Mainz
2609,germany,berlin,52.516667,13.4,3398362,2609,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Charité Berlin
2610,germany,hamburg,53.55,10,1733846,2610,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Medical Center Hamburg-Eppendorf
2611,united states of america,portland,45.5236111,-122.675,540513,2611,NCT01294176,NMOSD,NMOSD,Drug,Phase 1,54,Oregon Health & Science University
2612,austria,vienna,48.2,16.366667,1569315,2612,NCT01879527,NMOSD,NMOSD,Drug,Phase 2,78,Medical University of Vienna - Department of Neurology
